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ABSTRACT 
The cell cycle is the process of tightly integrated events leading to cell growth, DNA 
replication and cell division. Cell cycle dysregulation is the common reason for abnormal 
cell growth (cancer) and therefore, scientists are interested in determining the proportion 
of cells in each cell cycle phase for effective targeting of cancerous cells at a specific 
phase. 
Knowledge of cells’ electrophysiological properties can provide new insights in cell cycle 
events studies. Dielectrophoresis (DEP) is a technique that can be used to obtain these 
properties for cell characterisation. DEP is a fast, label-free, high-throughput, and cost-
effective micro-engineered technology that reduces the sample volume and provides 
automated real-time analysis. 
This thesis explores the application of the DEP-microwell electrode system (both the 
serial design and the parallel integrated system) in cell cycle analysis. It also investigates 
the variation of cellular electrophysiological properties (particularly the effective 
membrane capacitance (ceff), the effective membrane conductance (geff) and the 
cytoplasmic conductivity (σ𝐶𝑃)) during different phases through the cell cycle, in vitro. In 
addition, this work assesses the relation between the intracellular DNA percentage in each 
phase and the acquired DEP data to find out the possible correlation between cell cycle 
phases and cellular electrophysiological properties. 
For the purpose of having the cells at different stages of the cycle, a K562 cell line was 
synchronised at G0/G1, late G1/S and early S-phase, using serum starvation (SS), 
hydroxyurea (HU) and aphidicolin (APH). DEP measurements were carried out for cells 
before treatment (control cells), immediately after treatment (0h-study) and at 2, 4 and 24 
hours after releasing the cells back to the culture medium for each synchronisation 
method. Due to improved time resolution and frequency range in the parallel design of 
DEP-microwell electrode, acquired results of this method showed more accurate data. 
The obtained results demonstrated significant difference of electrophysiological 
properties through different phases of K562 cell cycle. Using the parallel design: 
- σ𝐶𝑃 at 0h-study: σ𝐶𝑃 (SS) greater than σ𝐶𝑃 (HU) and σ𝐶𝑃 (APH) by ~50% and 
~60%, respectively 
- geff at 0h-study: geff (HU) greater than geff (APH) and geff (SS) by ~90% and 
~65%, respectively 
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- ceff at 0h-study: ceff (HU) ≈ ceff (APH), both greater than ceff (SS) by ~22% 
In summary, results showed that a rising pattern for cell radii, a downward followed by an 
upward trend in σ𝐶𝑃 values, a falling followed by a rising pattern for ceff value, and a 
rising pattern for geff values were observed during the cell cycle. Furthermore, the change 
of these electrophysiological properties correlated with the proposed trends at different 
phases of the cell cycle. This suggests that the DEP-microwell electrode system can be 
used as an innovative, real-time, portable, cost-effective and high-throughput approach 
for cell characterisation at particular stages of the cell cycle. 
 
 
 
 
 
 
 
 
 
 
 
ACKNOWLEDGEMENTS 
Many people contributed to this project in innumerable ways and I am grateful to all of 
them. 
First and foremost, I would like to sincerely thank my principal supervisor, Dr Fatima 
Labeed and co-supervisor, Prof Michael Hughes for their support, academic advice and 
criticism in the preparation of this manuscript. I also gratefully acknowledge Dr Rita Jabr 
and Dr George Kass for their kind assistance, advice and contribution. 
My deepest appreciation is also expressed to my loving husband, Ali, for his endless love, 
moral support, patience, motivation and scientific comments which has taken the load off 
my shoulder. His support has been immeasurable and without it I would have never 
iii 
 
reached the end. Special thanks go to my family members, particularly my parents, for 
their invaluable encouragements, prayers and always believing in me. 
Sincere thanks are also extended to Dr Hayley Mulhall for her generous contribution, 
precious suggestions, constructive comments, technical recommendations, support and 
time. 
Many thanks go to the bio-imaging and flow cytometry support team, especially Dr 
Rachel Butler, for giving me the opportunity to work on the core facilities in the group 
and the technical assistances. 
I would like to gratefully thank the Postgraduate Skills Development Programme 
(PGSDP) staff in the University of Surrey, particularly Dr Dawn Duke, for their 
motivating workshops and kind support. Many thanks for being there from the very 
beginning. 
I would also like to thank all of my beloved friends for their encouragement and my 
fellow postgraduate students and staff in the Centre for Biomedical Engineering, 
University of Surrey. The group has been a source of friendships as well as good advice, 
collaboration and kind help.  
Finally, I would like to thank everybody who was important to this project, as well as 
expressing my apology that I could not mention personally one by one. 
 
STATEMENT OF ORIGINALITY 
"This thesis and the work to which it refers are the results of my own efforts. Any ideas, 
data, images or text resulting from the work of others (whether published or unpublished) 
are fully identified as such within the work and attributed to their originator in the text, 
bibliography or in footnotes. This thesis has not been submitted in whole or in part for 
any other academic degree or professional qualification. I agree that the University has 
the right to submit my work to the plagiarism detection service TurnitinUK for originality 
checks. Whether or not drafts have been so-assessed, the University reserves the right to 
require an electronic version of the final document (as submitted) for assessment as 
above." 
 
Nafiseh Naeemikhondabi 
iv 
 
July 2015 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOMENCLATURE 
Variables and constants 
∇   Gradient operator 
𝜀I  Real permittivity of the material                 [F · m
−1
] 
εm  Real permittivity of suspending medium                [F · m
−1
] 
εp  Real permittivity of the particle                 [F · m
−1
] 
𝜀𝑚
∗    Complex permittivity of the suspending medium               [F · m
−1
] 
𝜀𝑝
∗   Complex permittivity of the particle                [F · m
−1
] 
E  Amplitude (rms) of applied electric field      
σ  Electrical conductivity                                             [S · m−1] 
σCP  Cytoplasmic conductivity                 [S · m
−1
] 
σi  Real conductivity of the material                [S · m
−1
] 
τMW  “Maxwell-Wagner” charge relaxation time        [Sec] 
Im[K(ω)] Imaginary part of Clausius-Mossotti factor (polarisation factor) 
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Re[K(ω)] Real part of Clausius-Mossotti factor (polarisation factor) 
geff   Effective membrane conductance                 [S · m
−2
] 
ceff  Effective membrane capacitance                [F · m
−2
] 
fxo   Crossover frequency            [Hz] 
∅   Membrane folding factor 
ω  Angular frequency of applied electric field                     [Rad · Sec−1] 
 
Abbreviations and acronyms 
ANOVA Analysis of Variance 
APH  Aphidicolin 
BME  BioMedical Engineering 
Cdk  Cyclin-dependent kinase 
CdkI  Cyclin dependent kinase Inhibitors 
CM  Real part of Clausius-Mossotti factor 
CML  Chronic Myelogenous Leukaemia 
ceff  Effective membrane capacitance 
DACSync  Dielectrophoresis Activated Cell Synchroniser 
DEP  Dielectrophoresis 
DI water De-Ionised water 
DMEM  Dulbecco‘s Modified Eagles Medium 
DMSO  DiMethyl SulfOxide 
DNA  DeoxyriboNucleic Acid 
dNTP  DeoxyNucleotide TriPhosphate 
EO  ElectroOrientation 
FACS  Fluorescent Activated Cell Sorting 
FBS  Foetal Bovine Serum 
fxo  Crossover frequency 
FCM  Flow CytoMetry 
FDEP  Dielectrophoretic Force 
FSC  Forward angle SCattered (fluorescent light) 
geff  Effective membrane conductance 
HU  Hydroxyurea 
Hz  Hertz 
LASER  Light Amplification by Stimulated Emission of Radiation 
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n-DEP  Negative Dielectrophoresis 
PBS  Phosphate Buffered Saline 
p-DEP  Positive Dielectrophoresis 
PI  Propidium Iodide 
RF  Radio Frequency 
RNA  RiboNucleicAcid 
RNaseA Ribonuclease A 
RNR  RiboNucleotide Reductase 
rms  Root Mean Square 
ROT   Electrorotation 
RPMI  Roswell Park Memorial Institute medium 
SD  Standard Deviation 
SEM  Scanning Electron Microscopy 
SS  Serum Starvation 
SSC  Side angle SCattered (fluorescent light) 
twDEP  travelling wave DEP 
Vp-p  Peak-to-Peak Voltage 
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1 INTRODUCTION 
1.1 CELL CYCLE  
The building block of life is known as the cell which is composed of several 
organelles required for cell function, all embedded in a cytoplasm and enclosed by a 
cell membrane. It has all the essential properties that characterise life, including the 
capability to reproduce itself [1-3]. A cell is the smallest self-reproducing unit that is 
able to complete the construction of a new cell with a new duplicate of the heredity 
information.  
The “cell cycle” represents a chain of orderly processes and tightly integrated events, 
in which the cell grows, duplicates its genome contents (mitosis) and divides into two 
genetically identical daughter cells (cytokinesis), each of which will receive a copy of 
the intact genome [2, 4-7]. 
Cell cycle dysregulation and malfunction of checkpoints are the most common 
reasons for proliferation of potentially damaged cells which often result in abnormal 
cancer cell growth and tumour progression [4, 8-10]. Due to the loss of checkpoint 
integrity, tumour cells are unable to stop at predetermined points of the cycle. This 
can be due to abnormal activation or overexpression of Cyclin-dependent kinases 
(Cdks) or inactivation of their inhibitors (CdkIs) [4, 9, 10]. 
As such, cancer can be considered a cell cycle disease and scientists are interested in 
cell division events to help improve cancer therapy [4, 9, 10]. Understanding the 
molecular mechanisms of cell cycle dysregulation in cancer can potentially provide 
major insights into how normal cells become tumorigenic and how new cancer 
treatment methods can be developed [4, 5, 9-11]. Besides, determining the proportion 
of cells in each phase is valuable for targeting cancerous cells, as many anti-cancer 
drugs are most effective when used at a specific phase (typically cells in the S-phase) 
[12, 13]. 
Determining the proportion of cells in each phase can also be helpful in the 
evaluation of cell population growth potential.  For instance, tumour progression is 
usually related to the percentage of cells in the S-phase. Generally, a higher 
percentage of cells in the S-phase indicate a rapidly growing tumour [13]. 
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1.2 DIELECTROPHORESIS 
A new way of examining the cells is to examine them as electrical, rather than 
chemical objects. Dielectric studies and measurements can help to understand 
fundamental biological processes and obtain information about tissue compositions 
and structures such as presence of a tumour [14]. Knowledge of these 
electrophysiological properties, especially through the cell cycle, can potentially 
provide new insights in cancer studies, reveal differences between cancerous and 
normal cells and provide helpful information on diseased and non-diseased cells [14-
17]. 
For the purpose of dielectric studies, a phenomenon called dielectrophoresis (DEP) 
has been gaining interest for more than half a century. This technique can be used to 
manipulate, characterise and sort cells suspended in a fluidic medium based on their 
cellular electrophysiological properties [18, 19]. To characterise cells 
electrophysiological properties using DEP, the direction and strength of the DEP 
force is measured over a wide range of frequency [20]. Then, by fitting the cells 
mathematical model to the acquired DEP spectrum, the cells’ electrophysiological 
properties can be extracted [20]. Types of particles reflected to have 
dielectrophoretic effects include viruses, DNA and RNA molecules, mammalian, 
cancerous and stem cells [18-21]. 
This promising technique is potentially capable of eliminating the use of chemical 
labelling with stains and antibodies or any other type of cell alteration [21]. DEP is a 
portable, contactless and cost-effective technique, which reduces the sample volume 
and provides automated and real time analysis. It also does not require highly 
experienced operators to obtain the acceptable performance [18, 21, 22].  
1.3 THESIS AIMS 
This thesis explores the application of the DEP-microwell electrode system (both the 
serial design (as a prototype) and the parallel integrated system (which was 
developed during the course of this study)) in cell cycle analysis by using the 
modified DEP buffer with ions. This technique was developed and patented at the 
University of Surrey and has been applied for the first time in this research to 
characterise the electrophysiological properties of cells in two cell cycle phases. 
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The first aim of this research was to determine whether the DEP-microwell electrode 
system can be applied as a real time, fast, cost-effective, automated and label-free 
method to study electrophysiological properties of cells through their cell cycle. The 
second aim was to investigate whether the cellular electrophysiological properties 
(particularly the effective membrane capacitance (ceff), the effective membrane 
conductance (geff) and the cytoplasmic conductivity (σ𝐶𝑃)) vary between different 
phases through the cell cycle, in vitro. Finally, it aimed to assess the relation between 
the intracellular DNA percentage in each phase and the acquired DEP data to find 
out the possible correlation between cell cycle phases and cellular 
electrophysiological properties. 
In order to meet the aims of this thesis, the serial design and the parallel integrated 
DEP-microwell electrode (as an optimised system) were applied to obtain the 
dielectric spectra of a chronic myelogenous leukaemia cell line (K562) throughout 
the cell cycle and to characterise the cells in terms of their cellular 
electrophysiological properties. A single-shell model was used to determine these 
cell properties from the achieved DEP spectra. 
For the purpose of having the cells at different stages of the cycle, cells were 
synchronised at three main cell cycle checkpoints, G0/G1, late G1/S and early S-
phase, using serum starvation (SS), hydroxyurea (HU) and aphidicolin (APH), 
respectively [23-27]. In order to validate the obtained cell synchronisation results and 
to find out the possible correlation between cell cycle phases and cellular 
electrophysiological properties, flow cytometry was applied to determine cell cycle 
distributions by quantitation of intracellular DNA content of the cells.  
1.4 THESIS STRUCTURE AND OUTLINE 
The thesis begins with a review of the literature (Chapter 2), the first part of which 
focuses on cell cycle. It describes the topics related to the cell cycle and cell division 
stages, cell cycle checkpoints and cancer studies, methods in synchronising the cell 
cycle and a quick review of flow cytometry as a conventional cell assay technique. 
The second part of this chapter examines dielectrophoresis technique in detail. It 
describes the theoretical background of DEP, electrophysiological properties of cells 
and the DEP applications in cell cycle studies. 
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Chapter 3 conducts a study on the application of the serial design of the DEP-
microwell electrode system in analysis of cells’ electrophysiological properties 
through their cell cycle. It aims to investigate whether the cellular 
electrophysiological properties (particularly the effective membrane capacitance, the 
effective membrane conductance and the cytoplasmic conductivity) vary between 
different phases through the cell cycle. For the purpose of having the cells at 
different phases of the cycle, K562 cells were synchronised at two main cell cycle 
checkpoints, G0/G1 and G1/S, using serum starvation and hydroxyurea cell treatment 
methods, respectively. 
Chapter 4 continues with a further investigation of the cellular electrophysiological 
properties of K562 cells synchronised at three main cell cycle checkpoints and 
verifying the obtained results from the previous chapter using the parallel integrated 
DEP-microwell system as an optimised technique, in vitro. In order to have the cells 
at different stages of the cycle, cells were synchronised at three main cell cycle 
checkpoints, G0/G1, late G1/S and early S-phase, using serum starvation, hydroxyurea 
and aphidicolin cell treatment methods, respectively.  
The first part of Chapter 5 describes the proportion of cells in each cell cycle phase 
using flow cytometry (FCM) in order to validate the obtained cell synchronisation 
results. To assess the possible correlation between the cell cycle phases and cellular 
electrophysiological properties in more detail, the second part of this chapter uses an 
algorithm for the simultaneous analysis of the acquired cell radii, DEP and FCM data 
from chapters 4 and 5. 
Finally, Chapter 6 summarises the key findings from this research and draws general 
conclusions. It will also outline further work required and future recommendations. 
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2 A REVIEW OF THE LITERATURE  
2.1 INTRODUCTION 
This chapter explains the background knowledge associated with the main theme of 
this research. This research presents the application of two DEP-microwell electrode 
systems (the serial design and the parallel integrated system) in cell cycle analysis. 
This micro-engineered technique, developed and patented at the University of 
Surrey, had been applied for the first time in this thesis to characterise the 
electrophysiological properties of cells in two cell cycle phases. 
The first part of the background review focuses on the cell cycle. It describes the 
topics related to the cell cycle and cell division stages, cell cycle checkpoints and 
cancer studies, methods in synchronising the cell cycle and a quick review of flow 
cytometry as a conventional cell assay technique. The second part of this chapter 
describes dielectrophoresis technique in detail including theoretical background of 
DEP, electrophysiological properties of cells and the DEP applications in cell cycle 
studies. 
2.2 THE CELL CYCLE 
The building block of life, which distinguishes living things from non-living ones, is 
known as the cell. Each cell is composed of several organelles required for cell 
function, all embedded in a cytoplasm and enclosed by a cell membrane. It has all the 
essential properties that characterise life, including the capability to reproduce itself 
[1-3]. A cell is the smallest self-reproducing unit that is able to complete the 
construction of a new cell with a new duplicate of the heredity information. The 
structure and function of a cell is imprinted in an inheritable unit called 
deoxyribonucleic acid (DNA) which is in the form of a double helical molecule 
(Figure 2.1).  
DNA carries the genetic (hereditary) information of a cell. This information, which 
is kept in each cell as its genes, must be flawlessly replicated and transmitted from a 
parent cell to its daughter cells during cell division [1-3].  
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Figure 2.1. A schematic diagram of DeoxyriboNucleic Acid (DNA); a double helical molecule 
A DNA molecule consists of two long twisted polynucleotide chains and is in the form of double helical molecule. 
Each nucleotide contains one base, one phosphate molecule and the sugar molecule deoxyribose. The bases in 
DNA nucleotides are Cytosine, Guanine, Adenine and Thymine (Taken from [1]) 
2.2.1 Cell division 
In the human body, two essential processes known as cell proliferation and 
programmed cell death (apoptosis) control the number of cells. Any imbalance 
between these two main processes can lead to undesirable tissue atrophy or growth 
[2, 4, 5]. In order to proliferate and make a new cell, the existing cell must replicate 
and generate a precise copy of its genome (heredity information encoded in the 
DNA). At that point, the duplicated genomes must divide between the two growing 
daughter cells equally. In the end, during a division procedure the two daughter cells 
will separate [2, 4, 5]. 
The concept of the cell cycle, first introduced by Howard and Pelc in 1953, 
represents a chain of orderly processes of tightly integrated events, in which the cell 
grows, duplicates its genome contents (DNA synthesis) and divides into two 
genetically identical daughter cells (cytokinesis). Thus, each of which will receive a 
copy of the intact genome (Figure 2.2) [2, 4-7].  
       
Figure 2.2. A schematic diagram of the cell cycle  
A schematic diagram of the cell cycle is shown in this figure. The cell cycle represents a chain of orderly 
processes of tightly integrated events, in which (1) the cell grows, (2) duplicates its genome contents (mitosis) 
and (3) divides into two genetically identical daughter cells (cytokinesis) (Taken from [1]) 
1 
2 
3 
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Four coordinated sequences of events form most of the cell cycle: cell growth, DNA 
duplication, distribution (segregation) of the replicated chromosome to new daughter 
cells and cell division [1, 2, 5]. 
2.2.2 Cell cycle stages 
Microscopic observations indicate that the cell cycle is divided into two main phases: 
Mitotic (mitosis and cytokinesis) and Interphase (Intermitotic). Mitosis relates to the 
cellular component segregation, distribution of daughter chromosomes, nuclear 
division, and cytokinesis, which together form the process of cytoplasmic division 
(the final division of a cell into two new daughter cells) [1]. This phase is the most 
dynamic part of the cell cycle and usually for a typical mammalian cell takes about 
an hour to complete. 95% of cell cycle time span is spent in interphase, which is an 
interval between two mitotic events (M-phase). 
Mitosis can be divided into separate phases which include prophase, prometaphase, 
metaphase, anaphase and telophase. In prophase, the two DNA molecules divide 
gradually and condense into stiff and compact rod pairs the so-called sister 
chromatids. The nuclear envelope is broken down and spindle formation starts. 
Prometaphase acts as a transition period in which the sister chromatids shuffle to 
align in the centre of the cell. Then, over metaphase, these sister chromatids align 
with the mitotic spindle equator. At the beginning of anaphase, the sister chromatids 
cohesion starts to destruct and they separate to opposite poles of the cell. After that, 
in telophase, the spindle is disassembled and the separated chromosomes are packed 
into two nuclei which results into the physical division known as cytokinesis 
(Figures 2.3 and 2.4) [1, 8, 28]. 
 
Figure 2.3. A schematic diagram of eukaryotic cell division events 
A eukaryotic cell cycle is divided into two main phases: Mitotic (mitosis and cytokinesis) and Interphase 
(Intermitotic). Mitosis relates to the cellular component segregation, distribution of daughter chromosomes, 
nuclear division, and cytokinesis, which together form the process of cytoplasmic division. 95% of cell cycle time 
span is spent in interphase, which is an interval between two mitotic events (M-phase) (Taken from [1]) 
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Figure 2.4. Stages of M-Phase in an animal cell 
Fluorescence microscopy images of stages of mitosis phase include (A) prophase, (B) prometaphase, (C) 
metaphase, (D) anaphase, (E) telophase and (F) cytokinesis; chromosomes are in orange & microtubules are in 
green (Taken from [1]) 
According to microscopic observations, cells grow in size during the interphase. 
Different techniques show that interphase includes G1 (1
st
 gap), S (synthesis) and G2 
(2
nd
 gap) phases. Because most of the cells need more time to grow and duplicate 
mass, most cell cycles have the gap phases; G1 between M and S-phase and G2 
between S and M-phase. Therefore, the eukaryotic cell cycle is traditionally divided 
into four successive phases: G1, S, G2 and M (Figure 2.5) [1, 2, 5].  Each of these 
phases is for a specific function to ensure appropriate cell division. 
 
Figure 2.5. A schematic diagram of four specific phases of the cell cycle 
Different techniques show that interphase includes G1 (1
st gap), S (synthesis) and G2 (2
nd gap) phases. Therefore, 
traditionally eukaryotic cell cycle is divided into four successive phases: G1, S, G2 and M-phase (Taken from [1] ) 
Gap phases act not only as a time delay to allow cell growth, but also to provide time 
for the cell monitoring for internal and external conditions [1, 5]. During the G1-
phase, cells are metabolically active and continue their growth and cellular functions 
but do not duplicate their chromosomes. Over this phase, healthy cells can decide 
when to go through DNA replication and cell division or to leave the cycle and enter 
A B C 
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G0-phase; the resting state (quiescence) [2, 4, 5].  During quiescence, a cell can 
function normally but not divide. Cells in G0-phase are non-growing and non-
proliferating cells in the body. G2-phase acts as a buffer to ensure completion of 
DNA synthesis before cell cleavage in mitosis. Over G2-phase, cells continue their 
growth and synthesise RNA and proteins needed for chromosome condensation, 
spindle formation and nuclear breakdown required for M-phase [1, 2, 4, 5, 8, 28, 29]. 
DNA duplication occurs in a particular part of the interphase named the S-phase 
(DNA synthesis) which takes about approximately half of the cell cycle time in a 
typical mammalian cell to complete. This phase starts when the required proteins for 
DNA duplication reach an adequate level [1, 5]. This process of replicating the 
parent cells results in a single cell with two intact sets of each chromosome, so-called 
sister chromatids. For a typical human cell with a cell cycle time span of 24 hours, 
the G1-phase lasts about 9 - 11 hours, S-phase about 8 - 10 hours, G2-phase about 4 - 
4.5 hours and M-phase about 0.5 - 1 hour [1, 5, 8, 28].  
2.3 CELL CYCLE CHECKPOINTS 
As described earlier, three critical cellular processes are needed for cell division and 
maintenance of cellular homeostasis. Such processes are DNA synthesis, mitosis, and 
cytokinesis which are governed by diverse intra- and extra-cellular stimuli such as 
DNA damaging agents and growth factors [5, 9, 10, 30, 31]. 
In eukaryotic cells, the cell cycle progression is highly ordered and is under a strict 
quality control mechanism [5, 9, 10, 30, 31]. This mechanism evaluates the cell size 
and extracellular growth signals to protect their genome integrity from any genetic 
mutation due to DNA damage. Moreover, it serves to avoid the cell entering a new 
phase prior to completion of the previous phase [5, 9, 10, 30, 31].  
A specific network of proteins monitors these events the so-called cell cycle 
checkpoints to ensure proper cell replication (Figure 2.6) [8]. In 1988, Weinert and 
Hartwell first defined the concept of cell cycle checkpoints with the identification of 
the key proteins of the control system. They realised that these key proteins are 
distinct from the proteins that perform the processes in the cell cycle such as DNA 
replication [1]. The cell cycle checkpoints control structural and functional defects 
during cell cycle, in particular DNA replication and chromosome segregation. 
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Furthermore, they can induce a cellular response to delay progression of the cell 
cycle and activate DNA repair process. A checkpoint failure results in unlimited 
growth in a cancerous cell [5, 10, 30, 31]. 
 
Figure 2.6. The cell cycle checkpoint pathways 
Cell cycle “checkpoints” are specific biochemical signalling pathways which monitor cell cycle events. They can 
sense and diagnose different types of structural and functional defects in the major events such as DNA 
replication. Moreover, they can induce a cellular response to delay progression of the cell cycle and activate 
DNA repair process (Taken from [32]) 
Every checkpoint consists of three key components: (1) the “sensor mechanism” 
which detects abnormal cell cycle events such as DNA damage, (2) the “signal 
transduction pathway” that takes the signal from the sensor to (3) the “effectors” 
which request a cell cycle arrest until resolving the problem [5, 31]. 
The surveillance mechanism keeps all these events under control by means of a 
family of protein kinases (positive regulators) known as cyclin-dependent kinases 
(Cdks) and their cyclin partners which promotes the progression of cells through 
their cycles [1, 4]. There also exist inhibitory proteins, so-called negative regulators 
(Cdk inhibitors (CdkI) including p21, p27 and p57) which stop the cells from 
proceeding to the next stage of the cycle [1, 4, 11]. 
In the eukaryotic cell cycle, seven checkpoints have so far been identified: G0, G1/S, 
S, G2, M, cytokinesis or C, and the DNA damage checkpoints. When DNA damage 
is beyond repair, checkpoints eradicate those cells with damaged DNA by permanent 
cell cycle arrest or cell death [10]. 
During the G0-phase, the cell activates, reaches the homeostatic size and proper 
protein mass, and becomes ready to divide prior to the entrance to G1-phase. In early 
G1-phase, cells accumulate adequate nutrients for responding to mitogenic stimuli 
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and passing through all the phases. If the control system finds any problems outside 
or inside the cell, it prevents progression through these checkpoints [1, 10]. In the 
case of incomplete DNA duplication or any kind of DNA damage, the S-phase cell 
cycle checkpoint will prevent cells from entering the M-phase. The G2-phase 
checkpoint ensures that the duplication machinery has finished DNA replication. It 
also assures that all the defects should be repaired before cells enter prophase. After 
DNA duplication and repair, the cells must orderly go through chromosome 
segregation [1, 10]. The exit from the mitotic phase must not happen prior to 
chromosome segregation between the two daughter cells. 
The mitotic checkpoint is subdivided into three parts: “prophase (DNA structure)” 
checkpoint, “spindle assembly” checkpoint and “spindle positioning” checkpoint. 
Lastly, the DNA damage checkpoint is a “signal cascade”, which obstructs the cell 
cycle progression at G1, G2, metaphase, or reduces the rate of DNA replication in S-
phase [1, 10]. 
2.3.1 Cancer and the role of cell cycle 
Cell cycle dysregulation and the malfunction of checkpoints are the most common 
reasons for proliferation of potentially damaged cells which often result in abnormal 
cancer cell growth and tumour progression [4, 8-10]. Due to the loss of checkpoint 
integrity, tumour cells are unable to stop at predetermined points of the cycle. This 
can be due to abnormal activation or overexpression of Cyclin-dependent kinases 
(Cdks) or inactivation of their inhibitors (CdkIs) [4, 9, 10].  
As such, cancer can be considered a cell cycle disease and scientists are interested in 
cell division events to help improve cancer therapy [4, 9, 10]. Understanding the 
molecular mechanisms of cell cycle dysregulation in cancer can potentially provide 
major insights into how normal cells become tumorigenic and how new cancer 
treatment methods can be developed [4, 5, 9-11]. Besides, determining the proportion 
of cells in each phase is valuable for targeting cancerous cells, as many anti-cancer 
drugs are most effective when used at a specific phase (typically cells in the S-phase) 
[12, 13]. 
Determining the proportion of cells in each phase can also be helpful in evaluation of 
cell population growth potential. For instance, tumour progression is usually related 
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to the percentage of cells in the S-phase. Generally, the higher percentage of cells in 
the S-phase indicates a rapidly growing tumour [13]. 
2.4 CELL CYCLE SYNCHRONISATION: CONCEPT & METHODS 
Under normal cell culture conditions, each cell independently (so-called 
asynchronously) proceeds through the cell cycle. As a result, a group of cells are 
randomly distributed throughout different phases of the cycle. To study cell 
mechanisms and biological processes related to various phases of the cell cycle, 
regulatory events and checkpoints, it is important to have a large number of cells 
synchronised, i.e. cycling in a synchronous manner in a specific stage of the cycle 
[33, 34]. 
Synchronisation provides a useful means to study each cell cycle phase [23, 35]. To 
generate cell populations, which are synchronously progressing through the cell 
cycle, cells are arrested at a certain phase of the cell cycle (block) followed by block 
removing and allowing cells to continue progressing into the following cell cycle 
phase (release). Certain time points after release representing different phases of the 
cell cycle [36]. 
There are several factors which should be met to ensure the success of a cell cycle 
synchronisation in a specific cell line, including: (a) that it must be noncytotoxic and 
reversible, (b) a large number of synchronous cells should be obtained (~75% of a 
cell population should be arrested [37]), (c) the optimal time and concentration for 
synchronisation must be determined (depending on the cell type), (d) the cell culture 
confluencey and its rate of proliferation before synchronisation is of particular 
importance as well [23, 25, 37]. 
2.4.1 Synchronisation methods  
To obtain synchronised cells, numerous methods and techniques have been 
developed (Figure 2.7), all of which have their advantages and disadvantages. The 
main purpose of cell synchronisation methods is the acquisition of numerous cells 
with a uniform age distribution, which are capable of succeeding unperturbed 
development through the cycle [26, 33, 34, 37, 38]. To choose a cell synchronisation 
method, the most important factors to be considered are the cell properties and the 
cell cycle phases to be studied [26, 33, 34, 37, 38]. 
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2.4.1.1     Chemical blockade  
In order to arrest the cells at different stages of the cell cycle, one approach is to treat 
them with chemical inhibitors and metabolic agents (chemical blockade) [25, 33, 35]. 
An advantage of this approach is that it achieves numerous uniformly synchronised 
cells [33]. 
 
Figure 2.7. A schematic diagram showing where cells are arrested in the cycle applying different 
methods 
To obtain synchronised cells, numerous methods and techniques have been developed [25, 33, 35]. One approach 
is to treat cells with chemical inhibitors and agents (chemical blockade); some are shown in green in the 
diagram. Another approach is to apply drug-free techniques (physical fractionation); some are shown in blue in 
the diagram. To choose a cell synchronisation method, the most important factors to be considered are the cell 
properties and the cell cycle phases to be studied. Red arrows show the methods used in this research. 
Some of the most widely used and popular agents for synchronising cells in G1 and 
S-phase are lovastatin, mimosine, hydroxyurea, aphidicolin, and excess thymidine. 
After removing the metabolic block, cells will develop through the cycle in a 
synchronous manner [37, 38].  
Cell growth in the absence of a fundamental amino acid such as methionine causes 
cell arrest in early G1-phase. Treatment with lovastatin leads to synchronisation in 
early G1-phase. However, its mechanism for synchronisation is unknown [25].  
Lovastatin is a mevalonate synthesis inhibitor, but recently it has been demonstrated 
to cause apoptosis in a various types of cells [38]. Mimosine, which is a plant amino 
acid, reversibly prevents cell cycle development in late G1-phase, before the onset of 
DNA synthesis. 
By preventing DNA synthesis, hydroxyurea, aphidicolin and thymidine interfere in 
the cell cycle development. However, the action of the drugs in stopping DNA 
synthesis in each case is different. Hydroxyurea (HU), which was synthesised in 
Germany by Stein and Dressler in 1869, is one of the oldest antitumor drugs. It is an 
effective reversible ribonucleotide reductase (RNR) inhibitor, which stops DNA 
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synthesis (blocks the cells in late G1-phase) by blocking the nucleoside diphosphate 
reductase enzyme [25, 27]. HU stops the cells’ entry into the S-phase and blocks 
development of cells which have entered the S-phase at the time of treatment. Its 
action is satisfactorily reversed by replacing the medium with a drug free one [37]. 
But, the effectiveness of this agent is dependent on the cell line. 
In contrast, the antibiotic aphidicolin (APH), which is a tetracyclic diterpene and 
obtained from the fungus Cephalosporium aphidicola or Nigrospora sphaerica, 
inhibits the cell growth by inhibiting the binding of deoxynucleotide triphosphates 
(dNTPs; the building blocks for DNA) to DNA polymerases α and δ, in vitro [37, 39, 
40]. APH blocks the cells in S-phase and allows G1, G2 and M-phase cells to go 
through the cell cycle and to accumulate at the G1/S junction (blockage of G1 to S-
phase transition) [25, 40, 41]. Since APH does not affect viability of the cells (less 
toxicity) or S-phase duration and does not interfere with the DNA polymerases 
synthesis, it is a highly effective drug which can result in best synchrony and large 
population of synchronised cells [27, 41]. 
Nocodazole and colcimid are in widespread use to arrest cells at metaphase with a 
G2-phase amount of DNA. They specifically block cells at metaphase by disrupting 
the microtubule structure [37, 38]. 
Since all of these agents arrest cells at a particular point in the cell cycle and the cell 
cycle block is reversible, they are very useful for synchronisation studies. However, 
as drawbacks, the drug treatment may cause changes in the normal biochemical 
processes of a cell (cellular perturbations) [12, 33]. Moreover, treatment for a long 
period of time or at a high concentration can cause irreversible cell damage or cell 
death [33, 37]. 
2.4.1.2     Physical fractionation 
Another approach for cell cycle synchronisation is to apply drug-free techniques, so-
called physical fractionation [25]. Among these are to arrest cells in G0-phase by the 
serum deprivation/starvation, isolation of early G1-phase cells by cell contact 
inhibition, and centrifugal elutriation of cells in any stage of the cell cycle. In 
addition, mitotic shake-off is a non-disruptive technique for arresting mitotic cells. 
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However, a limitation of this approach is that, it results in a low cell yield, so that it 
cannot be used in some studies and experiments [38]. 
Serum starvation is one of the most popular ways to synchronise various cell types in 
G0/G1-phase. Culturing cells in serum free media (0% FBS) prevents them from 
taking up nutrients which are vital for growth and forces them into quiescence (G0-
phase). Addition of serum to starved cells leads them progress into G1-phase, to 
initiate cell division [37]. 
Whenever cells continually divide, the contact inhibition phenomenon in cell culture 
will happen, which leads to a high cell density (confluent) and cell-to-cell contact. At 
this stage, cells will be arrested in early G1-phase of the cell cycle. To release cells, 
they are cultured at low density (1×106 cells / 10 cm plate), and cell development 
into succeeding phases can be monitored by DNA content analysis using flow 
cytometry [38]. 
By using the centrifugal elutriation method, cells can be isolated (fractionated) in a 
specific phase of the cell cycle based on their size [33, 37]. For example, cells in 
early G1-phase are roughly half the cell size in late G2-phase or M-phase, whereas 
cells in S-phase show an intermediate size. This technique synchronises the cells by 
injecting them into an elutriation rotor [12]. Unfortunately, this technique requires 
specifically designated and expensive equipment, involves time consuming and 
complicated preparation and imposes high mechanical stress on the cells [12, 33]. 
However, it offers a number of considerable advantages. For instance, this rapid 
method can be applied to nearly all cell types; adherent or suspension. Elutriation can 
be used to acquire cells from any stage of the cell cycle and yield a large population 
of synchronised cells (uniform size populations) [33, 38]. Finally, cells can be 
elutriated at the room temperature and cultured in culture media rather than in 
buffered salt solutions. Thus, the nutrients keep cells alive for the max 1-2 hour 
needed for the experiment [26, 33, 37, 38] . 
As a conventional cell assay technique, flow cytometry is frequently used to measure 
many cellular parameters, to assess different cell cycle phases and to determine the 
proportion of cells in each cell cycle phases on a single cell basis. 
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2.5 FLOW CYTOMETRY 
Flow cytometry (FCM) is the science of measuring and analysing multiple physical 
and chemical properties of individual biological particles (usually cells) as they pass 
in a fluid of single-cell stream through a laser light beam [42, 43]. Thousands of 
biological particles can be sampled per second. The measured properties include 
relative size and shape of the particle, DNA and RNA content, relative cytoplasmic 
complexity and fluorescence intensity [42, 43]. Moreover, some flow cytometers 
termed as fluorescence-activated cell sorter (FACS) are equipped with a sorting 
device. It allows the selection of single cells from a population of interest on 
different basis such as physical parameter (e.g. size or shape of the cells). 
2.5.1 How it works 
In 1934, Moldovan reported a method based on bright field photoelectricity for 
counting individual cells flowing through a capillary tube located on a microscope 
stage [7]. It was the beginning of automated flow analysis of single cells which 
continued to design and develop more sophisticated instruments for analysing single 
cells based on a wide variety of functional, physical and biochemical cellular 
properties, since the mid 1960’s [7]. Particles from 0.2 to 150 µm in size are suited to 
a flow cytometric analysis [43]. 
In current flow cytometry machines, one or more focused laser beams interrogate 
each particle from the prepared suspension transported via a fluidic system as shown 
in Figure 2.8. This fluidic system is made of a sheath isotonic fluid (based on 
Phosphate Buffered Saline (PBS) suspension) which aligns the particles on a single 
cell basis (hydrodynamic focusing) [44, 45]. 
As shown in Figure 2.9, the interrogation of laser beams by each particle results in 
scattered fluorescent lights (forward angle light scattered (FSC) and side angle light 
scattered (SSC)) that can be detected as photons by photomultiplier detectors [42-
46]. Forward scattered fluorescent light, which is a result of diffraction, provides 
basic morphological information about the particle e.g. cell size. On the other hand, 
side scattered fluorescent light at an angle to the incident laser beam, which is a 
result of reflected and refracted incident light, is an indicator of cytoplasm 
granularity and membrane irregularities [42-46]. Thus, the FSC and SSC light 
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scattering information helps to identify a variety of cell types based on their relative 
cell size, granularity and topography [44]. 
                                    
Figure 2.8. A schematic diagram of hydrodynamic focusing of a suspended sample 
This figure schematically shows the hydrodynamic focusing of a suspended sample. One or more focused laser 
beams interrogate each particle from the prepared suspension transported via the fluidic system. This fluidic 
system is made of a sheath fluid (based on PBS suspension) which aligns the particles on a single cell basis 
called hydrodynamic focusing. 
                       
Figure 2.9. A schematic diagram of light scattering properties of a cell 
This diagram schematically shows the light scattering properties of a cell. Forward scattered fluorescent lights 
(FSC), which are shown as blue arrows, provide basic morphological information about the particle e.g. cell 
size. On the other hand, side scattered fluorescent lights, which are shown as orange arrows, are an indicator of 
cytoplasm granularity and membrane irregularities. 
Afterwards, an electronic system measures the degree and direction of light scatters 
detected by detectors and translates them into electronic signals with the intensity 
proportional to the intensity of scattered fluorescent lights signal. Finally, the 
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appropriate computer software digitises the intensity of these electronic signals, 
performs the necessary analyses and records them in a data bank [42, 43, 46]. 
In summary, components of a modern flow cytometry machine can be categorised 
into four inter-related groups: 1. fluidics system (the heart of the instrument), 2. 
illumination system, 3. optical and electronic components and 4. computer control 
system and data bank [44, 45]. The first group transports prepared particles through 
the FCM machine for data acquisition. The second system is used for particle 
interrogation. The optical and electronics components direct, collect and translate the 
scattered and fluorescent light signals which illuminated from the particle. The final 
group obtains meaningful data through interpreting electrical signals for storage and 
further analysis [44, 45]. Figure 2.10 shows a schematic diagram of a typical flow 
cytometry machine. 
 
Figure 2.10. A schematic of a typical flow cytometer set up 
This figure shows the flow cytometry system schematically. In general, it consists of a fluidic system, which 
creates a single file of particles known as hydrodynamic focusing and conveys them to the interrogation point 
and takes away the waste; the lasers, which are the light source for scatter and fluorescence; the optic system, 
which gather and direct the light; the detectors, which receive the light; and, the electronics and computer 
system, which convert the signals from the detectors into digital values and perform the necessary analyses 
(Taken from [47]). 
To obtain additional biological information about each particle such as intracellular 
DNA content, they may be stained with one or more DNA intercalating fluorescent 
markers and dyes (fluorochromes). The amount of intracellular DNA is directly 
19 
 
proportional to the amount of stain, since the dyes are binding to the DNA of the cell.  
Propidium iodide (PI) is one of the most widely used nucleic acid dye for this 
purpose and has red fluorescence [48]. Since PI is a DNA binding dye, the intensity 
of red fluorescence is indirectly proportional to the DNA content of cells and the cell 
cycle phases [12]. 
In general, cells must be fixed or permeabilised (cell membrane permeabilisation) 
before adding a dye to allow entry of dye to the cell [48].  Alcohol is usually used for 
this purpose. It is a dehydrating fixative that permeabilises the cell membrane as 
well. Since PI also binds to RNA, Ribonuclease A (RNaseA), which is a type of 
enzyme that catalyses the RNA degradation, is used to digest them before flow 
cytometry analysis. 
When stained cells with a DNA intercalating fluorescent dye were analysed by flow 
cytometry machine, a narrow distribution of fluorescent intensities is acquired. This 
is demonstrated as a histogram of fluorescence intensity (horizontal axis) v. number 
of counted cells (vertical axis) which is named as DNA content histogram. From the 
DNA histogram, the percentage of cells in the G1, S, and G2/M phases of the cell 
cycle can be extracted. The acquired fluorescence data are considered a measurement 
of the intracellular DNA content. Since the obtained cell cycle analysis data is not a 
direct measure of intracellular DNA content of cells, control (reference) cells should 
be included to identify the position of cells with the normal diploid (2N) amount of 
DNA [49]. 
Figure 2.11 shows an example of the DNA histogram presenting two peaks. The left 
one corresponds to the cells with two copies of N chromosomes (2N, called diploid) 
which are in G1-phase of the cell cycle [46, 48]. The right peak matches up with the 
cells with twice its normal intracellular DNA content (4N) that are in G2 or M-phase 
and ready for cell division. These two peaks are assumed to have Gaussian 
distributions. The cells in the inter-peak region correspond to cells with an 
intermediate DNA content (between 2N and 4N DNA) which are cells in S-phase of 
the cycle and in the process of duplicating DNA for cell division [46, 48]. 
To calculate the percentage of DNA content for synchronised populations, gating 
(drawing) of regions of interest on dot plots is performed. Gating is the identification 
of cell populations which have a particular function in common. Since doublets or 
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cellular aggregates and debris will interfere with the FCM measurements, it is vital to 
exclude them in the process of gating [49]. 
 
 
 
 
Figure 2.11. Single cell gating and DNA content histogram of a cell line v. number of counted cells as 
determined by the flow cytometer 
In this figure, stained cells with PI solution were gated on single cells using area and width signals. Doublets and 
dead cells were excluded from the measurements. Based on the gating of single cells, DNA content histogram of 
cell in each phase was then calculated. 
2.5.2 Limitations 
A flow cytometer is a costly and quite sophisticated instrument which usually 
requires a lot of space and skilled operators for the test to be effective and valid data 
acquisition to be achieved [48]. Furthermore, in most cases it needs cell fixation and 
fluorescence labelling, which may not be amenable to all researches since it can 
change some of the cell properties [20]. In addition, for cell sorting, labelling might 
be difficult to remove after the sorting process. The other major drawback of the flow 
cytometer is its low cell throughput rate which is normally less than a few thousand 
cells per second. This suggests that in case of the experiments which require large 
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number of cells to be analysed, the instrument needs to run for a longer duration, 
which is not only expensive but may also pose quality issues.  
To overcome these limitations, a new way of exploring the cells is to examine them 
as electrical, rather than chemical objects. For this purpose, a phenomenon called 
dielectrophoresis (DEP) has been gaining interest for more than half a century. It 
allows seeing how the cell works electrically in real time. This promising technique 
which operates on the cellular electrophysiological properties is potentially capable 
to eliminate the use of chemical labelling with stains and antibodies or any other type 
of cell alteration [21]. DEP is a portable, contactless and cost-effective technique 
which reduces the sample volume and can provide automated and real time analysis. 
It also does not require highly experienced operators to obtain the acceptable 
performance [18, 21, 22].  
This technique can be used to manipulate, characterise and sort cells suspended in a 
fluidic medium based on their cellular electrophysiological properties [18, 19]. It can 
discriminate between cells, which have different electrophysiological properties, 
without any biochemical labelling or cell modifications [20, 21, 50]. To characterise 
cells electrophysiological properties using DEP, the direction and strength of the 
DEP force is measured over a wide range of frequency [20]. Then by fitting the cells 
mathematical model to the achieved DEP spectrum, cells electrophysiological 
properties can be extracted [20]. Types of particles reflected to have 
dielectrophoretic effects include viruses, DNA and RNA molecules, mammalian, 
cancerous and stem cells [18-21]. 
2.6 DIELECTROPHORESIS 
The terms “AC electric field induced kinetics” and “AC electrokinetics” are used to 
describe the interaction of AC electric fields with induced dipoles in particles which 
shows a range of motions (e.g. rotation, repulsion and attraction) by changing the 
nature of the AC electric field [51]. 
AC electrokinetics techniques, such as electrorotation (ROT), travelling wave DEP 
(twDEP), electroorientation (EO) and dielectrophoresis (DEP), have been used for 
many years to manipulate, characterise and separate biological particles [22, 50, 51]. 
ROT describes the spinning of particles in a rotating electric field; twDEP the linear 
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motion of particles in a travelling electric field (an electric field wave that travels 
along the electrodes); EO the orientation (alignment) of non-spherical particles in a 
steady electric field and DEP the movement of particles in an inhomogeneous 
electric field  [22, 50-53]. 
Dielectrophoresis phenomenon was first observed early in the 20
th
 century, but fully 
described and named by Dr Herbert Pohl from Princeton University in 1951 [18, 54]. 
He merged the word “phorein” from the Greek (to carry) with the word “dielectric” 
to make this new terminology (a particle is carried due to its dielectrical properties) 
[54-56]. 
He performed major early experiments on uncharged tiny plastic particles, which 
were suspended in dielectric liquids [55, 57]. Pohl discovered that the use of a non-
uniform DC or AC electric field could move the particles. He mentioned that the 
most interesting part of the DEP is its ability to apply force on neutral particles that 
are larger than molecules [55, 56]. 
Therefore, DEP is the motion of a polarised particle, which is suspended in a 
conductive medium, induced by an inhomogeneous electric field. Pohl and his 
collaborator, Hawk, wrote about the separation of viable and non-viable yeast cells in 
a nonuniform AC electric field in 1966 [18, 51, 55-57]. In 1978, he predicted a bright 
future for biological DEP. 
The phenomenological bases of this definition are [57]: 
► Particles experience the DEP force only in presence of a non-uniform electric 
field. 
► The DEP force is not based on the polarity of the electric field. It is observed 
with both DC and AC excitations. 
► Whenever the permittivity of the particles (εp) exceeds the permittivity of the 
suspension medium (εm), i.e. εp > εm, they are attracted to the areas of the 
strongest electric field, the so-called positive DEP (p-DEP, +DEP) [51, 57]. 
► When εm > εp, particles are repelled from the areas of the strongest electric 
field, the so-called negative DEP (n-DEP, -DEP) [51, 57]. 
► The DEP force easily observed in particles with diameter of about a few nm 
up to 1 mm. 
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2.6.1 Theory 
Figure 2.12 shows a dielectric particle which is suspended in an inhomogeneous 
electric field. 
 
Figure 2.12. A schematic diagram of a dielectric particle suspended in an inhomogeneous electric field 
A schematic diagram of a polarisable particle suspended in an inhomogeneous electric field in a conductive 
medium experiencing FDEP. The orange arrow depicts the direction of particle motion (Taken from [58]) 
The electric field induces a dipole in this particle. The interaction between the 
electric field and the induced charges generates Coulomb forces. Because of the field 
gradient, these forces are not equivalent, and the net difference in force (|𝐅DEP|) 
causes a net motion [21, 51, 59].  
The magnitude and direction of the DEP force (FDEP) are related to dielectrical 
properties of the suspending medium and the particle (e.g. a cell) and frequency of 
the electric field. If a biological cell is assumed as a spherical particle, FDEP, which is 
acting on a homogeneous, isotropic, spherical body, will be equal to [21, 50, 51, 59]:   
FDEP = 2πr
3 εm Re[K(ω)] ∇E
2
 
where, r is radius of the particle, εm is absolute permittivity of suspending medium, E 
is the amplitude (rms) of applied electric field, ∇ is the gradient operator, and 
Re[K(ω)] is the real part of “Clausius-Mossotti factor” (polarisation factor which acts 
as a scaling factor on the magnitude of the FDEP) given by [21, 51, 59]: 
K(ω) =
εp
∗ − εm
∗
εp
∗ + 2εm
∗  
in which, εm
∗  and εp
∗  are the complex permittivity of the medium and particle, 
respectively. This factor is theoretically limited between -0.5 and 1 [54]. The 
complex permittivity is defined as εi
∗ = εi – jσi/ω, where 𝜀i is the (real) permittivity 
and σi is the (real) conductivity of the material i, j = √-1 and ω is the angular 
frequency of the applied electric field. As a result, Clausius-Mossotti factor not only 
(1) 
(2) 
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relies on the medium and particle dielectric properties, but also on frequency of the 
electric field [18, 50, 51, 59].  
Conductivity is defined as the ability and efficacy of material to conduct electricity 
(to transport the electric charges within the material). In contrast, permittivity 
measures the ability to store the electric charges and to polarise. Figure 2.13 shows 
the graph for Clausius-Mossotti factor v. frequency [18, 51, 60]. The frequency 
dependent K(ω) displays that the applied force on the particle changes with 
frequency. 
 
Figure 2.13. Graph of Clausius-Mossotti factor v. frequency 
The real part (Re[K(ω)]) and imaginary part (Im[K(ω)]) of the Clausius-Mossotti factor is plotted as a function 
of frequency. So a typical dielectric spectrum of a dielectric particle will have the form of Re[K(ω)]) as shown in 
this figure  (Taken from [60]) 
CM ( the real part of Clausius-Mossotti factor (Re[K(ω)]) )  varies based on the 
particle polarisability relative to the medium. If CM is positive (εp > εm), particles 
move to the areas with strongest field (p-DEP) (Figure 2.14.A). It indicates that work 
will be done to take the particle from these strongest field areas. On the other hand, if 
CM is negative (εm > εp), particles repel from these regions (n-DEP) (Figure 2.14.B). 
It means work is needed to push the particle from a weak to a strong field area [20, 
21, 51].  
In short, phenomenology of the DEP force is summarised as follows [21, 51]: 
 FDEP is directly proportional to the particle (cell) volume. 
 FDEP is directly proportional to the medium dielectric permittivity. 
 FDEP directs along the strength gradient of the applied electric field. 
 FDEP depends on the magnitude and sign of the Clausius-Mossotti factor. 
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 FDEP is zero if the field is homogeneous (∇E=0). 
     
Figure 2.14. A schematic diagram of positive and negative DEP 
A schematic diagram of a polarisable particle suspended in a non-uniform electric field in a conductive medium 
where the particle is (A) more polarisable and (B) less polarisable than the suspending medium. If the particle is 
more polarisable than the suspending medium, the particle will move towards the area with strongest field, the 
so-called positive DEP (p-DEP). If the particle is less polarisable than the suspending medium, the particle will 
be repelled from the high-field strength region, termed as negative DEP (n-DEP). The red arrows depict the 
direction of particle motion (Taken from [20] and modified) 
 
Re[K(ω)] can be expanded to [61]: 
 
Re[K] =
εp −  εm
εp +  2εm
+  
3(εmσp − εpσm)
τMW(σp +  2σm)
2
(1 + ω2τMW
2 )
 
 
in which τMW is the “Maxwell-Wagner” charge relaxation time [21, 61]: 
 
τMW =
εp + 2εm
σp +  2σm
 
After applying the electric field, the polarised particles return to their original state. 
However, charges take a limited time to replace. This is termed charge relaxation 
time (τMW) [21, 62]. 
It is useful to calculate the low frequency (ω       0) and high frequency (ω      ∞) 
responses of Re[K(ω)]. These can be approximated to [21, 63] : 
 
(3) 
(4) 
B 
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Re[K] =
σp − σm
σp +  2σm
 
Re[K] =
εp −  εm
εp +  2εm
 
It is easy to see that at low frequencies, conductivity is the main factor in 
determining CM. In contrast, permittivity dominates at high frequencies. At 
intermediate frequencies, both conductivity and permittivity of the particle and 
medium has an effect on FDEP [21]. 
The terms “DEP spectrum” and “crossover frequency” are used in order to explore 
FDEP dependence on CM at various frequencies of electric field. The DEP spectrum 
represents the variations of the CM at different frequencies. The crossover frequency 
(fxo) is the frequency at which CM changes its sign and becomes zero, i.e. FDEP = 0 
[58, 64] , where fxo is given by: 
  
𝑓𝑥𝑜 =  
1
2π
√
(σm − σp)(σp + 2σm)
(εm − εp)(εp + 2εm)
 
At the crossover frequency, the polarisability of the particle and medium is equal and 
the particle do not experience either n-DEP or p-DEP (no net movement; particle 
remains stationary) [58, 62, 65]. Shape of the cell, membrane morphology and cell 
size mainly affect the first fxo of cells [66].  
2.6.2 A spherical shell model 
Characterisation of cells is based on physical phenomena happening within the cell, 
e.g. changes in cytoplasm and membrane conductivities and permittivities. To extract 
these electrophysiological properties of a cell from the acquired DEP data (DEP 
spectra), mathematical modelling techniques are used to obtain best-fit line for a 
given data set [18, 61]. 
To characterise these physical phenomena happening within the heterogeneous and 
anisotropic biological cells with a complex internal structure, spherical single- or 
(6) If   ω  ∞ :  
(5) If   ω  0 :  
   (7) 
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multi-shell dielectric models are an approximation. They model the particles as 
concentric spheres. 
In a single-shell model, a cell is assumed to be a conductive homogeneous sphere 
representing the cell cytoplasm (interior of the cell), which is surrounded by a shell 
representing its plasma membrane [20, 52, 62, 67]. A multi-shell model breaks the 
homogeneous “core” of the single-shell model into different layers, usually adding 
the nuclear membrane and the nucleoplasm. A multi-shell model is limited by having 
many possible solutions, i.e. non-unique answers. 
As mentioned, the complex permittivity of a material is defined as ε∗ = 𝜀 – jσ/ω.  
Since the particle (cell) is composed of a shell surrounding a homogeneous core 
(Figure 2.15), this complex permittivity can be replaced with an effective value 
which combines the core and shell properties [18, 21, 52, 61], so: 
εeff
∗ =  ε2
∗
(
r2
r1
)
3
+ 2
ε1
∗ − ε2
∗
ε1
∗ + 2ε2
∗
(
r2
r1
)
3
− 
ε1
∗ − ε2
∗
ε1
∗ + 2ε2
∗
 
in which, subscripts 1 and 2 correspond to the core and shell, respectively. Hence, 
Clausius-Mossotti factor is equal to: 
 
K(ω) =  
εeff
∗ −  ε3
∗
εeff
∗ +  2ε3
∗  
The subscript 3 mentions the suspending medium. Therefore, Clausius-Mossotti 
factor relates to the complex permittivities of the cell and its surrounding medium 
[52]. 
 
 
 
 
 
 
(8) 
(9) 
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                                                Figure 2.15. A “Single-Shell Model” 
A schematic diagram of a cell, in which r1 is the radius of the cell interior, r2 is the radius of the cell exterior, 
ε1,σ1, ε2,σ2 and ε3,σ3 are the relative permittivity (ε) and conductivity (σ) of the cell interior, the cell membrane 
and the suspending medium, respectively. 
2.6.3 Electrophysiological properties of cells 
Studies of electrophysiological properties of biological materials have been of 
interest for many years and have increased strongly since the late 1800's. In 1910, 
Höber electrically demonstrated the existence of the cellular membrane by 
comparing conductivities of RBCs at low and high frequency (up to frequencies of 
10 MHz), which can be tracked as the earliest work in this field [54, 68, 69]. 
Dielectric studies and measurements can help to understand fundamental biological 
processes and obtain information about tissue compositions and structures such as 
presence of a tumour [14]. Knowledge of these electrophysiological properties, 
especially through the cell cycle, can potentially provide new insights in cancer 
studies, reveal differences between cancerous and normal cells and provide helpful 
information on diseased and non-diseased cells [14-17]. 
The electrophysiological properties of a biological material show the movement of 
electric charges inside it due to an external electric field. The dielectric 
characteristics of mammalian cells can be modelled electrically on the equivalent 
electrical circuit as shown in Figure 2.16 [54]. 
In dealing with cell suspensions and tissues, electrophysiological properties 
(permittivity and conductivity) always change with frequency (from less than 1 Hz to 
10 GHz) [16, 17, 70-72]. This dependency to the frequency of an applied electric 
field is called dielectric dispersion [70]. These frequency dependent 
r1 
r2 
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electrophysiological properties of cells can be understood with the depicted 
equivalent electrical circuit.  
 
 
 
 
 
 
 
 
Figure 2.16. The equivalent electrical circuit of a mammalian cell 
The cell membrane is shown as a parallel combination of the membrane capacitance (Cmem) and resistance 
(Rmem). The cytoplasm electrophysiological properties are represented as a series combination of cytoplasmic 
capacitance (Ccyto) and resistance (Rcyto) [54]. 
Despite the fact that tissue electrophysiological properties are varied from one to 
another, their general behaviour is the same and changes in three distinct levels (low, 
RF and GHz frequency ranges), often named as α-, β-, and γ-dispersions which were 
first fully described by H.P. Schwan in 1957 [72]. As a function of frequency, 
dielectric constant (ε) decreases and conductivity (σ) increases (Figure 2.17) [17, 69, 
70]. 
  
Figure 2.17. Changes of dielectric constant and conductivity as a function of frequency 
In dealing with cell suspensions and tissues, permittivity and conductivity always change with frequency (from 
less than 1 Hz to 10 GHz) which is known as α-, β-, and γ-dispersions. As a function of frequency, dielectric 
constant (ε) decreases and conductivity (σ) increases (Taken from [70]) 
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The α-dispersion typically happens below a few kHz. Due to electrode polarisation 
effects interference, it is not easy to measure this dispersion. However, it could be 
based on the counter ion (counter ion layer) displacement, which encloses the 
charged membrane [17, 71, 72].  
The β-dispersion occurs in the frequency range from kHz to MHz and is mainly a 
result of membrane systems interfacial polarisation (Maxwell-Wagner effect). Owing 
to the fact that the membrane is shorted electrically in this case, current can flow 
through the cytoplasm. This dispersion is linked to cell membrane, cellular proteins, 
and other macromolecules polarisation [17, 71, 72]. 
The γ-dispersion happens in the microwave frequency zone (above 1 GHz). This 
dispersion is due to water molecules reorientation leading to polarisation [17, 71]. 
There may be small dielectric dispersions between the β- and γ-dispersions, which 
might be the result of biopolymers and bound water relaxation [71, 72]. In medical 
applications, scientists are more interested in the α- and β-dispersion regions as most 
differences between normal and pathological cells occur in this range of frequencies 
[17, 71].  
Since bioparticles such as cells, viruses or bacteria show electrophysiological 
properties, DEP can detect any changes in cell cytoplasmic and membrane properties 
to differentiate between various types of bacteria, to notice whether cells are viable 
or non-viable etc. [18, 61]. The key parameters influencing the electrophysiological 
properties of a biological particle are the membrane capacitance and conductance, 
the surface charge, and the cytoplasmic conductivity [18, 61]. According to the 
single spherical shell model and equation 8, complex permittivity of a living cell is 
calculated by [52, 64, 73, 74] :  
εp
∗ =  εmem 
∗
(
r
r−d
)
3
+ 2(
εin
∗ − εmem
∗
εin
∗ + 2εmem
∗ )
(
r
r−d
)
3
− (
εin
∗ − εmem
∗
εin
∗ + 2εmem
∗ )
 
where subscripts in and mem stand for cell interior and cell membrane, respectively, 
d is the membrane thickness and r is the cell radius. The membrane of a living cell is 
less conducting than the cell interior (σmem ≪ σin). Therefore, at frequencies well less 
than the Maxwell-Wagner relaxation frequency (MHz), the following is true [73]: 
(10) 
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(
εin
∗ − εmem
∗
εin
∗ + 2εmem
∗ )  ≈ 1 
Now, if it is considered that the membrane thickness is very small in comparison to 
cell radius (d ≪ r), then cell complex permittivity can be simplified to [73]: 
εp
∗ =  
r
d
 εmem
∗ = r (ceff −  j
geff
2πf
) 
where ceff and geff are effective membrane capacitance and conductance, respectively. 
ceff = 
εmem
d
    ,     geff = 
σmem
d
     
This shows that, at low frequencies, complex permittivity of a living cell is the ratio 
of the cell radius to membrane thickness multiplied by the membrane complex 
permittivity. Consequently, membrane capacitance establishes cell 
electrophysiological properties in a specific range of frequencies [73].  
Based on the equation 13, ceff is a function of the cell membrane’s permittivity and 
its thickness. High values of ceff could reflect the large membrane surface area 
associated with complex surface morphology including high number of microvilli 
(density and size), blebs, ruffles and folds in the cell membrane [22, 52, 62, 74-76]. 
By increasing cell membrane surface area, microvilli may facilitate cell division 
process and cause rapid changes in cell membrane morphology [74]. Based on this, 
mitotic cells usually exhibit plenty of microvillous features. For mammalian cells, 
value of ceff often cited as 9 - 10 mF m
-2
 and for completely smooth spherical cell 
membrane, it has a value of approximately 6 mF m
-2
 [22, 74, 76, 77]. 
Based on the equation 14, geff is a function of the cell membrane’s conductivity and 
its thickness. Since the nature of lipid bilayer is near-insulating, membrane 
conductance is mainly evidence of the charge (ion) carriers’ net transport (flux) 
across the membrane through membrane pores, pumps and ion channels under the 
influence of the applied electric field [75, 77-79].  
When cells are suspended in a medium with lower conductivity than the cell 
cytoplasm, by using equation 12, Clausius-Mossotti factor in the range of frequencies 
dominated by “cell membrane effects” approximated to [73]: 
 
(11) 
(12) 
(13, 14) 
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CM =  [
r
d  ∅ εmem −  j 
σs
2πf
r
d ∅ εmem +  2j 
σs
2πf
] 
where, ∅ (named as membrane folding factor) is defined as the membrane 
topography parameter which represents the ratio of the actual membrane area 
covering a cell to the membrane area (4𝜋𝑟2) which would form a completely 
spherical and smooth covering of the cell cytoplasm [73, 74, 76]. The value 1 is 
assumed for an ideal smooth cell and higher values for cells with more complex 
surfaces [74, 77]. The parameter σs is the suspending medium conductivity, εmem is 
the real membrane permittivity, and f is the applied frequency [73]. Based upon this 
fact that at the crossover frequency (fxo) a cell experiences zero dielectrophoretic 
forces (CM=0), and using equation 15, the crossover frequency would be equal to 
[73]: 
fxo = 
K.σs
r.∅
 
in which, K = 28.1 Hz m
2 
S
-1
. Hence, at low frequencies, a cell with a large 
membrane folding factor (∅) and a large radius shows a small crossover frequency 
[73]. The simple fact is that a cell with large radius will take long time to charge the 
membrane by the constant density of ion charges in the surrounding electrolyte. 
Thus, a longer period means a lower frequency. Therefore, a large cell will show a 
lower crossover frequency than a small one [66]. 
Although, at low frequencies, fxo is sensitive to the cell size, the fxo when the FDEP can 
reverse its polarity again at higher frequencies does not change with size of the cell 
[21, 73]. Moreover, in low frequencies, fxo is sensitive to changes of the suspending 
medium conductivity, while there is no response to it at high frequencies [21]. 
2.6.4 DEP electrode geometries 
Different types of DEP electrode geometries which generate a high-field gradient 
have been used to perform DEP experiments [20]. In initial works, thin electrical 
wires were used to perform DEP measurements [80]. However, recent experiments 
are more focused on electrodes within the micrometre range. These electrodes can be 
powered with standard signal generators which supply between 5 Vp-p to 20 Vp-p and 
      (15) 
(16) 
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a frequency range between 500 Hz to 50 MHz [20]. The most common designs for 
DEP electrodes are needle electrodes, interdigitated electrodes, polynomial 
electrodes and DEP-microwell electrodes [20, 80].  
Needle electrodes offer the simplest and low cost electrode system. They consist of 
two triangular electrodes (needle shape) with their tips pointing at each other and a 
gap of 100 mm to 400 mm between them [20]. The main limitation of this electrode 
system is that only p-DEP can be detected. Interdigitated electrodes are made of 
parallel track of electrodes with opposite polarity [20, 80]. Again n-DEP is difficult 
to quantify with this system too. One of the common types of these electrodes is 
named as interdigitated castellated electrodes which consist of parallel tracks with 
castellation [80]. They have the advantage of n-DEP verification [20]. Another type 
of electrodes which have been of use is polynomial electrode which consists of four 
curved (e.g. circular or parabolic) electrodes arranged in a square [20]. They can 
easily detect p-DEP and n-DEP [80]. However, this type of geometry is hard to 
manufacture [81]. Some examples of these three types of electrodes are shown in 
Figure 2.18. 
                     
      
Figure 2.18. Three different types of DEP electrode geometries 
(A) Needle electrodes (Taken from [20]), (B) Interdigitated castellated electrode (Taken from [20]), (C) 
Polynomial electrodes (Taken from [20]) 
2.6.4.1 DEP-microwell electrode system 
A more recent development in electrode design is DEP-microwell electrodes which 
for the first time offer a low cost and rapid way to quantify both positive and 
A B 
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negative DEP [20, 81]. A DEP-microwell electrode system, developed and patented 
at the University of Surrey in 2003 [65], has been used in this research to analyse the 
DEP effect of a cancerous cell line in suspension.  
This system is composed of a laminate of alternating layers (stripes) of gold-plated 
copper ring electrodes (for better bio-compatibility and to prevent oxidation) and 
polyamide insulators with the holes drilled through the structure (named as wells) 
with a transparent base attached under the holes to contain the sample, as shown in 
Figure 2.19 [20, 81, 82]. Each well is typically 3 mm deep and 750 μm in diameter, 
with 8 layers of electrode around the well circumference with a thickness of 70 µm 
and gaps of 75 µm between the layers [20, 65, 81, 82]. 
Some of the advantages of DEP-microwell technology are as follows: the radially 
symmetric well and the electric filed within it allow reducing the mathematical 
complexity and simplifying the DEP analysis; fabrication is significantly easier and 
can be performed with high accuracy at low cost; and the wells structure allow a 
better sample containment and larger volumes to be processed [20, 81]. 
 
   
Figure 2.19. DEP-microwell electrode system 
(A) A photo of inside of a 1.2 mm diameter well shows the gold-plated copper stripes around the well 
circumference (Taken from [81]) (B) a cross-sectional schematic diagram of a DEP-microwell electrode system 
(Taken from [22]). Each well is typically 3 mm deep and 750 μm in diameter, with 8 layers of electrode around 
the well circumference with the thickness of 70 µm and gaps of 75 µm between the layers. 
For each DEP measurement, an aliquot of the stock cell solution is injected into a 
well in the DEP-microwell electrode. The electrodes were energised using a signal 
generator, over a wide range of frequencies between kHz to MHz. 
To monitor and evaluate the changes in cell distribution over time, a beam of light is 
passed through the well and a camera situated above the electrode captures images 
periodically. Cells’ movements are monitored by observing the changes in light 
intensity in the microwell during the application of an AC signal, as shown in Figure 
2.20.  
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Figure 2.20. A cross-sectional schematic diagram of the DEP-microwell electrode system 
A schematic diagram of the DEP-microwell electrode system containing a cell suspension is shown; (A) during 
positive DEP (cells attraction to the well edges and reduction in light scattering) and (B) during negative DEP 
(cells repulsion from the edges and accumulation in the centre of the well and as a result increase in light 
scattering). (Taken from http://www.DEP-Well.com/DEP-Well.html Last modified 11/07/2011) 
A contour plot is produced for each DEP frequency measurement. It displays the 
changes in light intensity that measured against time and radius of the well, as shown 
in Figure 2.21. 
 
 
Figure 2.21. Contour plot depicting a change in light intensity in the DEP-microwell electrode system 
An example of a contour plot indicating the change in light intensity in the DEP-microwell electrode system in 
case of positive DEP (generated by MATLAB software – at the frequency of 630 kHz). The x-axis represents the 
well radius and the y-axis indicates the period of time (in seconds) that electrodes are energised. The dark blue 
regions represent the accumulation of the cells (adjacent to the well) and reduction of light intensity, the dark red 
regions show that the light beam goes through the well (increased light intensity) and in the regions between 
them the density of the cells is changing. 
Applying the AC electric field results in p-DEP or n-DEP. During p-DEP, the 
concentration of cells near the electrodes at the well perimeter is increased which 
results in a decrease in light intensity in this area, and an increase in light intensity at 
the centre of the well. In contrast, during n-DEP, the concentration of cells located at 
(A) Positive DEP (B) Negative DEP 
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the centre of the well is increased which results in a decrease in light intensity in this 
area and an increase in light intensity around the edge of the well [22, 81, 82]. 
The change in light intensity across the well over the time of electrode excitation was 
assessed using a MATLAB (Maths Works) script which was developed by the BME 
Centre at the University of Surrey. This program is based on numerical methods to 
obtain the best-fit line for the collected data (light intensity) to the single-shell 
dielectric model [20]. Since the net cell polarisability is proportional to the change in 
light intensity, this method can be used to determine the cells electrophysiological 
properties [20, 22, 65].  
2.6.5 Applications of DEP in cell cycle studies 
As stated earlier in this chapter, studies of cellular electrophysiological properties 
can aid the understanding of fundamental biological processes and obtain 
information about tissue compositions and structures such as the presence of a 
tumour [14]. Knowledge of these electrophysiological properties, especially through 
the cell cycle, can potentially provide new insights in cancer studies. It also can 
reveal differences between cancerous and normal cells and provide helpful 
information on diseased and non-diseased cells [14-17]. Moreover, it could be a 
reliable method to detect the cells in particular stages, which could be of use for 
targeting the cancerous cells [12]. In addition, characterising the cells and 
investigating their electrophysiological properties during the cell cycle may help to 
elucidate the ion channels mechanism of action in detail. Over the past two decades, 
the electrophysiological properties of a range of cell types through the cell cycle have 
been studied applying AC electrokinetic techniques. 
In 1999, Huang and colleagues, by applying electrorotation (ROT), demonstrated 
that the electrophysiological properties of T-Lymphocyte cells vary through the cell 
cycle [52]. Since human peripheral blood T-lymphocytes are normally resting at the 
G0-phase, they used phytohemagglutinin (PHA) and interleukin-2 (IL-2) to stimulate 
the cells to go through the cell cycle. To determine cell cycle distributions, they 
examined the cells by flow cytometry at 24 h intervals for up to 96 h. The obtained 
results of the study showed that the average cytoplasmic conductivity of the cells 
decreased at 24 h after stimulation by 25%. The average cytoplasmic permittivity of 
the cells remained almost unchanged up to 96 h after stimulation [52]. The achieved 
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results also showed that the specific membrane capacitance decreased by 15% during 
the first 24 hour after stimulation. This value sharply increased by 60% between 24 h 
and 48 h and remained relatively unchanged thereafter. The authors considered that 
the observed changes in the membrane capacitance, before and after stimulation, 
were dominated by the alteration of cell membrane morphology [52]. Based on the 
membrane capacitance data and FCM results, they also suggested that there is a 
correlation between the specific membrane capacitance and cell cycle phases [52].  
Kim and co-workers (2007) applied the dielectrophoresis activated cell synchroniser 
(DACSync) as a non-invasive device to select and separate mammalian cells based 
on their cell cycle [12]. They used a human breast ductal carcinoma cell line (MDA-
MB-231). DACSync device separated the cells by using the relationship between the 
volume of a mammalian cell and its phase in the cell cycle [12]. It was shown in their 
study that the cell cycle was irreversible, and almost correlated to cell size. At every 
contact with an electrode, the smaller cells (G1/S-phase), experienced a smaller 
deflection force compared with the larger cells (G2/M-phase). MDA-MB-231 cells 
experienced significant changes in cell volume during the cell cycle. As an instance, 
cells in G1/S-phase had an average diameter of 10 µm which increased to an average 
diameter of 20 µm during the G2/M-phase [12]. They also found that the size of the 
cells was positively correlated with their DNA content in each phase.  
In January 2011, Valero and colleagues synchronised and analysed the budding yeast 
cells in late anaphase using equilibrium dielectrophoresis [35]. To achieve this 
purpose, they used equilibrium between DEP forces produced from both sides of a 
sorting channel. A yeast cell suspension having different cell cycle phases flowed 
through the sorting channel. They obtained the trend of yeast’s complex permittivity 
v. frequency throughout the cell cycle. The obtained results demonstrated that at low 
frequencies the largest differences between different cell cycle phases were visible 
[35]. However, this value no longer relied on the cell cycle phases at high 
frequencies. The results of the real part of complex permittivity showed that this 
value increased with cell cycle progression.  
Nevertheless, all of these works did not thoroughly investigate at what particular 
points these changes occurred. Moreover, they did not look into other 
electrophysiological properties of the cells during the cell cycle. To address the need 
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of a detailed study on the electrophysiological properties of cells through their cell 
cycle, this research aimed to investigate whether the cellular electrophysiological 
properties (particularly the effective membrane capacitance, the effective membrane 
conductance and the cytoplasmic conductivity) vary between different phases 
through the cell cycle, in vitro. Moreover, it aimed to assess the relation between the 
intracellular DNA percentage in each phase and the acquired DEP data to find out 
the possible correlation between cell cycle phases and cellular electrophysiological 
properties. 
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3 ELECTROPHYSIOLOGICAL PROPERTIES OF 
SYNCHRONISED K562 CELLS THROUGH THE CELL CYCLE - 
USING THE SERIAL DESIGN OF THE DEP-MICROWELL 
ELECTRODE SYSTEM 
3.1 INTRODUCTION 
As described in the previous chapter, studies of cellular electrophysiological 
properties can aid the understanding of fundamental biological processes and obtain 
information about tissue compositions and structures such as the presence of a 
tumour [14]. Knowledge of these electrophysiological properties, especially through 
the cell cycle, can potentially provide new insights in cancer studies [14-17]. 
Moreover, it could be a reliable method to detect particular stages which could be of 
use for targeting the cancerous cells. In addition, characterising the cells and 
investigating their electrophysiological properties during the cell cycle may help to 
elucidate the ion channels mechanism of action in detail. Over the past two decades, 
the electrophysiological properties of a range of cell types through the cell cycle have 
been studied applying AC electrokinetic techniques. 
In 1999, Huang and colleagues, by applying electrorotation, demonstrated that the 
electrophysiological properties of T-Lymphocyte cells vary through the cell cycle 
[52]. Since human peripheral blood T-lymphocytes are normally resting at the G0-
phase, they used phytohemagglutinin (PHA) and interleukin-2 (IL-2) to stimulate the 
cells to go through the cell cycle. To determine cell cycle distributions, they 
examined the cells by flow cytometry at 24 h intervals for up to 96 h. The obtained 
results of the study showed that the average cytoplasmic conductivity of the cells 
decreased at 24 h after stimulation by 25%. The average cytoplasmic permittivity of 
the cells remained almost unchanged up to 96 h after stimulation [52]. The achieved 
results also showed that the specific membrane capacitance decreased by 15% during 
the first 24 hour after stimulation. This value sharply increased by 60% between 24 h 
and 48 h and remained relatively unchanged thereafter. The authors considered that 
the observed changes in the membrane capacitance, before and after stimulation, 
were dominated by the alteration of cell membrane morphology [52]. Based on the 
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membrane capacitance data and FCM results, they also suggested that there is a 
correlation between the specific membrane capacitance and cell cycle phases [52].  
Kim and co-workers (2007) applied the dielectrophoresis activated cell synchroniser 
(DACSync) as a non-invasive device to select and separate mammalian cells based 
on their cell cycle [12]. They used a human breast ductal carcinoma cell line (MDA-
MB-231). DACSync device separated the cells by using the relationship between the 
volume of a mammalian cell and its phase in the cell cycle [12]. It was shown in their 
study that the cell cycle was irreversible, and almost correlated to cell size. At every 
contact with an electrode, the smaller cells (G1/S-phase) experienced a smaller 
deflection force compared with the larger cells (G2/M-phase). MDA-MB-231 cells 
experienced significant changes in cell volume during the cell cycle. As an instance, 
cells in G1/S-phase had an average diameter of 10 µm which increased to an average 
diameter of 20 µm during the G2/M-phase [12]. They also found that the size of the 
cells was positively correlated with their DNA content in each phase.  
In January 2011, Valero and colleagues synchronised and analysed the budding yeast 
cells in late anaphase using equilibrium dielectrophoresis [35]. To achieve this 
purpose, they used equilibrium between DEP forces produced from both sides of a 
sorting channel. A yeast cell suspension having different cell cycle phases flowed 
through the sorting channel. They obtained the trend of yeast’s complex permittivity 
v. frequency throughout the cell cycle. The obtained results demonstrated that at low 
frequencies the largest differences between different cell cycle phases were visible 
[35]. However, this value no longer relied on the cell cycle phases at high 
frequencies. The results of the real part of complex permittivity showed that this 
value increased with cell cycle progression. 
Nonetheless, they did not thoroughly investigate at what particular points these 
changes occurred. Moreover, they did not look into other electrophysiological 
properties of the cells during the cell cycle. 
3.1.1 Aims and Outline 
To address the need of a detailed study on the electrophysiological properties of cells 
through their cell cycle, this chapter aims to determine whether the serial design of 
the DEP-microwell electrode system, developed and patented at the University of 
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Surrey (2003), could be applied for the first time as a real time and label-free method 
to study electrophysiological properties of cells through the cell cycle. 
This chapter also aims to investigate whether the cellular electrophysiological 
properties (particularly the effective membrane capacitance, effective membrane 
conductance and the cytoplasmic conductivity) vary between different phases 
through the cell cycle, in vitro. Moreover, it aims to assess if each cell cycle phase 
has its own electrophysiological property, i.e. if the properties of different phases 
map on to a single sequence of electrophysiological properties. 
In order to meet the aims of the chapter, the serial design of the DEP-microwell 
electrode system was used to obtain the dielectric spectra of a chronic myelogenous 
leukaemia cell line (K562) throughout the cell cycle and to characterise the cells 
based on their cellular electrophysiological properties. A single-shell model was used 
to determine the electrophysiological properties of cells throughout the cell cycle 
from the dielectric spectra. For the purpose of having the cells at different stages of 
the cycle, cells were synchronised at two main cell cycle checkpoints, G0/G1 and 
G1/S, using serum starvation and hydroxyurea cell treatment methods, respectively. 
DEP measurements were carried out for cells before treatment (control cells), 
immediately after treatment (0h-study) and at 2, 4 and 24 hours after releasing the 
cells back to the culture medium for each synchronisation method. 
3.2 MATERIALS AND METHODS 
3.2.1 Cell culture 
In this chapter, the widely used and robust human chronic myelogenous leukaemia 
cell line (K562) was selected as a model cell line for cancer.  
The cells were bought from LGC Standards (Teddington, UK) and were distributed 
into 1 ml vials at a concentration of 1×10
6
 cells ml
-1
. The vials contained RPMI-1640 
solution supplemented with 10% (v/v) heat inactivated foetal bovine serum (FBS), 2 
mM L-glutamine and 5% (v/v) dimethyl sulfoxide (DMSO). They were stored frozen 
in liquid nitrogen tanks (-178 °C) and were thawed prior to use [83]. All cell culture 
reagents were obtained from Biosera (Labtech International Ltd, East Sussex, UK). 
In 1970, K562 cell line was derived by Lozzio and Lozzio from the blood of a 53 
year old female patient who suffered from chronic myelogenous leukaemia (CML) 
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for about 4 years [84]. In their research, these cells were described as rounded and 
non-adherent with short microvilli on cell surface (Figure 3.1). The majority of cells 
measured 14 - 17 µm in diameter. They started to proliferate actively as soon as they 
were incubated in the culture medium [84].  
   
Figure 3.1. K562 cell line under the microscope 
(A) K562 cell line in the culture medium which was observed under the inverted light microscope (Nikon, Tokyo, 
Japan) with 10× magnification (Scale bar = 50 μm), (B) Scanning electron microscopy (SEM) of a K562 
leukaemia cell ×6000 (Part B taken from [85]) 
K562 cells were cultured at a density of 5×105 cells ml-1 in suspension. They were 
grown in RPMI-1640 supplemented with 10% (v/v) heat inactivated FBS and 2 mM 
L-glutamine. The cells were cultured under standard cell culture conditions, i.e. in a 
humidified incubator (CO-150, New Brunswick Scientific, Edison, NJ, USA) with 
constant flow of 5% CO2 and 95% humidified air at 37 °C. 
The cells were grown in vented cap T80 culture flasks. The RPMI solution contained 
a pH indicator that will turn yellow from a red colour indicating a rise in cell wastes 
and dead cells. To keep the cells viable, they were sub-cultured regularly and the 
growth medium was changed three times a week, depending on cell growth and 
confluence (a population of 1×106 cells ml-1 was considered confluent (100% 
confluencey) - Appendix A). 
3.2.2 Cell radius measurements 
To investigate cell properties during the cell cycle in more detail, cell radius was 
measured. An aliquot of cell sample was transferred onto a haemocytometer 
(Marienfield superior, 0.0025 mm
2
, Germany). Then by means of a camera 
(Dolphine, F145B, Germany) connected to an inverted light microscope (Nikon, 
Tokyo, Japan) and a PC running ImageJ software (National Institute of Health, 
Maryland, U.S.), images of cells dispersed over the grid region of the 
haemocytometer were captured (Figure 3.2). Images of cells were analysed using this 
A B 
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software to measure cell diameters by placing a line across the centre of each cell. 
The cell radius was then determined by dividing the diameter by two. 75 cells were 
measured for each sample (n = 75). This experiment was repeated three times. 
     
Figure 3.2. K562 cell line dispersed over the haemocytometer grid region 
K562 cells in the culture medium which was observed under the haemocytometer using a camera connected to an 
inverted light microscope with 10× magnification (Scale bars = 50 μm). 
3.2.3 Cell viability measurements 
In order to determine the percentage of viable cells in a given volume, the viable 
cells were counted by the trypan blue dye exclusion method. For this purpose, a 
dilution of single cells suspension of interest and sterilised trypan blue (Sigma-
Aldrich Company Ltd., Dorset, UK) was prepared. This was followed by taking an 
aliquot of cell sample onto a haemocytometer. Using an inverted light microscope, 
dispersed viable cells over the grid region of the haemocytometer were counted. 
According to the fact that the dead cells have lost their membrane integrity, the 
exclusion dye can penetrate the cell membrane and make it blue. Thus, viable cells 
remain clear and appear unstained under the microscope.  
To determine the percentage of viable cells in a given volume, equation below was 
used: 
Viability % = [Number of viable cells / Total number of cells] × 100 
3.2.4 Cell cycle synchronisations 
In order to synchronise the cells in G0/G1 and G1/S-phase, serum starvation (growth-
arrested) and hydroxyurea treatment methods were used, respectively. 
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3.2.4.1 Serum starvation 
To arrest the K562 cells in G0-phase, they were cultured in the growth medium 
without FBS at a density of 5×10
5
 cells ml
-1 
(sub-confluence) for 36 hours, based on 
the recommended protocols from the literature [23]. Viability of the cells after 
treatment was above 90%. To release the cells from quiescence (G0-phase), they 
were placed in growth medium containing 10% (v/v) FBS. This experiment was 
repeated four times (n = 4). 
3.2.4.2 Hydroxyurea treatment 
Hydroxyurea (HU) was used to arrest the K562 cells near the G1/S checkpoint. To 
prepare the HU (Sigma-Aldrich Company Ltd., Dorset, UK - Appendix B) stock 
solution, the powder was dissolved in RPMI solution and filter-sterilised. To arrest 
the cells, they were treated with an aliquot of HU stock solution to provide a final 
concentration of 10 mM. They were cultured at a density of 5×10
5
 cells ml
-1 
for 4 
hours, based on the recommended protocols from the literature [86] . 
Treating the cells for 4 hours and the concentration of 10 mM arrested them in late 
G1-phase and their viability was above 90%. After 4 hours of incubation under 
standard cell culture conditions, cell suspensions were centrifuged at room 
temperature at 150 × g for 5 minutes and supernatant was removed. Cells were then 
washed twice with pre-warmed culture medium at 37 °C, and then resuspended in the 
medium. This experiment was repeated three times (n = 3). 
3.2.5 DEP sample preparation 
The DEP buffer was a low conductivity medium, described in detail as follows: The 
cells were resuspended in the DEP buffer prior to DEP experiments. This iso-osmotic 
medium consisted of 8.5% (w/v) Sucrose (Sigma Aldrich, UK) and 0.3% (w/v) 
Glucose (Sigma Aldrich, UK) dissolved in de-ionised (DI) water [22, 79, 87].  The 
final conductivity of the DEP medium was adjusted to 14 mS m
-1
 using phosphate 
buffered saline (PBS), 100 µM CaCl2 and 250 µM MgCl2 (Sigma Aldrich, UK). 
CaCl2 and MgCl2 were added to modify the ionic composition of the DEP buffer with 
ionic composition close to that of physiological media. The DEP buffer conductivity 
was verified with a Jenway 470 conductivity meter (VWR Jencons, Leicestershire, 
UK) at room temperature. 
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After pelleting the cells by centrifuging at 150 × g for 5 minutes at room 
temperature, they were washed twice by centrifugation at 50 × g for 5 minutes in the 
DEP buffer then resuspended in this iso-osmotic medium. The final cell 
concentration was adjusted to 3 × 10
6
 cells ml
-1
 (± 20%) for the DEP measurements.  
3.2.6 The experimental set up using the serial design of the DEP-microwell electrode 
system and measurement procedures 
As shown in Figure 3.3, the serial design (prototype) of the DEP-microwell electrode 
experimental system consisted of an upright light microscope (Nikon-Eclipse-50i, 
Tokyo, Japan) with 4× magnification equipped with a camera (AVT Dolphine, 
F145B, Germany) connected to a PC, a signal generator (FG100, Digimess®, UK) 
and an oscilloscope (IDS 710, ISO-Tech). The DEP-microwell electrode was placed 
on the microscope stage. 
       
            (A)                                                           (B) 
Figure 3.3. DEP-microwell electrode and the experimental set up 
(A) The DEP-microwell electrode used in the current study (Scale bar = 5 mm), a. the connecting points to the 
signal generator using some wires, b. DEP-microwells, (B) The experimental set up: 1. PC running MATLAB 
program, 2. Camera, 3. DEP-microwell electrode, 4. Upright microscope, 5. Cell sample in an eppendorf , 6. 
Oscilloscope, 7. Function generator 
DEP measurements were obtained using this serial design of DEP-microwell 
electrode system developed and patented at the University of Surrey in 2003 [65]. As 
described in section 2.6.4.1, this system composed of a laminate of alternating layers 
(stripes) of gold-plated copper ring electrodes and polyamide insulators with the 
holes drilled through the structure (named as wells) with a transparent base attached 
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under the holes [81, 82]. Each well was typically 3 mm deep and 750 μm in 
diameter, with 8 layers of electrode around the well circumference with a thickness 
of 70 µm and gaps of 75 µm between the layers [20, 65, 81, 82]. 
Once the set up was prepared, for each DEP measurement, approximately 10µl of the 
stock cell solution (section 3.2.5) was injected into a well in the DEP-microwell 
electrode. Thereafter, the well was covered with a thin layer microscope cover slip 
and all the possible bubbles inside were removed gently using the needle tip of the 
loading syringe. The cell sample was viewed under an upright light microscope with 
a 4× magnification. A camera connected to a PC captured images of the well 
throughout the DEP experiment using Photolite software (Photonic science, 
Cambridge). 
The electrodes were energised using a signal generator, generating a sinusoidal wave 
with a 10 Vp-p signal over a wide range of frequencies between 1 kHz and 20 MHz at 
5 frequencies per decade. The signal was monitored by a digital oscilloscope (IDS 
710, ISO-Tech). To monitor and evaluate the changes in cell distribution over time, 
images were captured every 3 seconds for a period of 60 seconds of electrode 
excitation at each frequency. Cells movements were monitored by observing the 
changes in light intensity in the microwell during the application of an AC signal. 
Once the signal generator started delivering the desired AC signal, the image 
acquisition was manually started. 
The applied AC electric field resulted in positive or negative DEP. During p-DEP, 
the concentration of cells near the electrodes at the well perimeter was increased 
which resulted in a decrease in light intensity in this area, and an increase in light 
intensity at the centre of the well. In contrast, during n-DEP, the concentration of 
cells located at the centre of the well was increased which resulted in a decrease in 
light intensity in this area and an increase in light intensity around the edge of the 
well [22, 81, 82].  
The change in light intensity across the well over the time of electrode excitation was 
assessed using a MATLAB (R2012a, The Mathwork Inc., Natick, USA) script; 
“DEP-well plotter”, as shown in Figure 3.4, which was developed by the BME 
Centre at the University of Surrey. 
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Figure 3.4. DEP-well plotter - MATLAB script 
The change in light intensity across the well over the time of electrode excitation was assessed using a MATLAB 
(R2012a, The Mathwork Inc., Natick, USA) script; “DEP-well plotter”, which was developed by the BME Centre 
at the University of Surrey. This program is based on numerical methods to obtain the best-fit line for the 
collected data to the single-shell dielectric model. 
This program was based on numerical methods to obtain the best-fit line for the 
collected data (light intensity) to the single-shell dielectric model [20]. Since the net 
cell polarisability is proportional to the change in light intensity, this method can be 
used to determine the cells electrophysiological properties [20, 22, 65]. The change 
in light intensity was normalised to an image taken before energising the electrodes 
at time zero (overall, 21 images were recorded).  
DEP measurements were carried out for cells before treatment (control cells), 
immediately after treatment (0h-study) and at 2, 4 and 24 hours after releasing the 
cells back to culture medium for each synchronisation method. After each frequency 
run, the cell sample was extracted from the well by syringe suction. Then, the well 
was cleaned with the DEP buffer and wiped thoroughly. After that, a new cell sample 
was injected into the DEP well to prevent any possible detrimental electric current 
effects on the cells. In order to reduce the effect of variation in the cell number in 
each sample, the DEP measurements were repeated at least three times (n = 3). 
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3.2.7 Data presentation and statistical analysis 
At least three dielectric spectra (n = 3) were obtained for controls and each cell 
synchronisation methods at different time points throughout the cell cycle (0, 2, 4 & 
24h-study). The cytoplasmic conductivity and the effective membrane capacitance 
and conductance for each DEP spectrum were determined by curve-fitting a single-
shell model to each spectrum. The best fit model was found by matching the curve to 
the measured data, and then adjusting the membrane and the cytoplasm’s dielectric 
parameters until the best match was found. For all measurements, the best-fit line had 
a correlation coefficient of 0.95 or above. The mean cell radius, cytoplasmic 
conductivity and effective membrane capacitance and conductance for each cell 
sample were calculated by averaging the values obtained for each spectrum. Data 
were presented as mean ± standard deviation (SD). 
Statistical analysis was carried out using the SPSS software (IBM SPSS Statistics, 
Version 22, SPSS Inc. Chicago, IL). Cellular electrophysiological properties and cell 
radius measurements were analysed performing the following tests: Non-parametric 
independent-samples Kruskal-Wallis 1-way ANOVA (to compare the distributions 
across groups), Non-parametric Related-samples Wilcoxon signed rank test (to 
compare median of differences between groups) and Non-parametric Related-
samples Friedman’s 2-way ANOVA by ranks (to compare the distributions across 
groups). A p value of less than 0.05 was considered statistically significant. 
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3.3 RESULTS 
3.3.1 Changes in the cell radius 
In order to achieve a better understanding of the effects of cell synchronisation 
methods (described in 3.2.4) on the K562 cells, the cell radii of the untreated 
(control) and treated cells were measured throughout the experiments. Moreover, the 
cell radius measurements were needed for the DEP analysis. The cell radii of SS and 
HU treated cells were obtained before starting the treatment (control) and after each 
treatment for different time points throughout the cell cycle (0, 2, 4 & 24h-study) as 
shown in Figure 3.5. 
 
Figure 3.5. Changes in cell radii of K562 cells before and after the serum starvation (SS) and 
hydroxyurea (HU) treatments 
Trends in cell radii of K562 cells as a function of time after the serum starvation (SS) and hydroxyurea (HU) 
treatments (releasing them back into the cell cycle) compared to control cells is shown. The cell radius was 
determined by using ImageJ software to measure cell diameters for each sample. Data points are average of at 
least three experiments (n = 3). 75 cells were measured per experiment. Data are mean values ± SD. Error bars 
denote the standard deviation. 
The mean cell radius of SS treated cells immediately after treatment (0h-study) 
remained almost the same as the control cells (decreased in size by 0.14%). Two 
hours after releasing cells back into the cell cycle, this value reduced by 1.6% 
compared to the control. It was 7.03 µm (±0.08) for the 0h-study and became 6.92 
µm (±0.24) for the 2h-study. Four hours after releasing cells back into the cell cycle, 
the mean cell radius showed a relative increase by 4.6% compared to the 2h-study 
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cells (from 6.92 µm (±0.24) to 7.24 µm (±0.37)). All these changes were not 
statistically significant (p = 0.406 (based on non-parametric independent-samples 
Kruskal-Wallis 1-way ANOVA test) - Appendix D - section 8.4.1). The mean cell 
radius of SS treated cells at 24 hours after treatment was back to the size of the 
control cells. 
For HU treated cells, mean cell radius after 4 hours of treatment reduced by 4.95% 
(from 7.28 µm (±0.18) for control to 6.92 µm (±0.1) for the 0h-study). The radius of 
treated cells reduced by 0.7% compared to the 0h-study, two hours after releasing 
cells back into the cell cycle. However, the size of the cells showed a relative 
increase by 2.5% (from 6.87 µm (±0.26) to 7.04 µm (±0.28)), 4 hours after releasing 
cells back into the cell cycle. Finally, the mean cell radius of HU treated cells at 24 
hours after treatment increased by 5.7% (from 7.04 µm (±0.28) for the 4h-study to 
7.44 µm (±0.15) for the 24h-study). All these changes were not statistically 
significant (p = 0.406 (based on non-parametric independent-samples Kruskal-Wallis 
1-way ANOVA test) - Appendix D - section 8.4.1).  
Based on the results of statistical tests, the median of differences between the cell 
radii values for these two synchronisation methods are equal to zero (p = 0.655 
(based on non-parametric Related-samples Friedman’s 2-way ANOVA by ranks test) 
- Appendix D - section 8.4.1). This suggests that there is no significant change in cell 
radii throughout the cell cycle comparing these two synchronisation methods. 
3.3.2 DEP experiments and spectra 
The aim of performing these experiments was to analyse the untreated (control) and 
treated K562 cells’ motion in the presence of DEP electric force over a wide range of 
frequencies. Dielectric spectra of control, SS and HU treated K562 cells were 
obtained in this study. DEP measurements were carried out for control cells and after 
each treatment for different time points throughout the cell cycle (0, 2, 4 & 24h-
study) for each synchronisation method. 
The DEP-well plotter MATLAB script was used to obtain the best-fit line for a 
single-shell dielectric model fitted to the measured data [20]. The best-fit line was 
obtained by scaling the polarisability by an arbitrary factor to match the curve to the 
collected data, and then altering the electrophysiological properties of the cytoplasm 
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and membrane until a best curve fitting was found. An example of a dielectric 
spectrum of control K562 cells is shown in Figure 3.6.  
 
 
Figure 3.6. A typical DEP spectrum of control K562 cells 
An example of a DEP spectrum of K562 cells is shown. Data points are average of at least three experiments (n 
= 3). Cell motion was analysed using the serial design of DEP-microwell electrode system as a function of 
frequency. Five frequencies per decade from 1 kHz to 20 MHz were measured. The error bars represent the 
standard deviation of the average change in light intensity. A best-fit line was added to the DEP spectra. It was 
used to fit the light intensity measurement to the single-shell model to determine the cells electrophysiological 
properties. The best-fit line had a correlation coefficient above 0.95. 
 
Averaged dielectric spectra of SS and HU treated K562 cells were determined and 
presented in Figures 3.7 and 3.8. The error bars represent the standard deviation of 
the average change in light intensity. 
 
 
 
 
 
 
 
 
Control 
R = 0.993 
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Figure 3.7. DEP spectra of serum starved (SS) K562 cells at 0, 2, 4, 24 h after releasing from treatment 
DEP spectra of serum starved (SS) K562 cells at 0, 2, 4, 24 hours after releasing from 36 h of treatment and back 
to cell cycle for average of four repeats per experiment (n = 4) as a function of frequency are shown. For all 
measurements, a best-fit line was added to the DEP spectra, which had a correlation coefficient of 0.95 or above. 
The error bars represent the SD of the average change in light intensity. 
 
 
 
 
 
 
 
 
SS – 0h 
SS – 24h SS – 4h 
SS – 2h 
R = 0.989 R = 0.984 
R = 0.993 R = 0.990 
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Figure 3.8. DEP spectra of hydroxyurea (HU) treated K562 cells at 0, 2, 4, 24 h after releasing from 
treatment 
DEP spectra of hydroxyurea (HU) treated K562 cells at 0, 2, 4, 24 hours after releasing from 4 h of treatment 
and back to cell cycle for average of three repeats per experiment (n = 3) as a function of frequency are shown. 
For all measurements, a best-fit line was added to the DEP spectra, which had a correlation coefficient of 0.95 or 
above. The error bars represent the SD of the average change in light intensity. 
3.3.3. Electrophysiological properties of control and treated K562 cells 
To investigate the cellular electrophysiological properties of untreated (control) and 
treated K562 cells at different phases through the cell cycle and to determine whether 
these properties vary between different phases, these parameters were inferred by 
fitting the obtained DEP spectra to a single-shell dielectric model [88, 89]. The 
acquired electrophysiological properties were cytoplasmic conductivity, effective 
membrane capacitance and effective membrane conductance. 
The electrophysiological properties for control, SS and HU treated cells are shown in 
Figures 3.9 to 3.11. The data points are the average of at least three experiments (n = 
3). Untreated K562 cells were employed as a control set relative to treated cells. 
Each set had its own control. For all DEP experiments, conductivity and permittivity 
of the DEP buffer were 14 mS m
-1
 and 0.7 nF m
-1
, respectively. 
Figure 3.9 demonstrates the overall trends in the cytoplasmic conductivity after 
releasing the cells from the SS and HU treatments compared to control K562 cells. 
HU – 24h HU – 4h 
HU – 2h HU – 0h 
R = 0.984 R = 0.992 
R = 0.989 R = 0.992 
54 
 
For the SS and HU treatments, results showed an increase (at the 0h-study) in 
cytoplasmic conductivity compared to the control cells. 
For the SS treated cells, cytoplasmic conductivity results showed a rising trend from 
control to the 0h-study which subsequently decreased in the initial 24 hours after 
releasing cells back to the cell cycle.  After 36 hours of treatment, this value 
increased by 28.4% from 0.6 S m
-1
 (±0.1) for control to 0.8 S m
-1
 (±0.2) for the 0h-
study. It rapidly reduced by 53.8%, two hours after releasing cells back into the cell 
cycle. It was 0.8 S m
-1
 (±0.1) for the 0h-study and became 0.4 S m
-1
 (±0.1) for the 
2h-study. However, this value showed a relative increase by 27% (from 0.4 S m
-1 
(±0.1) to 0.5 S m
-1 
(±0.2)), 4 hours after releasing cells back into the cell cycle. 
Finally, 24 h after releasing the cells, this value decreased by 36.2% (from 0.5 S m
-1 
(±0.2) for the 4h-study to 0.3  S m
-1 
(±0.1) for the 24h-study). All these changes were 
not statistically significant (p = 0.406 (based on non-parametric independent-samples 
Kruskal-Wallis 1-way ANOVA test) - Appendix D - section 8.4.2). 
 
Figure 3.9. Changes in cytoplasmic conductivity after releasing K56 cells from serum starvation (SS) 
and hydroxyurea (HU) treatments 
A summary of cytoplasmic conductivity of control, SS and HU treated K562 cells as a function of time is shown. 
There was an increase in cytoplasmic conductivity compared to the control for both treatments. The DEP 
response was measured by a change in light intensity at five frequencies per decade between 1 kHz and 20 MHz 
for a period of 60 seconds per frequency. Data points are average of at least three experiments (n = 3). Data are 
mean values ± SD. Error bars denote the standard deviation.  
The trend in the variations of cytoplasmic conductivities throughout the cell cycle for 
HU treated cells was almost the same as SS treated cells. In this case, cytoplasmic 
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conductivity after 4 hours of treatment increased by 32% (from 0.8 S m
-1
 (±0.1) for 
control to 1 S m
-1
 for the 0h-study). This value greatly reduced by 51.5%, two hours 
after releasing cells back into the cell cycle. It was 1 S m
-1
 for the 0h-study and 
became 0.5 S m
-1
 (±0.1) for the 2h-study. However, this value showed a rapid 
increase by 81.3% (from 0.5 S m
-1 
(±0.14) for the 2h-study to 0.9 S m
-1 
(±0.1)) 4 h 
after release. Finally, after 24 h of releasing cells back into the cell cycle, this value 
decreased by 19.5% (from 0.9 S m
-1 
(±0.1) for the 4h-study to 0.7 S m
-1 
(±0.2) for the 
24h-study). All these changes were not statistically significant (p = 0.406 (based on 
non-parametric independent-samples Kruskal-Wallis 1-way ANOVA test) - 
Appendix D - section 8.4.2).  
Based on the results of statistical tests, the median of differences between the 
cytoplasmic conductivity values for these two synchronisation methods are not equal 
to zero (p = 0.042 (based on non-parametric Related-samples Wilcoxon signed rank 
test) - Appendix D - section 8.4.2). This may suggest that by comparing these two 
synchronisation methods, there is a significant change in cytoplasmic conductivity 
values throughout the cycle. 
Figure 3.10 reveals the trends in ceff after releasing the cells from the SS and HU 
treatments. 
For the SS treatment, a decrease by ~8% can be seen in the 0h-study compared to the 
control cells. However, this reduction gradually increased by ~2% two hours after 
releasing cells back into the cell cycle which continued through the cell cycle. It was 
9.8 mF m-2 (±2.4) for the 0h-study and became 10 mF m-2 (±1.7) for the 2h-study. 
Four hours after release, this value again showed a rising trend by 4%. Finally, after 
24 h of releasing cells back into the cell cycle, ceff increased more by 8.7% (from 
10.4 mF m-2 (±0.7) for the 4h-study to 11 mF m-2 (±3.5) for the 24h-study). All these 
changes were not statistically significant (p = 0.406 (based on non-parametric 
independent-samples Kruskal-Wallis 1-way ANOVA test) - Appendix D - section 
8.4.3). 
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Figure 3.10. Changes in ceff after releasing K562 cells from serum starvation (SS) and hydroxyurea 
(HU) treatments 
A summary of ceff of control, SS and HU treated K562 cells as a function of time is shown. There was an increase 
in ceff for HU treated cells and a decrease for SS treated cells compared to the control. The DEP response was 
measured by a change in light intensity at five frequencies per decade between 1 kHz and 20 MHz for a period of 
60 seconds per frequency. Data points are average of at least three experiments (n = 3). Data are mean values ± 
SD. Error bars denote the standard deviation. 
In contrast, for HU treatment, a rise in ceff value by 76.5% can be seen in the 2h-
study compared to control cells. Then ceff started to gradually reduce by ~45% from 
the 2h-study to 24 hours after releasing cells back into cell cycle (a downward trend). 
All these changes were not statistically significant (p = 0.406 (based on non-
parametric independent-samples Kruskal-Wallis 1-way ANOVA test) - Appendix D - 
section 8.4.3). 
Based on the results of statistical tests, the median of differences between the ceff 
values for these two synchronisation methods are not equal to zero (p = 0.042 (based 
on non-parametric Related-samples Wilcoxon signed rank test) - Appendix D - 
section 8.4.3). This may suggest that by comparing these two synchronisation 
methods, there is a significant change in ceff values throughout the cycle. 
Figure 3.11 reveals the trends in geff after releasing the cells from the SS and HU 
treatments. 
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Figure 3.11. Changes in geff after releasing K562 cells from serum starvation (SS) and hydroxyurea 
(HU) treatments 
A summary of geff of control, SS and HU treated K562 cells as a function of time is shown. There was an increase 
in geff for HU treated cells and a decrease for SS treated cells compared to the control. The DEP response was 
measured by a change in light intensity at five frequencies per decade between 1 kHz and 20 MHz for a period of 
60 seconds per frequency. Data points are average of at least three experiments (n = 3). Data are mean values ± 
SD. Error bars denote the standard deviation. 
For the SS treatment, a decrease by ~23% can be seen in the 0h-study compared to 
control cells. However, this value gradually increased by 10.6%, two hours after 
releasing cells back into the cell cycle. Four hours after release, this value again 
showed a falling trend by 8%. Finally, after 24 h of releasing cells back into the cell 
cycle, geff increased by 23.5% (from 1278 S m
-2 (±343) for the 4h-study to 1578 Sm-2 
(±32) for the 24h-study). All these changes were not statistically significant (p = 
0.406 (based on non-parametric independent-samples Kruskal-Wallis 1-way ANOVA 
test) - Appendix D - section 8.4.4). 
In contrast, for HU treatment, a rise in geff value by 19.3% can be seen in the 0h-
study compared to the control cells. Then geff started to gradually reduce by 9.6% 
from the 0h-study to 2h-study. However, this reduction in the value of geff increased 
by 21.4% from the 2h-study to 24 hours after releasing cells back into cell cycle (a 
rising trend). All these changes were not statistically significant (p = 0.406 (based on 
non-parametric independent-samples Kruskal-Wallis 1-way ANOVA test) - Appendix 
D - section 8.4.4). 
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Based on the results of statistical tests, the median of differences between the geff 
values for these two synchronisation methods are equal to zero (p = 0.138 (based on 
non-parametric Related-samples Wilcoxon signed rank test) - Appendix D - section 
8.4.4). This suggests that there is no significant change in geff throughout the cell 
cycle comparing these two synchronisation methods. 
3.3.4. Electrophysiological properties of control and treated K562 cells compared to the 
cell radii trends 
In order to advance the understanding of the effects of cell synchronisation methods 
used in this study (described in 3.2.4) on K562 cells and to investigate the changes in 
electrophysiological properties in more detail, the trends in the variations of 
electrophysiological properties  are compared to the cell radii of the untreated and 
treated cells in this section. Figures 3.12 to 3.17 are trends in the variations of the 
cytoplasmic conductivity, ceff and geff values after releasing cells from the SS and HU 
treatments compared to the cell radius trends. Data points are average of at least three 
repeats (n = 3). 
 
Figure 3.12. Changes in cytoplasmic conductivity after releasing K562 cells from serum starvation 
(SS) compared to cell radius as a function of time 
Comparison of cytoplasmic conductivity of control and serum starved (SS) K562 cells to cell radius data as a 
function of time is shown. The DEP response was measured by a change in light intensity at five frequencies per 
decade between 1 kHz and 20 MHz for a period of 60 seconds per frequency. A single-shell model was used to 
determine the electrophysiological properties of each DEP spectrum. The cell radius was determined by using 
ImageJ software to measure cell diameters for each sample. Data points are average of four experiments (n = 4). 
75 cells were measured per experiment. Data are mean values ± SD. Error bars denote the standard deviation.  
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In Figure 3.12, cytoplasmic conductivity against cell radius for the SS treatment, the 
obtained results showed an increase in cytoplasmic conductivity value from control 
to the 0h-study which subsequently decreased in the initial 24 hours after releasing 
cells back to the cell cycle. However, this falling trend showed a relative increase 
followed by a decrease in the cytoplasmic conductivity value at 2 h and 4 h after 
releasing cells back into the cell cycle, respectively. For the cell radius after 36 hours 
of serum starvation, there was not a significant change compared to the control cells. 
However, it showed a relative decrease followed by an increase in the value after 2 h 
and 4 h after releasing cells back into the cell cycle, respectively. Finally, the mean 
cell radius of SS treated cells at 24 h after treatment was back to the size of the 
control cells (a downward trend).  
 
Figure 3.13. Changes in cytoplasmic conductivity after releasing K562 cells from hydroxyurea (HU) 
treatment compared to cell radius as a function of time 
Comparison of cytoplasmic conductivity of control and hydroxyurea (HU) treated K562 cells to cell radius data 
as a function of time is shown. The DEP response was measured by a change in light intensity at five frequencies 
per decade between 1 kHz and 20 MHz for a period of 60 seconds per frequency. A single-shell model was used 
to determine the electrophysiological properties of each DEP spectrum. The cell radius was determined by using 
ImageJ software to measure cell diameters for each sample. Data points are average of three experiments (n = 
3). 75 cells were measured per experiment. Data are mean values ± SD. Error bars denote the standard 
deviation. 
In Figure 3.13, cytoplasmic conductivity against cell radius for the HU treatment, the 
acquired results showed an increase in cytoplasmic conductivity for the 0h-study 
followed by a subsequent decrease for the 2h-study. However, this falling trend 
showed a rapid increase followed by another decrease in the value for 4 h and 24 h 
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after releasing cells back into the cell cycle, respectively. In terms of the cell radius, 
the mean value for the 2h-study reduced by 5.6% compared to the control cells. Cell 
size showed a relative increase during the first 24 hours after releasing cells back into 
cell cycle. 
In Figure 3.14, ceff against cell radius for the SS treatment, a decrease by ~8% can be 
seen in ceff value immediately after incubation compared to control cells. However, 
two hours after releasing cells back into the cell cycle, this reduction in the value of 
ceff gradually increased which continued through the cycle. For the cell radius after 
36 hours of serum starvation, there was not a significant change compared to the 
control cells. However, it showed a relative decrease followed by an increase in the 
value after 0 h and 2 h after releasing cells back into the cell cycle. Finally, the mean 
cell radius of SS treated cells at 24 hours after treatment was back to the size of the 
control cells (a downward trend).  
 
Figure 3.14. Changes in the effective membrane capacitance after releasing K562 cells from serum 
starvation (SS) compared to cell radius as a function of time 
Comparison of the effective membrane capacitance (ceff) of control and serum starved (SS) K562 cells to cell 
radius data as a function of time is shown. The DEP response was measured by a change in light intensity at five 
frequencies per decade between 1 kHz and 20 MHz for a period of 60 seconds per frequency. A single-shell 
model was used to determine the electrophysiological properties of each DEP spectrum. The cell radius was 
determined by using ImageJ software to measure cell diameters for each sample. Data points are average of four 
experiments (n = 4). 75 cells were measured per experiment. Data are mean values ± SD. Error bars denote the 
standard deviation.  
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In Figure 3.15, ceff against cell radius for the HU treatment, a rise in ceff value by 
~52% can be seen in the 0h-study compared to control cells. This rising trend 
continued through the cell cycle by ~16% for the 4h-study. Then ceff started to 
gradually reduce by ~45% from 2 h to 24 h after releasing cells back into cell cycle 
(a downward trend). In terms of the cell radius, the mean value after 4 hours of 
treatment reduced by 5.6% compared to control cells. It showed a relative increase 
during the first 24 hours after releasing cells back into cell cycle. 
 
Figure 3.15. Changes in the effective membrane capacitance after releasing K562 cells from 
hydroxyurea (HU) treatment compared to cell radius as a function of time 
Comparison of the effective membrane capacitance (ceff) of control and hydroxyurea (HU) treated K562 cells to 
cell radius data as a function of time is shown. The DEP response was measured by a change in light intensity at 
five frequencies per decade between 1 kHz and 20 MHz for a period of 60 seconds per frequency. A single-shell 
model was used to determine the electrophysiological properties of each DEP spectrum. The cell radius was 
determined by using ImageJ software to measure cell diameters for each sample. Data points are average of 
three experiments (n = 3). 75 cells were measured per experiment.. Data are mean values ± SD. Error bars 
denote the standard deviation. 
In Figure 3.16, geff against cell radius for the SS treatment, a decrease by ~23% can 
be seen in geff value immediately after incubation compared to the control cells. 
However, two hours after releasing cells back into the cell cycle, this reduction in the 
value of geff gradually increased which continued through the cycle. For the cell 
radius after 36 hours of serum starvation, there was not a significant change 
compared to the control cells. However, it showed a relative decrease followed by an 
increase in the value after 0 h and 2 h after releasing cells back into the cell cycle. 
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Finally, the mean cell radius of SS treated cells at 24 hours after treatment was back 
to the size of the control cells (a downward trend). 
 
Figure 3.16. Changes in the effective membrane conductance after releasing K562 cells from serum 
starvation (SS) compared to cell radius as a function of time 
Comparison of the effective membrane conductance (geff) of control and serum starved (SS) K562 cells to cell 
radius data as a function of time is shown. The DEP response was measured by a change in light intensity at five 
frequencies per decade between 1 kHz and 20 MHz for a period of 60 seconds per frequency. A single-shell 
model was used to determine the electrophysiological properties of each DEP spectrum. The cell radius was 
determined by using ImageJ software to measure cell diameters for each sample. Data points are average of four 
experiments (n = 4). 75 cells were measured per experiment. Data are mean values ± SD. Error bars denote the 
standard deviation.  
In Figure 3.17, geff against cell radius for the HU treatment, a rise in geff value by 
~19% can be seen in the 0h-study compared to control cells. Then geff started to 
gradually reduce by 9.6% from the 0h-study to 2h-study. However, this reduction in 
the value of geff gradually increased by 21.4% from the 2h-study to 24 hours after 
releasing cells back into cell cycle (a rising trend). In terms of the cell radius, the 
mean value after 4 hours of treatment reduced by 5.6%. It showed a relative increase 
during the first 24 hours after releasing cells back into the cell cycle. 
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Figure 3.17. Changes in the effective membrane conductance after releasing K562 cells from 
hydroxyurea (HU) treatment compared to cell radius as a function of time 
Comparison of the effective membrane conductance (geff) of control and hydroxyurea (HU) treated K562 cells to 
cell radius data as a function of time is shown. The DEP response was measured by a change in light intensity at 
five frequencies per decade between 1 kHz and 20 MHz for a period of 60 seconds per frequency. A single-shell 
model was used to determine the electrophysiological properties of each DEP spectrum. The cell radius was 
determined by using ImageJ software to measure cell diameters for each sample. Data points are average of four 
experiments (n = 4). 75 cells were measured per experiment. Data are mean values ± SD. Error bars denote the 
standard deviation.  
3.4 DISCUSSION 
This research chapter sought to determine whether the cellular electrophysiological 
properties (particularly the cytoplasmic conductivity, the effective membrane 
capacitance and the effective membrane conductance) were distinct in different 
phases through the cell cycle, applying the serial design of the DEP-microwell 
electrode system, in vitro. Moreover, it aimed to assess if each cell cycle phase has 
its own electrophysiological property, i.e. if the properties of different phases map on 
to a single sequence of electrophysiological properties. 
Hence, the dielectric spectra of control, serum starved and hydroxyurea treated K562 
cells were obtained. Best-fit lines were applied to the spectra and the single-shell 
model was used to infer the σ𝐶𝑃, ceff and geff for each treatment at different time 
points. 
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3.4.1 Comparison between the effects of serum starvation and hydroxyurea treatment 
methods on the cytoplasmic conductivity 
The cytoplasmic conductivities of untreated and treated (section 3.2.4) K562 cells 
were compared throughout the cell cycle at different stages in this research chapter. 
As explained in the results (section 3.3.3), 36 hours of serum starvation increased the 
cytoplasmic conductivity mean value to its peak for the 0h-study by ~28%. After 
restoration of FBS, there was a decreasing trend in this value in the proceeding 24 
hours. However, this falling trend showed a relative increase followed by a decrease 
in the value for 2 h and 4 h after releasing the cells back into the cell cycle. 
Differences in the values of cytoplasmic conductivity are attributed to many factors 
owing to the complex intracellular environment. Cytoplasmic conductivity is 
attributed to the concentration or mobility of free ions through the cytoplasm which 
may be due to the activity of certain ion channels or pumps [22, 72, 75, 78, 90]. 
Based on this, the ionic leakage (efflux) from the cytoplasm through the cell 
membrane into the extracellular medium may cause a decrease in cytoplasm 
conductivity values [75]. Moreover, the increase in cytoplasmic conductivity could 
correspond with the loss of the cell volume (cell radius) as a result of water loss 
which may cause the intracellular ions to become more concentrated inside the cell 
[91]. Hence, the cytoplasmic conductivity value may be inversely proportional to the 
cell radius which is an indication of the cell volume. 
As the cell radius graph showed (Figure 3.5 - section 3.3.1), for the SS treated cells, 
which were arrested at G0/G1-phase, the average size for the 2h-study was smaller 
than the cells in other phases. It could be a sign of cell arrest at G0/G1-phase by SS 
treatment since the cells in G0/G1-phase had not grown sufficiently in volume like the 
cells in mitosis, which are ready to divide. Therefore, the decrease in the cytoplasmic 
conductivity value at this point might be due to the decreased activity of certain ion 
channels. 
A closer look at the cytoplasmic conductivity values for the SS treated cells shows 
that this parameter had an overall decreasing trend from the 0h-study to 24h-study 
after releasing cells back to the growth medium (from 0.8 S m
-1 
(±0.2) to 0.3  S m
-1 
(±0.1)). Based on the given information from the literature [22, 72, 75, 78], this 
reduction might be due to the decreased activity of certain ion channels or the ionic 
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leakage from the cytoplasm. Moreover, the increasing trend in cell radius after the 
2h-study could be another reason for the decrease in cytoplasmic conductivity 
values. Nonetheless, the cytoplasmic conductivity was not inversely proportional to 
the cell radius, as reported in the literature [91]. 
For HU treated cells (as explained in section 3.3.3), results showed an increase in the 
cytoplasmic conductivity value for the 0h-study compared to the control cells which 
subsequently decreased after releasing from the treatment. However, this falling 
trend showed a rapid increase followed by a decrease in the value for 4 h and 24 h 
after releasing cells back into the cell cycle. 
A closer look at the cytoplasmic conductivity values for the HU treated cells shows 
that this parameter had an overall decreasing trend from the 0h-study to 24h-study 
(from 1 S m
-1 
to 0.7 S m
-1 
(±0.2)). Based on the given information from the literature 
[22, 72, 75, 78], this reduction might be due to the decreased activity of certain ion 
channels or the ionic leakage from the cytoplasm. 
When the arrested cells at S-phase were released back to the cell cycle, they should 
start growing through the cell cycle at the following phases, i.e. G2 and M-phase. 
When they pass through mitosis, they will divide and produce new daughter cells. 24 
hours after releasing cells back to the cell cycle, cells were supposed to be in the S-
phase again. That means, in preparation for cytokinesis, they grow in size which 
causes less internal ionic strength. This might be the reason for a sudden drop in 
cytoplasmic conductivity for the 24h-study. However, the cytoplasmic conductivity 
was not inversely proportional to the cell radius, as reported in the literature [91]. 
Overall, the represented mean cytoplasmic conductivity values for HU treated cells 
for the 0h-study (1 S m-1) were higher than SS treated cells values at this point (0.8 S 
m-1) by 25% (p = 0.042). This could suggest that the intracellular ionic strength for 
the HU treated cells was higher than the control and SS treated cells which may be 
confirmed by the smaller cell radius for HU treated cells at this point. 
Generally, the obtained results (for both treatments) may indicate that the σ𝐶𝑃 values 
varied between different phases through the cell cycle, applying the serial design of 
the DEP-microwell electrode system. However, no correlation between the σ𝐶𝑃 
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values at different phases and the cell radii measurements (as an indication of the 
phases through the whole cell cycle) was strongly evident. 
3.4.2 Comparison between the effects of serum starvation and hydroxyurea treatment 
methods on the effective membrane capacitance 
The effective membrane capacitance of untreated and treated (section 3.2.4) K562 
cells were examined throughout the cell cycle at different stages in this study. 
As explained in the results (section 3.3.3), serum starving K562 cells for 36 hours 
caused a reduction by 8% in the cell effective membrane capacitance value 
immediately after incubation compared to control cells. However, this reduction in 
the value of ceff gradually increased by ~2% two hours after releasing cells back into 
the cell cycle which continued through the cell cycle (overall increase by ~12% from 
the 0h-study to 24h-study). 
As described in review of the literature (section 2.6.3), high values of ceff could 
reflect the large membrane surface area associated with complex surface morphology 
including high number of microvilli (density and size), blebs, ruffles and folds in the 
cell membrane [22, 52, 62, 74-76]. By increasing cell membrane surface area, 
microvilli may facilitate cell division process and cause rapid changes in cell 
membrane morphology [74]. So, a reduction in cell membrane effective capacitance 
is mainly due to the changes in the surface morphology of the cells (a decrease in cell 
surface size and complexity) [22, 52].  
Another basic fact is that for a cell to double its volume prior to division, it needs to 
grow continuously throughout the cycle [52].  In this case, the mother cell must have 
~26% excess of membrane prior to cell division [75]. It follows that ceff should 
increase prior to M-phase and decrease after cytokinesis. Therefore, when cells are 
going through the G1-phase, they will have a fall in ceff value [52]. 
Based on these explanations, the reduction in cell effective membrane capacitance 
value for SS treated cells, immediately after incubation compared to the control cells, 
may indicate that cells were arrested at G0/G1-phase and then started to go through 
the G1-phase. It may also show that there existed some considerable changes in the 
morphology of the cells (cell surface size and complexity decreased). However, this 
reduction in the value of ceff gradually increased 2 hours after releasing cells back 
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into the cell cycle which continued through the cell cycle. High values of ceff could 
reflect the large membrane surface area associated with complex surface morphology 
including high number of microvilli (density and size), blebs, ruffles and folds in the 
cell membrane owing to cell growth and going through the cell cycle. Thus, these 
trends may reflect that the effective membrane capacitance values for the SS treated 
cells were dependent on the cell cycle phases.  
In case of HU treated K562 cells, a rise in ceff value can be seen in the 0h-study 
compared to control cells by ~52%. This rising trend continued through the cell cycle 
by ~16% at the 4h-study. Then ceff started to gradually reduce by 45% from 2 h to 24 
h after releasing cells back into cell cycle (a downward trend). This increase in cell 
effective membrane capacitance value (from control to the 4h-study) may indicate 
that the cells were arrested at G1/S-phase and there existed some considerable 
changes in the morphology of the cells in S-phase (cell surface size and complexity 
increased). As noted earlier, for cytokinesis occurrence, cells should be doubled in 
size, which may have a direct effect on the membrane morphology.  
Furthermore, the obtained ceff values for the HU treated cells at the 0h-study were 
higher than the values for SS treated and control cells. Therefore, this experiment 
showed that there existed some variations in case of effective membrane capacitance 
in G0/G1 and S-phase through the cell cycle. It can be seen that there was a difference 
between the ceff of these two phases, with values for SS treated cells being 25% 
lower than those of HU treated cells for the 0h-study (SS treated cells 9.8 mF m-2 
(±2.4) v. HU treated cells 12.3 mF m-2 (±0.6)) which was statistically significant (p = 
0.042). 
Generally, the obtained results (for both treatments) may indicate that the cell 
effective membrane capacitance values varied between different phases through the 
cell cycle, applying the serial design of the DEP-microwell electrode system. 
However, no correlation between the ceff values at different phases and the cell radii 
measurements (as an indication of the phases through the whole cell cycle) was 
strongly evident. 
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3.4.3 Comparison between the effects of serum starvation and hydroxyurea treatment 
methods on the effective membrane conductance 
The effective membrane conductance of untreated and treated (section 3.2.4) K562 
cells were compared throughout the cell cycle at different stages in this study. 
Based on the given information from the literature (section 2.6.3), geff is a function of 
the cell membrane’s conductivity and its thickness. Since the nature of lipid bilayer 
is near-insulating, membrane conductance is mainly evidence of the charge (ion) 
carriers’ net transport (flux) across the membrane through membrane pores, pumps 
and ion channels under the influence of the applied electric field [75, 77-79].   
So, the corresponding trends of increase in the effective membrane conductance 
values should result in great loss of ions from the cytoplasm and considerable ionic 
leakage through the cell membrane, resulting in a decrease of the cytoplasmic 
conductivity. Furthermore, the decreasing trends in geff values possibly accounted for 
less ions efflux from the cytoplasm and less ionic leakage through the membrane. 
Thus, these trends may indicate that the effective membrane conductance results 
should correlate negatively with the cytoplasmic conductivity values.  
As explained in the results (section 3.3.3), for the SS treatment, a decrease by ~23% 
can be seen in the geff value for the 0h-study compared to control cells. However, this 
reduction gradually increased by ~11% two hours after releasing cells back into the 
cell cycle. Four hours after release, this value again showed a falling trend by 8%. 
Finally, after 24 h of releasing cells back into the cell cycle, geff increased by ~24%. 
Moreover, 36 hours of serum starvation increased the cytoplasmic conductivity mean 
value to its peak by ~28%. After restoration of FBS, there was a decreasing trend in 
this value in the proceeding 24 hours. However, this falling trend showed a relative 
increase followed by a decrease in the value for 2 h and 4 h after releasing cells back 
into the cell cycle. So, the obtained results may indicate that the effective membrane 
conductance was inversely proportional to the cytoplasmic conductivity values, as 
reported in the literature. 
For HU treatment, a rise in geff value by ~19% can be seen in the 0h-study compared 
to control cells. Then geff started to gradually reduce by ~10% from the 0h-study to 
the 2h-study. However, this reduction in the value of geff gradually increased by 
~21% from the 2h-study to 24 hours after releasing cells back into cell cycle (a rising 
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trend). Moreover, results showed an increase in cytoplasmic conductivity compared 
to control cells which subsequently decreased immediately after treatment (0h-
study). This falling trend showed a rapid increase followed by a decrease in the value 
for 4 h and 24 h after releasing cells back into the cell cycle. So, the obtained results 
for the HU treated cells showed that the geff value only correlated negatively with the 
σCP at the transition point of the 4h to 24h-study. 
The obtained geff values for the HU treated cells at the 0h-study were higher than 
values for SS treated and control cells. Therefore, this experiment showed that there 
existed some variations in case of effective membrane conductance in G0/G1 and S-
phase through the cell cycle. It can be seen that there was a difference between the 
geff of these two phases, with values for SS treated cells being 37% lower than those 
of HU treated cells at the 0h-study (SS treated cells 1256 S m-2 v. HU treated cells 
1722 S m-2) which was not statistically significant. 
Generally, the obtained results (for both treatments) may indicate that the cell 
effective membrane conductance values varied between different phases through the 
cell cycle, applying the serial design of the DEP-microwell electrode system. 
However, no correlation between the geff values at different phases and the cell radii 
measurements (as an indication of the phases through the whole cell cycle) was 
strongly evident.  
 
Figure 3.18. Summary of the results and discussion of this research chapter 
This figure presents a summary of results and discussion of this research chapter. Key positive and significant 
findings are marked with the bright teal background. 
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3.5 CONCLUDING REMARKS 
In this chapter, the serial design of the DEP-microwell electrode system was applied 
to reveal any electrophysiological properties variation in different phases through the 
cell cycle, in vitro. Hence, the dielectric spectra of control, serum starved and 
hydroxyurea treated K562 cells were obtained. Best-fit lines were applied to the 
spectra and the single-shell model was used to infer the cytoplasmic conductivity, 
effective membrane capacitance and effective membrane conductance for each 
treatment. The obtained results of the study indicated that the cellular 
electrophysiological properties of K562 cells varied between different phases 
through the cell cycle, in vitro. However, no correlation between the obtained 
electrophysiological properties values at different phases and the cell cycle phases 
was strongly evident and the properties of different phases did not map on to a single 
sequence of electrophysiological properties. This possibly happened due to the weak 
time resolution (long time taken to perform each measurement), applying the serial 
design of the DEP-microwell electrode system. 
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4 ELECTROPHYSIOLOGICAL PROPERTIES OF 
SYNCHRONISED K562 CELLS THROUGH THE CELL CYCLE - 
USING THE PARALLEL INTEGRATED DEP-MICROWELL 
ELECTRODE SYSTEM - AN OPTIMISATION STUDY 
4.1 INTRODUCTION 
As described in the previous research chapter, measurements of cellular 
electrophysiological properties can aid the understanding of fundamental biological 
processes. Knowledge of these electrophysiological properties, especially through 
the cell cycle, can potentially provide new insights in cancer studies.  
In chapter three, by using the serial design of the DEP-microwell electrode system, 
electrophysiological properties variation in different phases through the cell cycle 
was revealed, in vitro. As described earlier, the obtained results of the study 
indicated that K562 cell line’s cellular electrophysiological properties (particularly 
the cytoplasmic conductivity, the effective membrane capacitance and the effective 
membrane conductance) varied between different phases through the cell cycle, in 
vitro. 
However, no correlation between the obtained electrophysiological properties values 
at different phases and the cell cycle phases was strongly evident and the properties 
of different phases did not map on to a single sequence of electrophysiological 
properties. This possibly happened due to the weak time resolution (long time taken 
to perform each measurement), applying the serial design of the DEP-microwell 
electrode system. 
4.1.1 Aims and Outline 
To further investigate the cellular electrophysiological properties of synchronised 
K562 cells and to improve the obtained results from the previous research chapter, 
this chapter continues the study by using the parallel integrated DEP-microwell 
system (which was developed during the course of this study) as an optimised 
technique to identify the electrophysiological properties of cells synchronised at 
three main cell cycle checkpoints. 
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This chapter firstly aims to determine whether the cellular electrophysiological 
properties of K562 cells (particularly the σ𝐶𝑃 , ceff and geff) vary between different 
phases through the cell cycle. Secondly, it aims to determine the ability of the 
parallel design of DEP-microwell electrode system, as an optimised system, to detect 
these differences throughout the cell cycle and to improve the obtained results from 
the previous chapter. Moreover, it aims to assess if each cell cycle phase has its own 
electrophysiological property. It studies the connection between different methods of 
synchronisation to see if this creates a map of electrophysiological property changes 
across the whole cell cycle. 
In order to meet these aims, the parallel integrated DEP-microwell electrode system 
was applied for the first time to obtain the dielectric spectra of K562 cells. For the 
purpose of having the cells at different stages of the cycle, cells were synchronised at 
three main cell cycle checkpoints, G0/G1, late G1/S and early S-phase, using serum 
starvation, hydroxyurea and aphidicolin cell treatment methods, respectively. 
4.2 MATERIALS AND METHODS 
4.2.1 Cell culture 
In this chapter, a new batch of K562 cells which was different from the previously 
used batch in chapter 3 was also selected as a model cell line for cancer (since the 
previous batch has been lost due to the cell contamination). As explained in 3.2.1, 
K562 cells were cultured in RPMI-1640 supplemented with 10% (v/v) heat 
inactivated FBS and 2 mM L-glutamine at a density of 5×10
5
 cells ml
-1
 in 
suspension. The cells were cultured under standard cell culture conditions at 37 °C. 
To keep the cells viable, they were sub-cultured three times a week, depending on 
cell growth and confluence (a population of 1×10
6
 cells ml
-1 
was considered 
confluent (100% confluencey) - Appendix A). 
4.2.2 Cell radius measurements 
To investigate cell properties during the cell cycle, cell radius was measured as 
explained in 3.2.2. In short, an aliquot of cell sample was transferred onto a 
haemocytometer and images of cells dispersed over the grid region of it were 
captured. Images of cells were analysed using Image J software to measure cell 
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diameters for each sample. 100 cells were measured for each sample (n = 100). This 
experiment was repeated five times. 
4.2.3 Cell viability measurements 
In order to determine the percentage of viable cells in a given volume, the viable 
cells were counted by the trypan blue dye exclusion method detailed in 3.2.3. To 
determine the percentage of viable cells in a given volume, equation below was used: 
Viability % = [Number of viable cells / Total number of cells] × 100 
4.2.4 Cell cycle synchronisations 
In order to synchronise the cells in G0/G1, late G1/S and early S-phase, serum 
starvation (growth-arrested), hydroxyurea and aphidicolin treatment methods were 
used, respectively. 
4.2.4.1 Serum starvation 
To arrest the K562 cells in G0-phase, they were cultured in the growth medium 
without FBS at a density of 5×10
5
 cells ml
-1 
(sub-confluence) for 36 hours detailed in 
3.2.4.1. To release cells from quiescence (G0-phase), the cells were placed in growth 
medium containing 10% (v/v) FBS. This experiment was repeated five times (n = 5). 
4.2.4.2 Hydroxyurea treatment 
Hydroxyurea was used to arrest the cells at late G1/S checkpoint. HU stock solution 
preparation and effective concentration were based on the protocol detailed in section 
3.2.4.2. Cells were cultured at a density of 5×10
5
 cells ml
-1 
for 4 hours in the 
presence of HU drug. After 4 hours of incubation, cells were washed twice with pre-
warmed culture medium at 37 °C and then resuspended in the growth medium. This 
experiment was repeated five times (n = 5). 
4.2.4.3 Aphidicolin treatment 
In this study, APH obtained from Sigma-Aldrich (Sigma-Aldrich Company Ltd., 
Dorset, UK - Appendix C) was supplied as 1 mg mL
-1
, 0.2 mm filtered solution in 
DMSO, which does not affect the activities of DNA polymerase α at a concentration 
of 3.3% (v/v) in the media [92, 93]. APH was produced by fungus Nigrospora 
sphaerica and stored at -20 °C. To arrest K562 cells at the G1/S boundary, they were 
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cultured at a density of 5×10
5
 cells ml
-1 
with an aliquot of APH stock solution to 
provide a final concentration of 15 µM for 24 hours (one cycle), based on the 
recommended protocols from the literature [27, 94, 95]. 
After 24 hours incubation under standard cell culture conditions, cell suspension was 
centrifuged at room temperature at 150 × g for 5 minutes and then supernatant was 
removed. Cells were thereafter washed twice with RPMI culture medium pre-
warmed to 37 °C and fed with fresh RPMI to release them into S-phase. This 
experiment was repeated five times (n = 5).   
4.2.5 DEP sample preparation 
Based on the protocol detailed in section 3.2.5, the DEP buffer was prepared and the 
final conductivity of it was adjusted to 15 mS m
-1
. After pelleting the cells by 
centrifuging at 150 × g for 5 minutes, they were washed twice in the DEP buffer then 
resuspended in this iso-osmotic medium. The final cell concentration was adjusted to 
3 × 10
6
 cells ml
-1
 (± 20%) for DEP measurements.  
4.2.6 The parallel integrated DEP-microwell electrode system set up and measurement 
procedures 
DEP measurements were obtained using the parallel integrated DEP-microwell kit 
(named as 3DEP system), developed and provided by DEPTech Ltd (East Sussex, 
UK), a joint venture between Labtech International Limited (East Sussex, UK) and 
the University of Surrey (Surrey, UK), in 2012.  
This experimental set up was an integrated kit consisted of two parts: the DEP- 
microwell electrode and the 3DEP reader system. The stand-alone 3DEP reader 
system contained 20 independently controllable signal generators, capable of 
supplying 10 Vp-p signals over a wide range of frequencies between 1 kHz and 50 
MHz, a built-in bi-telecentric lens and LED light with a digital camera connected to a 
PC to capture 20 wells at once, and a DEP-microwell electrode with 20 separated 
wells placed on the stage, as shown in Figure 4.1. 
The DEP-microwell electrode (as shown in Figure 4.1.B) had 20 wells. As 
mentioned earlier in chapter 3, each well was typically 3 mm deep and 750 μm in 
diameter, with 8 layers of electrode around the well circumference with a thickness 
of 70 µm and gaps of 75 µm between the layers [20, 65, 81, 82]. 
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(A)                                                                   (B) 
                  
                    (C)                                (D) 
 
Figure 4.1. The parallel integrated DEP-microwell set up and the DEP-microwell electrode 
(A) The parallel set up: 1. PC running DEP-well plotter MATLAB program, 2. Built-in upright microscope and 
camera, 3. The lens and light source of the microscope, 4. DEP-microwell electrode, 5. Inbuilt function 
generators, 6. Kit door (B) 20 DEP-microwells loaded with the cells under the microscope (in the middle of 
sample run), (C) The DEP-microwell electrode used in the current study (Scale bar = 5 mm), a. the connecting 
points to the signal generators, b. 20 separate DEP-microwells (D) Loading the cell samples into the electrode 
wells in one step using a syringe.  
For the parallel set up, several DEP-microwells were used individually on the same 
electrode to increase the throughput and efficiency. To increase flexibility, these 20 
separate wells on the electrode were independently connected to 20 sources of AC 
signals to excite each one of them separately at specific frequency over a wide range 
of frequencies (between 1 kHz and 50 MHz) at 5 frequencies per decade. Applying 
different frequencies to several wells in parallel allowed the DEP spectra 
measurements to be done in only one step. 
For each DEP measurement, approximately 20 µl of the stock cell solution (section 
3.2.5) was injected into a well on the DEP-microwell electrode (Figure 4.1.D) to load 
all the wells at the same time. Thereafter, the wells were covered with a thin layer 
microscope cover slip and all the possible bubbles in the wells were removed gently 
using the needle tip of the loading syringe. Before starting the electrode excitations, 
2 
3 
4 
5 
6 
a 
b 
1 
76 
 
the door of the kit was shut properly to avoid any possible lights form the 
experimental environment penetrating the wells and reducing the accuracy of the 
measurements. Once the signal generators started delivering the desired AC signal, 
the image acquisition was manually started.  
A camera connected to a PC captured images of the wells throughout the DEP 
experiment using Photolite software (Photonic science, Cambridge). To monitor and 
evaluate the changes in cell distribution over time, images were captured every 2 
seconds for a period of 10 seconds of electrode excitation at each frequency.  
The change in light intensity across the well over the time of electrode excitation was 
assessed using a MATLAB (R2012a, The Mathwork Inc., Natick, USA) script; 
“DEP-well plotter”, as was shown in Figure 3.4. It was used to fit the light intensity 
measurement to the single-shell model to determine the cells electrophysiological 
properties [20]. The change in light intensity was normalised to an image taken 
before energising the electrodes at time zero (overall, 21 images were recorded).  
DEP measurements were carried out for cells before treatment (control cells), 
immediately after treatment (0h-study) and at 2, 4 and 24 hours after releasing the 
cells back to culture medium for each synchronisation method. After each frequency 
run, the cell sample was extracted from the well by syringe suction. Then, the well 
was cleaned with the DEP buffer and wiped thoroughly. After that, a new cell sample 
was injected into the DEP well to prevent any possible detrimental electric current 
effects on the cells. In order to reduce the effect of variation in the cell number in 
each sample, the DEP measurements were repeated at least three times (n = 5). 
4.2.7 Data presentation and statistical analysis 
Five dielectric spectra (n = 5) were obtained for controls and each cell 
synchronisation methods at different time points throughout the cell cycle (0, 2, 4 & 
24h-study). The cytoplasmic conductivity, the effective membrane capacitance and 
the effective membrane conductance for each DEP spectrum were determined by 
curve-fitting a single-shell model to each spectrum. The best fit model was found by 
matching the curve to the measured data, and then adjusting the membrane and the 
cytoplasm’s dielectric parameters until the best match was found. For all 
measurements, the best-fit line had a correlation coefficient of 0.95 or above. The 
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mean cell radius, cytoplasmic conductivity and effective membrane capacitance and 
conductance for each cell sample were calculated by averaging the values obtained 
for each spectrum. Data were presented as mean ± standard deviation (SD). 
Statistical analysis was carried out using the SPSS software (IBM SPSS Statistics, 
Version 22, SPSS Inc. Chicago, IL). Cellular electrophysiological properties and cell 
radius measurements were analysed performing the following tests: Non-parametric 
independent-samples Kruskal-Wallis 1-way ANOVA (to compare the distributions 
across groups), Non-parametric Related-samples Wilcoxon signed rank test (to 
compare median of differences between groups) and Non-parametric Related-
samples Friedman’s 2-way ANOVA by ranks (to compare the distributions across 
groups). A p value of less than 0.05 was considered statistically significant. 
4.3 RESULTS 
4.3.1 Changes in the cell radius 
In order to achieve a better understanding of the effects of cell synchronisation 
methods (described in 3.2.4) on the K562 cells, the cell radii of the untreated and 
treated cells were measured throughout the experiments. Moreover, the cell radius 
measurements were needed for the DEP analysis. The cell radii of serum starved, HU 
and APH drug treated K562 cells were obtained before starting the treatment 
(control) and after each treatment for different time points throughout the cell cycle 
(0, 2, 4 & 24h-study) as shown in Figure 4.2. 
The mean cell radius of SS treated cells immediately after treatment (0h-study) 
remained almost the same as the control cells (a decrease in size by only 1.5%). Two 
hours after releasing cells back into the cell cycle, the radius of treated cells 
increased by 4.4% compared to the 0h-study. It was 7.24 µm (±0.86) for the 0h-study 
and became 7.56 µm (±0.86) for the 2h-study. Twenty four hours after releasing cells 
back into the cell cycle, there was a downward trend and the mean cell radius 
showed a relative decrease by ~9% compared to the 2h-study cells (from 7.56 µm 
(±0.86) to 6.89 µm (±0.81)). All these changes were not statistically significant (p = 
0.406 (based on non-parametric independent-samples Kruskal-Wallis 1-way 
ANOVA test) - Appendix D - section 8.4.5).  
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Figure 4.2. Changes in cell radii of K562 cells before and after the serum starvation (SS), hydroxyurea 
(HU) and aphidicolin (APH) treatment methods 
Trends in cell radii of K562 cells as a function of time after the serum starvation (SS), hydroxyurea (HU) and 
aphidicolin (APH) treatments (releasing them back into the cell cycle) compared to control cells, is shown. The 
cell radius was determined by using ImageJ software to measure cell diameters for each sample. Data points are 
average of five experiments (n = 5). 100 cells were measured per experiment. Data are mean values ± SD. Error 
bars denote the standard deviation. 
For HU treated cells, mean cell radius after 4 hours of treatment remained almost the 
same as the control cells. The radius of treated cells showed substantial increase by 
22.8% compared to the control, 2 hours after releasing cells back into the cell cycle. 
It was 6.31 µm (±0.85) for control cells and became 7.75 µm (±0.81) for the 2h-
study. This value increased more for the 4h-study by ~4% compared to the 2h-study. 
However, the size of the cells showed a relative decrease by ~5% (from 8.05 µm 
(±0.9) at the 4h-study to 7.67 µm (±0.9) at the 24h-study), 24 hours after releasing 
cells back into the cell cycle. All these changes were not statistically significant (p = 
0.406 (based on non-parametric independent-samples Kruskal-Wallis 1-way 
ANOVA test) - Appendix D - section 8.4.5). 
For APH treated cells, mean cell radius after 24 hours of treatment increased by 
23.4% compared to the control cells. It was 7.664 µm (±0.38) for control cells and 
became 9.456 µm (±0.68) for the 0h-study. For the 2h-study there was a peak in this 
value and the cell radius reached its maximum at 9.914 µm (±0.47). After this point, 
there was a decreasing trend. It was 9.914 µm (±0.47) for the 2h-study and became 
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8.4 µm (±0.3) for the 24h-study (a decrease by 15.3%). All these changes were not 
statistically significant (p = 0.406 (based on non-parametric independent-samples 
Kruskal-Wallis 1-way ANOVA test) - Appendix D - section 8.4.5). Overall, it can be 
seen that the cell radius values for the APH treated cells were higher than the other 
two treatments. 
Based on the results of statistical tests, the median of differences between the cell 
radii values for SS and HU synchronisation methods are equal to zero (p = 0.686 
(based on non-parametric Related-samples Wilcoxon signed rank test) - Appendix D 
- section 8.4.5). This suggests that there is no significant change in cell radius 
throughout the cell cycle comparing these two synchronisation methods. However, 
the median of differences between the cell radii values for SS - APH and HU - APH 
synchronisation methods are not equal to zero (p = 0.043 (based on non-parametric 
Related-samples Wilcoxon signed rank test) - Appendix D - section 8.4.5). This may 
suggest by comparing these synchronisation methods that there is a significant 
change in cell radii values throughout the cycle. 
4.3.2 DEP experiments and spectra 
The aim of performing these experiments was to analyse the untreated and treated 
K562 cells’ motion in the presence of DEP electric force over a wide range of 
frequencies. Based on these DEP measurements, a single-shell model was used to 
determine the cellular electrophysiological properties throughout the cell cycle. 
Dielectric spectra of control, SS, HU and APH treated K562 cells were obtained in 
this study. DEP measurements were carried out for control cells and after each 
treatment for different time points throughout the cell cycle (0, 2, 4 & 24h-study) for 
each synchronisation method. For each experiment, the cells in 20 separate wells 
were excited using 20 independent sources of electric fields of 10 Vp-p sinusoidal 
wave over a wide range of frequencies between 1 kHz and 50 MHz at 5 frequencies 
per decade for a period of 10 seconds. As mentioned in 3.3.2, the DEP-well plotter 
MATLAB script was used to obtain the best-fit line for a single-shell dielectric 
model fitted to the measured data [20]. Averaged dielectric spectra of SS, HU and 
APH treated K562 cells were determined and presented in Figures 4.3 to 4.5. The 
error bars represent the standard deviation of the average change in light intensity.  
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Figure 4.3. DEP spectra of serum starved (SS) K562 cells at 0, 2, 4, 24 h after releasing from treatment 
DEP spectra of serum starved (SS) K562 cells at 0, 2, 4, 24 hours after releasing from 36 hours of treatment and 
back to cell cycle for average of five repeats per experiment (n = 5) as a function of frequency are shown. For all 
measurements, a best-fit line was added to the DEP spectra, which had a correlation coefficient of 0.95 or above. 
The error bars represent the standard deviation of the average change in light intensity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
SS – 0h SS – 2h 
SS – 4h SS – 24h 
R = 0.978 R = 0.988 
R = 0.989 R = 0.984 
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Figure 4.4. DEP spectra of hydroxyurea (HU) treated K562 cells at 0, 2, 4, 24 h after releasing from 
treatment 
DEP spectra of hydroxyurea (HU) treated K562 cells at 0, 2, 4, 24 hours after releasing from 4 hours of 
treatment and back to cell cycle for average of five repeats per experiment (n = 5) as a function of frequency are 
shown. For all measurements, a best-fit line was added to the DEP spectra, which had a correlation coefficient of 
0.95 or above. The error bars represent the SD of the average change in light intensity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
HU – 0h HU – 2h 
HU – 4h HU – 24h 
R = 0.971 R = 0.989 
R = 0.981 R = 0.981 
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Figure 4.5. DEP spectra of aphidicolin (APH) treated K562 cells at 0, 2, 4, 24 h after releasing from 
treatment 
DEP spectra of aphidicolin (APH) treated K562 cells at 0, 2, 4, 24 hours after releasing from 24 hours of 
treatment and back to cell cycle for average of five repeats per experiment (n = 5) as a function of frequency are 
shown. For all measurements, a best-fit line was added to the DEP spectra, which had a correlation coefficient of 
0.95 or above. The error bars represent the SD of the average change in light intensity. 
4.3.3. Electrophysiological properties of control and treated K562 cells 
In order to advance the understanding of the effects of cell synchronisation methods 
used in this study (described in 4.2.4) on K562 cells and to investigate the changes in 
electrophysiological properties in more detail, the trends in the variations of 
electrophysiological properties are presented in this section. The acquired 
electrophysiological properties were cytoplasmic conductivity, effective membrane 
capacitance and effective membrane conductance. 
The electrophysiological properties for control, SS, HU and APH treated cells are 
shown in Figures 4.6 to 4.8. The data points are the average of five experiments (n = 
5). Untreated K562 cells were employed as a control set relative to treated cells. 
Each set had its own control. For all DEP experiments, conductivity and permittivity 
of the DEP buffer were 15 mS m
-1
 and 0.7 nF m
-1
, respectively. 
APH – 0h APH – 2h 
APH – 4h APH – 24h 
R = 0.970 R = 0.966 
R = 0.966 R = 0.972 
83 
 
Figure 4.6 demonstrates the general trends in cytoplasmic conductivity after 
releasing cells from the SS, HU and APH treatments compared to control K562 cells.  
 
Figure 4.6. Changes in cytoplasmic conductivity after releasing K56 cells from serum starvation (SS), 
hydroxyurea (HU) and aphidicolin (APH) treatments 
A summary of cytoplasmic conductivity of control, SS, HU and APH treated K562 cells as a function of time is 
shown. There was an increase in cytoplasmic conductivity compared to the control for SS treatment and a 
decreasing trend for both HU and APH methods. The DEP response was measured by a change in light intensity 
at five frequencies per decade between 1 kHz and 50 MHz for a period of 10 seconds per frequency. Data points 
are average of five experiments (n = 5). Data are mean values ± SD. Error bars denote the standard deviation.  
For the SS treated cells, cytoplasmic conductivity results showed a rising trend from 
control to the 0h-study which subsequently decreased in the initial 24 hours of 
releasing cells back to the cell cycle.  After 36 hours of treatment, this value 
increased by 48.5% from 0.5 S m
-1
 (±0.2) for control to 0.7 S m
-1
 (±0.1) for the 0h-
study. It reduced by 44.4%, 4 hours after releasing cells back into the cell cycle. It 
was 0.7 S m
-1
 (±0.1) for the 0h-study and became 0.4 S m
-1
 (±0.2) for the 4h-study. 
Finally, after 24 hours of releasing cells, this value for SS treated cells increased by 
30% (from 0.4 S m
-1 
(±0.2) for the 4h-study to 0.5 S m
-1 
(±0.2) for the 24h-study). 
All these changes were not statistically significant (p = 0.406 (based on non-
parametric independent-samples Kruskal-Wallis 1-way ANOVA) - Appendix D - 
section 8.4.6). 
The cytoplasmic conductivity after 4 hours of HU treatment decreased by 32.7% 
(from 0.6 S m
-1
 (±0.2) for control to 0.37 S m
-1
 (±0.1) for the 0h-study). This value 
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increased by 8.1%, 2 hours after releasing cells back into the cell cycle. However, 
cytoplasmic conductivity showed a decrease by 20% from 0.4 S m
-1 
(±0.1) for the 
2h-study to 0.3 S m
-1 
(±0.2), 24 hours after releasing the cells back to the cycle. All 
these changes were not statistically significant (p = 0.406 (based on non-parametric 
independent-samples Kruskal-Wallis 1-way ANOVA) - Appendix D - section 8.4.6). 
The cytoplasmic conductivity after 24 hours of APH treatment increased by ~4%. 
This value reduced by ~11%, 4 hours after releasing cells back into the cell cycle. 
However, this value showed a relative increase by 8% (from 0.25 S m
-1 
(±0.1) for the 
4h-study to 0.27 S m
-1 
(±0.1) for the 24h-study), 24 hours releasing the cells back to 
the cycle. All these changes were not statistically significant (p = 0.406 (based on 
non-parametric independent-samples Kruskal-Wallis 1-way ANOVA) - Appendix D 
- section 8.4.6). 
In summary, for the HU treatment, results showed a decrease in cytoplasmic 
conductivity (at the 0h-study), compared to the control cells. However, there was an 
increase (at the 0h-study) in this value for the SS treatment and almost no change for 
the APH drug treatment. Overall, the cytoplasmic conductivity values for the SS 
treated cells were higher than the other two treatments. The cytoplasmic conductivity 
values for the HU treatment were also greater than APH obtained results for the 
cytoplasmic conductivity. 
Based on the results of statistical tests, the median of differences between the 
cytoplasmic conductivity values for SS and HU synchronisation methods are equal to 
zero (p = 0.138 (based on non-parametric Related-samples Wilcoxon signed rank test 
- Appendix D - section 8.4.6). This suggests that there is no significant change in 
σ𝐶𝑃 throughout the cell cycle comparing these two synchronisation methods. 
However, the median of differences between the σ𝐶𝑃 values for SS - APH and HU - 
APH synchronisation methods are not equal to zero (p = 0.043 (based on non-
parametric independent-samples Kruskal-Wallis 1-way ANOVA) - Appendix D - 
section 8.4.6). This may suggest that by comparing these synchronisation methods, 
there is a significant change in σ𝐶𝑃 values throughout the cycle. 
Figure 4.7 reveals the trends in ceff after releasing cells from the SS, HU and APH 
treatments.  
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Figure 4.7. Changes in ceff after releasing K562 cells from serum starvation (SS), hydroxyurea (HU) 
and aphidicolin (APH) treatments 
A summary of ceff of control, SS, HU and APH treated K562 cells as a function of time is shown. The DEP 
response was measured by a change in light intensity at five frequencies per decade between 1 kHz and 50 MHz 
for a period of 10 seconds per frequency. Data points are average of five experiments (n = 5). Data are mean 
values ± SD. Error bars denote the standard deviation. 
For the SS treatment, an increase by 6.7% can be seen in this value at the 0h-study 
compared to the control cells. However, ceff decreased to its minimum value by 
25.6%, 2 h after releasing cells back into the cell cycle. It was 8.7 mF m-2 (±1.3) for 
the 0h-study and became 6.4 mF m-2 (±1) for the 2h-study. Four hours after release, 
this value showed an increase by 10%. Finally, after 24 hours of releasing cells back 
into the cell cycle, ceff increased by ~50% (from 7.1 mF m
-2 (±1.4) for the 4h-study to 
10.6 mF m-2 (±3.2) for the 24h-study). All these changes were not statistically 
significant (p = 0.406 (based on non-parametric independent-samples Kruskal-Wallis 
1-way ANOVA) - Appendix D - section 8.4.7). 
For the HU treatment, a decrease by ~14% can be seen in this value at the 0h-study 
compared to the control cells. However, ceff increased to its maximum value by ~24% 
at the 2h-study. Four hours after release, this value decreased to 8.1 mF m-2 (±1.7) by 
37%. Finally, after 24 hours of releasing cells back into the cell cycle, ceff increased 
by 1.2% (from 8.1 mF m-2 (±1.7) for the 4h-study to 8.2 mF m-2 (±2.1) for the 24h-
study). All these changes were not statistically significant (p = 0.406 (based on non-
parametric independent-samples Kruskal-Wallis 1-way ANOVA) - Appendix D - 
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section 8.4.7). 
For the APH treatment, a relative increase by 15.5% can be seen in the ceff value at 
the 0h-study compared to the control cells. Thereafter, this value decreased to its 
minimum at 4 hours after releasing cells back into the cell cycle by 44.4%. It was 
10.8 mF m-2 (±1.5) for the 0h-study and became 6 mF m-2 (±1.4) for the 4h-study. 
Finally, for 24 hours after releasing cells back into the cell cycle, ceff increased by 
~77% (from 6 mF m-2 (±1.4) for the 4h-study to 10.6 mF m-2 (±2.2) for the 24h-
study). All these changes were not statistically significant (p = 0.406 (based on non-
parametric independent-samples Kruskal-Wallis 1-way ANOVA) - Appendix D - 
section 8.4.7). 
Based on the results of statistical tests, the median of differences between the ceff 
values for these synchronisation methods are equal to zero (p > 0.05 (based on non-
parametric Related-samples Wilcoxon signed rank test) - Appendix D - section 
8.4.7). This suggests that there is no significant change in ceff throughout the cell 
cycle comparing these three synchronisation methods. 
Figure 4.8 reveals the trends in geff after releasing cells from the SS, HU and APH 
treatments.  
For the SS treatment, an increase by ~88% can be seen in geff value immediately after 
incubation compared to the control cells. Two hours after releasing cells back into the 
cell cycle, this trend in the value of geff continued through the cycle. It was 168 S m
-2 
(±48) for the 0h-study and became 344 S m-2 (±270) for the 2h-study. Four hours 
after release, this value showed a decrease by 87%. Finally, after 24 hours of 
releasing cells back into the cell cycle, geff increased again from 45 S m
-2 (±1) for the 
4h-study to 333 S m-2 (±64) for the 24h-study. All these changes were not statistically 
significant (p = 0.406 (based on non-parametric independent-samples Kruskal-Wallis 
1-way ANOVA) - Appendix D - section 8.4.8). 
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Figure 4.8. Changes in geff after releasing K562 cells from serum starvation (SS), hydroxyurea (HU) 
and aphidicolin (APH) treatments 
A summary of geff of control, SS, HU and APH treated K562 cells as a function of time is shown. The DEP 
response was measured by a change in light intensity at five frequencies per decade between 1 kHz and 50 MHz 
for a period of 10 seconds per frequency. Data points are average of five experiments (n = 5). Data are mean 
values ± SD. Error bars denote the standard deviation. 
For the HU treatment, an overall decreasing trend can be seen in geff values after 
treatment through the cell cycle. This value decreased by ~12% immediately after 
incubation compared to the control cells. Four hours after releasing cells back into 
the cell cycle, this trend in the value of geff continued through the cycle. Finally, after 
24 hours of releasing cells back into the cell cycle, geff decreased more by ~53% 
compared to the 0h-study (from 1667 S m-2 (±600) for the 0h-study to 778 S m-2 
(±370) for the 24h-study). All these changes were not statistically significant (p = 
0.406 (based on non-parametric independent-samples Kruskal-Wallis 1-way 
ANOVA) - Appendix D - section 8.4.8). 
For the APH treatment, an increase by ~11% can be seen in the geff value 
immediately after incubation compared to the control cells. Two hours after releasing 
cells back into the cell cycle, this value decreased by ~20%. Four hours after release, 
this value again showed an increase by ~53%. Finally, after 24 hours of releasing 
cells back into the cell cycle, geff increased more by ~96% compared to the 4h-study. 
All these changes were not statistically significant (p = 0.406 (based on non-
parametric independent-samples Kruskal-Wallis 1-way ANOVA) - Appendix D - 
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section 8.4.8).  
In summary, for the HU treatment, results showed a decrease in the geff value (at the 
0h-study), compared to the control cells. However, there was an increase (at the 0h-
study) in this value for the SS and APH treatments. Overall, geff values for the HU 
treated cells were much higher than the other two treatments. The geff values for APH 
treatment were also greater than SS obtained results for the geff.  
Based on the results of statistical tests, the median of differences between the geff 
values for HU and APH synchronisation methods are equal to zero (p = 0.138 (based 
on non-parametric Related-samples Wilcoxon signed rank test) - Appendix D - 
section 8.4.8). This suggests that there is no significant change in cell radius 
throughout the cell cycle comparing these two synchronisation methods. However, 
the median of differences between the geff values for SS - HU and SS - APH 
synchronisation methods are not equal to zero (p = 0.043 (based on non-parametric 
Related-samples Wilcoxon signed rank test) - Appendix D - section 8.4.8). This may 
suggest that by comparing these synchronisation methods, there is a significant 
change in geff values throughout the cycle. 
4.3.4. Electrophysiological properties of control and treated K562 cells compared to the 
cell radii trends 
In order to achieve a better understanding of the effects of cell synchronisation 
methods used in this study (described in 4.2.4) on K562 cells and to investigate the 
changes in electrophysiological properties  in more detail, the trends in the variations 
of electrophysiological properties  are compared to the cell radii of the untreated and 
treated cells in this section. Figures 4.9 to 4.17 are trends in the variations of σ𝐶𝑃, ceff 
and geff values after releasing cells from the SS, HU and APH treatments compared to 
the cell radii trends. Data points are average of five repeats of experiments (n = 5). 
In Figure 4.9, cytoplasmic conductivity against cell radius for the SS treatment, 
results showed an increase in cytoplasmic conductivity which subsequently 
decreased in the initial 24 hours of releasing cells back to the cell cycle. For the cell 
radius after 36 hours of serum starvation (0h-study), there was not a change 
compared to the control cells (a decrease in size by only 1.5%). However, it showed 
an increasing trend in the value at 2 h after releasing cells back into the cell cycle. 
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For 4 h and 24 h studies, there were a downward trend and the mean cell radius 
showed a relative decrease. 
 
Figure 4.9. Changes in cytoplasmic conductivity after releasing K562 cells from serum starvation (SS) 
compared to cell radius as a function of time 
Comparison of cytoplasmic conductivity of control and serum starved (SS) K562 cells to cell radius data as a 
function of time is shown. The DEP response was measured by a change in light intensity at five frequencies per 
decade between 1 kHz and 50 MHz for a period of 10 seconds per frequency. A single-shell model was used to 
determine the electrophysiological properties of each DEP spectrum. The cell radius was determined by using 
ImageJ software to measure cell diameters for each sample. Data points are average of five experiments (n = 5). 
100 cells were measured per experiment. Data are mean values ± SD. Error bars denote the standard deviation. 
In Figure 4.10, cytoplasmic conductivity against cell radius for the HU treatment, 
results showed a decrease in cytoplasmic conductivity from control to the 0h-study 
followed by a relative increase 2 hours after release. However, this rising trend 
showed a relative decrease in the value 24 hours after releasing cells back into the 
cell cycle. In terms of the cell radius, the mean value for 2 hours after releasing cells 
back into the cell cycle showed substantial increase compared to the control cells. 
This value increased more for the 4h-study compared to the 2h-study. However, the 
size of the cells showed a relative decrease for the 24h-study. 
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Figure 4.10. Changes in cytoplasmic conductivity after releasing K562 cells from hydroxyurea (HU) 
treatment compared to cell radius as a function of time 
Comparison of cytoplasmic conductivity of control and hydroxyurea (HU) treated K562 cells to cell radius data 
as a function of time is shown. The DEP response was measured by a change in light intensity at five frequencies 
per decade between 1 kHz and 50 MHz for a period of 10 seconds per frequency. A single-shell model was used 
to determine the electrophysiological properties of each DEP spectrum. The cell radius was determined by using 
ImageJ software to measure cell diameters for each sample. Data points are average of five experiments (n = 5). 
100 cells were measured per experiment). Data are mean values ± SD. Error bars denote the standard deviation. 
In Figure 4.11, cytoplasmic conductivity against cell radius for the APH treatment, 
the cytoplasmic conductivity after 24 hours of APH treatment increased by ~4%. 
This value reduced by ~11%, 4 hours after releasing cells back into the cell cycle. 
However, cytoplasmic conductivity showed a relative increase by 8%, 24 hours 
releasing the cells back to the cycle. In terms of the cell radius, the mean value 
immediately after treatment showed an increase compared to the control cells. For 
the 2h-study there was a peak in this value and the cell radius value reached its 
maximum. However, after this point, there was a decreasing trend and the size of the 
cells showed a relative decrease for 4 h and 24 h after releasing cells back into the 
cell cycle. 
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Figure 4.11. Changes in cytoplasmic conductivity after releasing K562 cells from aphidicolin (APH) 
treatment compared to cell radius as a function of time 
Comparison of cytoplasmic conductivity of control and aphidicolin (APH) treated K562 cells to cell radius data 
as a function of time is shown. The DEP response was measured by a change in light intensity at five frequencies 
per decade between 1 kHz and 50 MHz for a period of 10 seconds per frequency. A single-shell model was used 
to determine the electrophysiological properties of each DEP spectrum. The cell radius was determined by using 
ImageJ software to measure cell diameters for each sample. Data points are average of five experiments (n = 5). 
100 cells were measured per experiment. Data are mean values ± SD. Error bars denote the standard deviation.  
In Figure 4.12, ceff against cell radius for the SS treatment, an increase by ~7% can 
be seen in ceff value immediately after incubation compared to the control cells. 
However, ceff decreased to its minimum value, 2 hours after releasing cells back into 
the cell cycle. Four hours after release, this value showed an increase by 10%. 
Finally, after 24 hours of releasing cells back into the cell cycle, ceff increased by 
~50%. For the cell radius after 36 hours of serum starvation (0h-study), there was not 
a change compared to the control cells. However, it showed a relative increase in the 
value 2 hours after releasing cells back into the cell cycle. For 4 h and 24 h studies, 
there were a downward trend and the mean cell radius showed a relative decrease.  
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Figure 4.12. Changes in effective membrane capacitance after releasing K562 cells from serum 
starvation (SS) compared to cell radius as a function of time 
Comparison of effective membrane capacitance (ceff) of control and serum starved (SS) K562 cells to cell radius 
data as a function of time is shown. The DEP response was measured by a change in light intensity at five 
frequencies per decade between 1 kHz and 50 MHz for a period of 10 seconds per frequency. A single-shell 
model was used to determine the electrophysiological properties of each DEP spectrum. The cell radius was 
determined by using ImageJ software to measure cell diameters for each sample. Data points are average of five 
experiments (n = 5). 100 cells were measured per experiment. Data are mean values ± SD. Error bars denote the 
standard deviation.   
In Figure 4.13, ceff against cell radius for the HU treatment, a decrease by ~14% can 
be seen in the 0h-study compared to the control cells. However, ceff increased to its 
maximum value by ~24% at the 2h-study. Four hours after release, this value 
decreased by 37%. Finally, after 24 hours of releasing cells back into the cell cycle, 
ceff increased by 1.2%. In terms of the cell radius, the mean value for 2 hours after 
releasing cells back into the cell cycle showed a substantial increase compared to the 
control cells. This value increased more for the 4h-study compared to the 2h-study. 
However, the size of the cells showed a relative decrease for 24 h after releasing cells 
back into the cell cycle. 
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Figure 4.13. Changes in effective membrane capacitance after releasing K562 cells from hydroxyurea 
(HU) treatment compared to cell radius as a function of time 
Comparison of effective membrane capacitance (ceff) of control and hydroxyurea (HU) treated K562 cells to cell 
radius data as a function of time is shown. The DEP response was measured by a change in light intensity at five 
frequencies per decade between 1 kHz and 50 MHz for a period of 10 seconds per frequency. A single-shell 
model was used to determine the electrophysiological properties of each DEP spectrum. The cell radius was 
determined by using ImageJ software to measure cell diameters for each sample. Data points are average of five 
experiments (n = 5). 100 cells were measured per experiment. Data are mean values ± SD. Error bars denote the 
standard deviation. 
In Figure 4.14, ceff against cell radius for the APH treatment, a relative increase by 
~16% can be seen in the 0h-study compared to control cells. Thereafter, this value 
decreased to its minimum at 4 hours after releasing cells back into the cell cycle by 
~45%. Finally, for 24 hours after releasing cells back into the cell cycle, ceff 
increased substantially by ~77%. In terms of the cell radius, the mean value 
immediately after treatment showed an increase compared to the control cells. For 
the 2h-study there was a peak in this value and the cell radius reached its maximum. 
However, after this point, there was a decreasing trend and the size of the cells 
showed a relative decrease at 4 h and 24 h after releasing cells back into the cell 
cycle.  
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Figure 4.14. Changes in effective membrane capacitance after releasing K562 cells from aphidicolin 
(APH) treatment compared to cell radius as a function of time 
Comparison of effective membrane capacitance (ceff) of control and aphidicolin (APH) treated K562 cells to cell 
radius data as a function of time is shown. The DEP response was measured by a change in light intensity at five 
frequencies per decade between 1 kHz and 50 MHz for a period of 10 seconds per frequency. A single-shell 
model was used to determine the electrophysiological properties of each DEP spectrum. The cell radius was 
determined by using ImageJ software to measure cell diameters for each sample. Data points are average of five 
experiments (n = 5). 100 cells were measured per experiment. Data are mean values ± SD. Error bars denote the 
standard deviation. 
In Figure 4.15, geff against cell radius for the SS treatment, a substantial increase by 
~89% can be seen in the geff value immediately after incubation compared to the 
control cells. Two hours after releasing cells back into the cell cycle, this trend in the 
value of geff continued through the cycle. Four hours after release, this value showed 
a decrease by 87%. Finally, after 24 hours of releasing cells back into the cell cycle, 
geff increased again. For the cell radius after 36 hours of serum starvation, there was 
not a change compared to the control cells. However, it showed an increase in the 
value 2 hours after releasing cells back into the cell cycle. Finally, the mean cell 
radius of SS treated cells at 24 hours after treatment was back to the size of the 
control cells (a downward trend). 
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Figure 4.15. Changes in effective membrane conductance after releasing K562 cells from serum 
starvation (SS) compared to cell radius as a function of time 
Comparison of effective membrane conductance (geff) of control and serum starved (SS) K562 cells to cell radius 
data as a function of time is shown. The DEP response was measured by a change in light intensity at five 
frequencies per decade between 1 kHz and 50 MHz for a period of 10 seconds per frequency. A single-shell 
model was used to determine the electrophysiological properties of each DEP spectrum. The cell radius was 
determined by using ImageJ software to measure cell diameters for each sample. Data points are average of five 
experiments (n = 5). 100 cells were measured per experiment. Data are mean values ± SD. Error bars denote the 
standard deviation. 
In Figure 4.16, geff against cell radius for the HU treatment, an overall decreasing 
trend can be seen in the geff values after treatment through the cell cycle. After 24 
hours of releasing cells back into the cell cycle, geff decreased by ~53% compared to 
the 0h-study. In terms of the cell radius, the mean value for 2 hours after releasing 
cells back into the cell cycle showed a substantial increase compared to the control 
cells. This value increased more for the 4h-study compared to the 2h-study. However, 
the size of the cells showed a relative decrease for 24 h after releasing cells back into 
the cell cycle.  
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Figure 4.16. Changes in effective membrane conductance after releasing K562 cells from hydroxyurea 
(HU) treatment compared to cell radius as a function of time 
Comparison of effective membrane conductance (geff) of control and hydroxyurea (HU) treated K562 cells to cell 
radius data as a function of time is shown. The DEP response was measured by a change in light intensity at five 
frequencies per decade between 1 kHz and 50 MHz for a period of 10 seconds per frequency. A single-shell 
model was used to determine the electrophysiological properties of each DEP spectrum. The cell radius was 
determined by using ImageJ software to measure cell diameters for each sample. Data points are average of five 
experiments (n = 5). 100 cells were measured per experiment. Data are mean values ± SD. Error bars denote the 
standard deviation. 
In Figure 4.17, geff against cell radius for the APH treatment, an increase by ~11% 
can be seen in the geff value immediately after incubation compared to the control 
cells. Two hours after releasing cells back into the cell cycle, this value decreased by 
~20%. Four hours after release, geff value showed a substantial increase by ~53%. 
Finally, after 24 hours of releasing cells back into the cell cycle, geff increased more 
by 96.6% compared to the 4h-study. In terms of the cell radius, the mean value 
immediately after treatment showed an increase compared to the control cells. For 
the 2h-study there was a peak in this value and the cell radius value reached its 
maximum. However, after this point, there was a decreasing trend and the size of the 
cells showed a relative decrease at 4 h and 24 h after releasing cells back into the cell 
cycle. 
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Figure 4.17. Changes in effective membrane conductance after releasing K562 cells from aphidicolin 
(APH) treatment compared to cell radius as a function of time 
Comparison of effective membrane conductance (geff) of control and aphidicolin (APH) treated K562 cells to cell 
radius data as a function of time is shown. The DEP response was measured by a change in light intensity at five 
frequencies per decade between 1 kHz and 50 MHz for a period of 10 seconds per frequency. A single-shell 
model was used to determine the electrophysiological properties of each DEP spectrum. The cell radius was 
determined by using ImageJ software to measure cell diameters for each sample. Data points are average of five 
experiments (n = 5). 100 cells were measured per experiment. Data are mean values ± SD. Error bars denote the 
standard deviation. 
4.4 DISCUSSION 
This chapter further investigated the cellular electrophysiological properties of 
untreated and treated K562 cells at different phases through the cell cycle and aimed 
to improve the obtained results from the previous research chapter by using the 
parallel integrated DEP-microwell electrode as an optimised system and treating 
them with three different synchronisation methods. Moreover, it aimed to assess if 
each cell cycle phase has its own electrophysiological property, i.e. if the properties 
of different phases map on to a single sequence of electrophysiological properties. 
Hence, the dielectric spectra of control, serum starved, hydroxyurea and aphidicolin 
treated K562 cells were obtained using the parallel integrated DEP-microwell 
electrode system. Best-fit lines were applied to the spectra and the single-shell model 
was used to infer σ𝐶𝑃, ceff and geff for each treatment at different time points. 
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4.4.1 Comparison between the effects of serum starvation, hydroxyurea and aphidicolin 
treatment methods on the cytoplasmic conductivity 
The cytoplasmic conductivities of untreated and treated (section 4.2.4) K562 cells 
were compared throughout the cell cycle at different stages in this study. 
As explained in the results (section 4.3.3), 36 hours of serum starvation increased the 
cytoplasmic conductivity mean value to its peak (for the 0h-study) by 48.5%. After 
restoration of FBS, there was a decreasing trend in this value by 28% in the 
proceeding 24 hours.  
As explained in chapter 3 (section 3.4.1), differences in the values of cytoplasmic 
conductivity are attributed to many factors owing to the complex intracellular 
environment. Cytoplasmic conductivity is attributed to the concentration or mobility 
of free ions through the cytoplasm which may be due to the activity of certain ion 
channels or pumps [22, 72, 75, 78, 90]. Based on this, the ionic leakage (efflux) from 
the cytoplasm through the cell membrane into the extracellular medium may cause a 
decrease in cytoplasm conductivity values [75]. Moreover, the increase in 
cytoplasmic conductivity could correspond with the loss of the cell volume (cell 
radius) as a result of water loss which may cause the intracellular ions to become 
more concentrated inside the cell [91]. Hence, the cytoplasmic conductivity value 
may inversely be proportional to the cell radius which is an indication of the cell 
volume. 
As the cell radius graph showed (Figure 4.2 - section 4.3.1), for the SS treated cells, 
which were arrested at G0/G1-phase, the average size at the 0h-study was smaller 
than control cells and the cells in the 2h and 4h-study. It could be a sign of cells 
arrest at G0/G1-phase by SS treatment since the cells in G0/G1-phase did not grow 
sufficiently in volume like the cells in mitosis, which are ready to divide. Therefore, 
the increase in the ionic strength at this point might be due to the cell size reduction 
or the increased activity of certain ion channels. 
A closer look at the cytoplasmic conductivity values for the SS treated cells confirms 
that this parameter had an overall decreasing trend from the 0h-study to 24h-study 
after releasing cells back to the growth medium. Based on the given information 
from the literature [22, 72, 75, 78], this reduction might be due to the decreased 
activity of certain ion channels or the ionic leakage from the cytoplasm. Moreover, 
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despite the previously obtained results in chapter 3, the cytoplasmic conductivity was 
almost inversely proportional to the cell radius, as reported in the literature [91]. 
For HU treated cells (as explained in section 4.3.3), results showed a decrease in the 
cytoplasmic conductivity from control to the 0h-study followed by a relative increase 
2 hours after release. However, this rising trend showed a relative decrease in the 
value 24 hours after releasing cells back into the cell cycle. Four hours after releasing 
the cells back to growth medium, there exists a peak in cell radius value. This may 
indicate that the majority of cells that were arrested at S-phase were released back to 
the cell cycle and they started growing through the cell cycle at the following phases, 
i.e. G2 and M-phase. When they pass through mitosis, they will divide and produce 
new daughter cells, so they would be smaller in size (in the 24h-study). That means, 
in preparation for cytokinesis, they grow in size that causes less internal ionic 
strength. This might be the reason for a sudden drop in the cytoplasmic conductivity 
value at the 24h-study. 
A closer look at the cytoplasmic conductivity values for the HU treated cells suggests 
that this parameter had an overall decreasing trend from the 0h-study to 24h-study. 
Based on the given information from the literature [22, 72, 75, 78], this reduction 
might be due to the decreased activity of certain ion channels or the ionic leakage 
from the cytoplasm. However, the cytoplasmic conductivity was not inversely 
proportional to the cell radius, as reported in the literature [91]. 
The overall trend in the variations between the cytoplasmic conductivity values 
throughout the cell cycle for APH treated cells was almost similar to the HU treated 
K562 cells as expected, because these two drugs block the cells at nearly the same 
checkpoint. Twenty four hours of APH treatment increased the cytoplasmic 
conductivity value by ~4%. Four hours after releasing the cells back into the cell 
cycle, this value reduced to its minimum by ~11%. Nonetheless, the cytoplasmic 
conductivity was not inversely proportional to the cell radius, as reported in the 
literature [91]. 
Overall, the cytoplasmic conductivity values for the SS treated cells throughout the 
cycle were higher than the other two treatments. The HU values were also greater 
than APH obtained results. This may suggest that the intracellular ionic strength for 
the SS treated cells was higher than the HU and APH treated cells. In the same 
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manner, it indicates that the intracellular ionic strength for the HU treated cells was 
higher than the APH treated cells. 
Moreover, the fact that the cell radius values for the APH treated cells were higher 
than the other two treatments supports these findings. The substantial increase in the 
cell size after APH treatment is in agreement with the previously reported data [96-
98]. Based on the literature [96-98], this could be as a result of the increase in protein 
content (by approximately 2-folds) relative to DNA content due to the lipids and 
proteins synthesis during the cell cycle arrest.  
As mentioned above, the obtained conductivity value for the SS treated cells 
immediately after treatment (the point that cells are supposed to be at the same phase 
e.g. G0/G1 for SS and S-phase for HU and APH treatments) was significantly larger 
than values for HU and APH treated cells by ~52% and ~60%, respectively. It was 
0.7 S m
-1
 (±0.1) for SS treated cells, 0.4 S m
-1
 (±0.1) for HU treatment and 0.3 S m
-1
 
(±0.1) for APH treated K562 cells. This distinct difference in the cytoplasmic value 
in different phases was even larger than the obtained data from the previous chapter, 
which was ~25%. Therefore, this experiment showed that there exist some variations 
in case of cytoplasmic conductivity values in G0/G1 and S-phase throughout the cell 
cycle. 
In summary, the acquired results of this study may indicate that the cytoplasmic 
conductivity values varied between different phases through the cell cycle, applying 
the parallel integrated DEP-microwell electrode system. However, it was difficult to 
correlate directly between electrophysiological properties and cell cycle stages. 
4.4.2 Comparison between the effects of serum starvation, hydroxyurea and aphidicolin 
treatment methods on the effective membrane capacitance 
The effective membrane capacitance of untreated and treated (section 4.2.4) K562 
cells were examined throughout the cell cycle at different stages in this study. 
As explained in the results (section 4.3.3), serum starving K562 cells for 36 hours 
caused an increase by ~7% in the cell effective membrane capacitance value 
immediately after incubation compared to the control cells. However, this value 
decreased to its minimum value by ~26%, 2 hours after releasing cells back into the 
cell cycle. Four hours after release, this value showed an increase by 10%. Finally, 
101 
 
after 24 hours of releasing cells back into the cell cycle, ceff considerably increased 
by ~50%. 
As described in review of the literature (section 2.6.3), ceff is a function of the cell 
membrane’s permittivity and its thickness. High values of ceff could reflect the large 
membrane surface area associated with complex surface morphology including high 
number of microvilli (density and size), blebs, ruffles and folds in the cell membrane 
[22, 52, 62, 74-76]. So, a reduction in cell membrane effective capacitance is mainly 
due to the changes in the surface morphology of the cells (cell surface size and 
complexity decrease) [22, 52].  
Another basic fact is that for the cell to double its volume prior to division, it needs 
to grow continuously throughout the cycle [52].  In this case, the mother cell must 
have ~26% excess of membrane prior to cell division [75]. It follows that ceff should 
increase prior to M-phase and decrease after cytokinesis. Therefore, when cells are 
going through the G1-phase, they will have a fall in ceff value [52]. 
Based on these explanations, the reduction in the effective membrane capacitance 
value for SS treated cells at the 2h-study compared to the control cells may indicate 
that the cells were arrested at G0/G1-phase and then started to go through G1-phase. It 
could also show that there existed some substantial changes in the morphology of the 
cell (cell surface size and complexity decreased). However, this reduction in the 
value of ceff gradually increased 4 hours after releasing cells back into the cell cycle 
which continued through the cell cycle. High values of ceff could reflect the large 
membrane surface area associated with complex surface morphology including high 
number of microvilli (density and size), blebs, ruffles and folds in the cell membrane 
owing to cell growth and going through the cell cycle. Thus, these trends may reflect 
that the effective membrane capacitance values for SS treated cells were dependent 
on the cell cycle phases. 
In case of HU treated K562 cells, a decrease by ~14% can be seen in the 0h-study 
compared to the control cells. However, ceff value increased to its maximum by 
~24% at the 2h-study. Four hours after release, this value decreased by 37%. Finally, 
after 24 hours of releasing cells back into the cell cycle, ceff increased by 1.2%. This 
increase in the effective membrane capacitance value (from control to the 2h-study) 
may indicate that the cells were arrested at G1/S-phase and there existed some 
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considerable changes in the morphology of the cells in S-phase (cell surface size and 
complexity increased). As noted earlier, in order to cytokinesis occurrence, cells 
should be doubled in size, which may have a direct effect on the membrane 
morphology. 
For APH treatment, a relative increase in ceff can be seen for the 0h-study compared 
to control cells. Thereafter, this value decreased to its minimum at 4 hours after 
releasing cells back into the cell cycle by ~45%. Finally, for 24 hours after releasing 
cells back into the cell cycle, ceff increased greatly by ~77%. As mentioned, this 
increase in the effective membrane capacitance value (from control to the 0h-study) 
may indicate that the cells were arrested at G1/S-phase and there exist some 
substantial changes in the morphology of the cells in S-phase (cell surface size and 
complexity increased).  
Overall, the obtained ceff values for the HU and APH treated cells at the 0h-study 
were higher than values for SS treated K562 cells by ~22%. Therefore, this study 
showed that there existed some variations in case of the effective membrane 
capacitance in G0/G1 and S-phase through the cell cycle.  
In summary, the obtained results may indicate that the effective membrane 
capacitance values varied between different phases through the cell cycle, applying 
the parallel integrated DEP-microwell electrode system. However, it was difficult to 
correlate directly between electrophysiological properties and cell cycle stages. 
4.4.3 Comparison between the effects of serum starvation, hydroxyurea and aphidicolin 
treatment methods on the effective membrane conductance 
The effective membrane conductance of untreated and treated (section 4.2.4) K562 
cells were compared throughout the cell cycle at different stages in this study. 
Based on the given information from the literature (section 2.6.3), geff is a function of 
the cell membrane’s conductivity and its thickness. Since the nature of lipid bilayer 
is near-insulating, membrane conductance is mainly evidence of the charge (ion) 
carriers’ net transport (flux) across the membrane through membrane pores, pumps 
and ion channels under the influence of the applied electric field [75, 77-79]. 
So, the corresponding trends of increase in the effective membrane conductance 
values should result in great loss of ions from the cytoplasm and considerable ionic 
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leakage through the cell membrane, resulting in a decrease of the cytoplasmic 
conductivity. Furthermore, the decreasing trends in geff values possibly accounted for 
less ions efflux from the cytoplasm and less ionic leakage through the membrane. 
Thus, these trends may indicate that the effective membrane conductance results 
should correlate negatively with the cytoplasmic conductivity values. 
As explained in the results (section 4.3.3), for the SS treatment, an increase by ~89% 
can be seen in the geff value immediately after incubation compared to the control 
cells. Two hours after releasing cells back into the cell cycle, this trend in the value 
of geff continued through the cycle. Four hours after release, this value showed a 
decrease by 87%. Finally, after 24 hours of releasing cells back into the cell cycle, 
geff increased again. Moreover, 36 hours of serum starvation increased the 
cytoplasmic conductivity mean value to its peak (for the 0h-study) by ~50%. After 
restoration of FBS, there was a decreasing trend in this value by 28% in the 
proceeding 24 hours. So, the obtained results showed that the geff value only 
correlated negatively with the σCP at the transition point of the 0h to 2h-study. 
For HU treatment, an overall decreasing trend can be seen in the geff values after 
treatment through the cell cycle. After 24 hours of releasing cells back into the cell 
cycle, geff decreased by ~53% compared to the 0h-study. Moreover, results showed a 
decrease in cytoplasmic conductivity from control to the 0h-study followed by a 
relative increase, 2 hours after release. However, this rising trend showed a relative 
decrease in the value 24 hours after releasing cells back into the cell cycle. So, the 
acquired results showed that the geff value only correlated negatively with the σCP at 
the transition point of the 0h to 2h-study. 
For the APH treatment, an increase by ~11% can be seen in the geff value 
immediately after incubation compared to the control cells. Two hours after releasing 
cells back into the cell cycle, this value decreased by ~20%. Four hours after release, 
this value showed an increase by ~53%. Finally, after 24 hours of releasing cells 
back into the cell cycle, geff increased more by ~97% compared to the 4h-study. 
Furthermore, cytoplasmic conductivity after 24 hours of APH treatment increased by 
~4%. This value reduced to its minimum by ~11%, 4 hours after releasing cells back 
into the cell cycle. However, cytoplasmic conductivity showed a relative increase by 
8%, 24 hours releasing the cells back to the cycle. Thus, the acquired results showed 
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that the geff value only correlated negatively with the σCP at the transition points of 
the 0h to 2h and the 2h to 4h-study. 
Furthermore, the obtained geff values for the HU treated cells at the 0h-study were 
higher than values for SS (by ~90%) and APH (by ~65%) treated and control cells. 
Therefore, this experiment showed that there existed some variations in case of 
effective membrane conductance in G0/G1 and S-phase through the cell cycle. 
Generally, the obtained results may indicate that the cell effective membrane 
conductance values varied between different phases through the cell cycle, applying 
the parallel integrated DEP-microwell electrode system. Nevertheless, it was difficult 
to correlate directly between electrophysiological properties and cell cycle stages. 
 
Figure 4.18. Summary of the results and discussion of this research chapter 
This figure presents a summary of results and discussion of this research chapter. Key positive and significant 
findings are marked with the bright teal background. Parameters which improved compared to previously 
acquired data (results from chapter 3) are marked with a red star. 
4.4.4 The serial design against the parallel integrated DEP-microwell electrode system 
optimisation 
As described earlier (Chapters 3 and 4), to address the need of a detailed study on the 
electrophysiological properties of cells through their cell cycle, the serial design and 
the parallel integrated (as an optimised system) DEP-microwell electrodes were 
applied to study electrophysiological properties of synchronised K562 cells through 
their cell cycle. This section aims to make a comparison between these two systems 
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based on their set up and the obtained results for electrophysiological properties of 
cells throughout the cell cycle. 
As explained in chapter three (section 3.2.6), the experimental set up of the serial 
design consisted of an upright light microscope with 4× magnification equipped with 
a camera which was connected to a PC, a signal generator, an oscilloscope and a 
DEP-microwell electrode placed on the microscope stage. This electrode system was 
composed of a laminate of alternating layers (stripes) of gold-plated copper ring 
electrodes and polyamide insulators with the holes drilled through the structure 
(named as wells) with a transparent base attached under the holes [81, 82]. 
The electrodes were energised using a signal generator, generating a sinusoidal wave 
with a 10 Vp-p signal over a wide range of frequencies between 1 kHz and 20 MHz at 
5 frequencies per decade. To monitor and evaluate the changes in cell distribution 
over time, images were captured every 3 seconds for a period of 60 seconds of 
electrode excitation at each frequency. Cells’ movements were monitored by 
observing the changes in light intensity in the microwell during the application of an 
AC signal.  
As described in this chapter (section 4.2.6), the optimised integrated DEP-microwell 
kit consisted of an inbuilt 20 independently programmable channels signal generator, 
capable of supplying 10 Vp-p signals over a wide range of frequencies between 1 kHz 
and 50 MHz, a built-in bi-telecentric lens and LED light with a digital camera 
connected to a PC to capture 20 wells at once, and a DEP-microwell electrode with 
20 separated wells placed on the stage.  
For the parallel set up, several DEP-microwells were used in parallel on the same 
electrode to increase the throughput and efficiency. To increase flexibility, these 20 
separate wells on the electrode were independently connected to 20 sources of AC 
signals to excite each one of them separately at specific frequency. Applying 
different frequencies to several wells in parallel allowed the DEP spectra 
measurements to be done in only one step. To monitor and evaluate the changes in 
cell distribution over time, images were captured every 2 seconds for a period of 10 
seconds of electrode excitation at each frequency.  
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Based on this information, some important differences can be identified clearly. The 
first is that the frequency range of the parallel integrated system has been increased 
from 20 MHz to 50 MHz, which will provide more information on cytoplasmic 
conductivity of the examined cells.  For the integrated DEP-microwells system, the 
obtained cytoplasmic conductivity value for the SS treated K562 cells immediately 
after treatment (the point that cells are supposed to be at the same phase) was 
significantly larger than values for HU and APH treated cells by ~50% and ~60%, 
respectively. It was 0.7 S m
-1
 (±0.1) for SS treated cells, 0.4 S m
-1
 (±0.1) for HU 
treatment and 0.3 S m
-1
 (±0.05) for APH treated K562 cells. This distinct difference 
in the cytoplasmic value in different phases was even larger than the obtained data 
from the serial design of system, which was ~25%. 
As the second difference, since several DEP-microwells were used individually on 
the same electrode, this system was providing rapid analysis of the cells at the same 
time which increase the throughput, efficiency and real time analysis. This 
parallelisation will provide a very fast analysis of the cells, i.e. more experiments can 
be done at a shorter time compared to the serial design of the DEP-microwells 
electrode system. For example, a complete frequency analysis for a set of treated 
cells in the serial design of system could take about 2 - 3 hours, whereas it could only 
take few minutes for the integrated optimised system. As a result, this will reduce the 
possible side effects of the DEP buffer and the excitation itself on the natural 
behaviour of cells.  
4.5 CONCLUDING REMARKS 
This chapter further investigated the cellular electrophysiological properties of 
untreated and treated K562 cells at different phases through the cell cycle and aimed 
to improve the obtained results from the previous research chapter by treating them 
with three different methods and using the parallel integrated DEP-microwell 
electrode as an optimised system. Hence, the dielectric spectra of control, serum 
starved, hydroxyurea and aphidicolin treated K562 cells were obtained using the 
parallel integrated DEP-microwell electrode system. Best-fit lines were applied to the 
spectra and the single-shell model was used to infer the cytoplasmic conductivity, the 
effective membrane capacitance and the effective membrane conductance for each 
treatment at different time points. 
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Based on the acquired results of this chapter, the parallel DEP-microwell kit 
successfully revealed electrophysiological properties variation in different phases 
through the cell cycle, in vitro. The obtained results of the study indicated that K562 
cells’ cellular electrophysiological properties (particularly the σ𝐶𝑃, ceff and geff) 
varied in different phases through the cell cycle. Nevertheless, it was difficult to 
correlate directly between electrophysiological properties and cell cycle stages and 
the properties of different phases did not map on to a single sequence of 
electrophysiological properties. In order to address this, it may be necessary to 
establish which phases cells are in by using a gold-standard technique such as flow 
cytometry. 
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5 CELL CYCLE DISTRIBUTION ANALYSIS OF 
SYNCHRONISED K562 CELLS - SIMULTANEOUS ANALYSIS 
OF ACQUIRED DEP AND FCM DATA 
5.1 INTRODUCTION 
As explained in previous chapters, the cell cycle represents a chain of orderly 
processes of tightly integrated events leading to cell growth, DNA replication and 
cell division. The cell cycle dysregulation is the common reason for abnormal cancer 
cell growth and alterations in checkpoint signalling system over tumour progression 
[10]. As such, cancer can be considered a cell cycle disease and scientists are 
interested in cell division events to help improve cancer therapy [4, 9, 10]. 
Understanding the molecular mechanisms of cell cycle dysregulation in cancer can 
potentially provide major insights into how normal cells become tumorigenic and 
how new cancer treatment methods can be developed [4, 5, 9-11]. Therefore, 
determining the proportion of cells in each phase is valuable for targeting cancerous 
cells, as many anti-cancer drugs are most effective when used at a specific phase 
(typically cells in the S-phase) [12, 13]. Investigation of cellular electrophysiological 
properties especially through the cell cycle can potentially provide new insights in 
cancer studies as well. Moreover, it could be a reliable method to detect the cells in 
particular stages, which could be of use for targeting the cancerous cells.  
In chapters three and four, by using the serial design and the parallel integrated DEP-
microwell electrode systems, electrophysiological properties variation in different 
phases through the cell cycle was revealed, in vitro. As described earlier, the 
obtained results of the study indicated that K562 cell’s cellular electrophysiological 
properties (particularly the cytoplasmic conductivity, the effective membrane 
capacitance and the effective membrane conductance) were distinct in different 
phases through the cell cycle. However, it was difficult to correlate directly between 
electrophysiological properties and cell cycle stage. In order to address this, it may 
be necessary to establish which phases cells are in by using a gold-standard 
technique such as flow cytometry.  
Flow cytometry, as a conventional cell assay technique, is frequently used to assess 
different cell cycle phases and to determine the proportion of cells in each cell cycle 
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phase on a single cell basis. In order to validate the obtained cell synchronisation 
results, to further investigate the cellular characteristics of untreated and treated 
K562 cells and to find the possible correlation between electrophysiological 
properties and cell cycle stage, flow cytometry was used for cell cycle analysis by 
quantitation of intracellular DNA content of cells. 
5.1.1 Aims and Outline 
This chapter firstly aims to determine the proportion of cells in each cell cycle phase 
using flow cytometry technique in order to validate the obtained cell synchronisation 
results and further investigate the cellular characteristics of untreated and treated 
K562 cells at different phases throughout the cell cycle, in vitro. It will assess 
whether the treated K562 cells arrested up to the level of acceptance at different 
phases through the cell cycle by quantitation of DNA content of cells. 
Secondly, it aims to find out the possible correlation between cell cycle phases and 
cellular electrophysiological properties in more detail by using an algorithm for the 
simultaneous analysis of the acquired cell radius, DEP and FCM data from the 
chapters 3, 4 and 5.  
In order to meet the aims of the chapter and obtain additional biological information 
about treated cells such as intracellular DNA content, the examined cells have been 
stained with one fluorescent dye (fluorochrome). Afterwards, precise optical and 
electronic parts of the flow cytometry machine collected the scattered lights, 
converted them into digital data and sent them to a computer for analysis. 
For the purpose of having the cells at different stages of the cycle, cells were 
synchronised at three main cell cycle checkpoints, G0/G1, late G1/S and early S-
phase, using serum starvation, hydroxyurea and aphidicolin cell treatment methods, 
respectively. 
5.2 MATERIALS AND METHODS 
5.2.1 Cell culture 
In this chapter, K562 cell line was also selected as a model cell line for cancer. As 
explained in 3.2.1, K562 cells were cultured in RPMI-1640 supplemented with 10% 
(v/v) heat inactivated FBS and 2 mM L-glutamine at a density of 5 × 10
5
 cells ml
-1
 in 
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suspension and under standard cell culture conditions. To keep the cells viable, they 
were sub-cultured three times a week. 
5.2.2 Cell radius measurements 
To investigate cell properties during the cell cycle, cell radius was measured as 
explained in 3.2.2. In short, an aliquot of cell sample was transferred onto a 
haemocytometer and images of cells dispersed over the grid region of it were 
captured. Images of cells were analysed using Image J software to measure cell 
diameters for each sample. One hundred cells were measured for each sample 
(number of repeats = 5). 
5.2.3 Cell viability measurements 
In order to determine the percentage of viable cells in a given volume, the viable 
cells were counted by the trypan blue dye exclusion method detailed in 3.2.3.  
5.2.4 Cell cycle synchronisations 
In order to synchronise the cells in G0/G1, late G1/S and early S-phase, serum 
starvation (growth-arrested), hydroxyurea and aphidicolin treatment methods were 
used, respectively. 
5.2.4.1 Serum starvation 
K562 cells were cultured in the growth medium without FBS at a density of 5 × 10
5
 
cells ml
-1 
for 36 hours detailed in 3.2.4.1. To release cells from quiescence (G0-
phase), the cells were placed in growth medium containing 10% (v/v) FBS. This 
experiment was repeated five times (n = 5). 
5.2.4.2 Hydroxyurea treatment 
Hydroxyurea was used to arrest cells near the G1/S checkpoint. HU stock solution 
preparation and effective concentration were based on the protocol detailed in section 
3.2.4.2. Cells were cultured at a density of 5 × 10
5
 cells ml
-1 
for 4 hours in the 
presence of HU drug. After 4 hours of incubation, cells were washed twice with pre-
warmed culture medium at 37 °C and then resuspended in the medium. This 
experiment was repeated five times (n = 5). 
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5.2.4.3 Aphidicolin treatment 
In this study, to arrest K562 cells at the G1/S boundary, they were cultured at a 
density of 5 × 10
5
 cells ml
-1 
with an aliquot of APH stock solution to provide a final 
concentration of 15 µM for 24 hours (one cycle), as explained in 4.2.4.3. This 
experiment was repeated five times (n = 5).  
5.2.5 Cell cycle analysis: PI staining, instrumentation, and FCM measurements 
In order to validate the cell synchronisation results and further investigate the cellular 
characteristics of untreated and treated K562 cells, flow cytometry technique was 
used to determine cell cycle distributions by quantitation of intracellular DNA 
content of cells. In this study, PI stain was used to determine the DNA distribution of 
cells in G0/G1, S, and G2/M-phases. 
To prepare the cells for cell cycle analysis, based on the recommended protocols 
from the literature [99], approximately 2 × 106 cells ml-1 from each sample were 
fixed in 5 ml of 70% (v/v) ice-cold ethanol for at least 24 hours at 4 °C. These cells 
can be stored in 70% (v/v) ethanol at 4 °C for several months. 0.1% (w/v) RNaseA 
(Sigma Aldrich, UK) and 200 μg of PI stain (Sigma Aldrich, UK) were dissolved in 
10 ml of PBS solution (Biosera Ltd. UK). After fixation, cells were washed twice 
with PBS and suspended in sufficient volume of PI solution to provide a cell 
concentration of 1 × 106 cells ml-1. Cells were then incubated in the dark for 20 – 30 
minutes at room temperature to allow for digestion of RNaseA. 
Finally, cells were transferred to the cytometer and their fluorescence was measured 
using a BD FACSCantoII
TM
 flow cytometer (Becton Dickinson Biosciences, San 
Jose, CA, USA) as shown in Figure 5.1.  
The excitation wavelength for the blue solid state laser used was 488 nm. PI red-
orange fluorescence emission level was measured using a band-pass filter at 585/42 
nm (PE detector).  
Higher particle flow rate during data acquisition can result in lower data resolution as 
it allows more cells to enter the cells flow within a given moment [43, 44]. Based on 
this, cell cycle analysis was performed on the acquisition of 10000 events (cells) per 
sample with an approximate rate of 100 events per second to have well defined and 
high resolution DNA profiles. 
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Determination of the percentage of cells in each phases of the cell cycle was made by 
BD FACSDiva
TM
 software analysis (Becton Dickinson Biosciences, Version 5.0.3, 
2007, San Jose, CA, USA). To calculate the percentage of DNA content for 
synchronised populations, gating (drawing) of regions of interest on dot plots was 
performed manually. 
                                   
Figure 5.1. BD FACSCantoIITM flow cytometer experimental set-up 
The FCM experimental set up which mainly consisted of: 1. the main cytometer, 2. the fluidics cart and 3. the PC 
running BD FACSDivaTM software. The fluidics cart holds fluid tanks necessary to operate and maintain the FC 
machine as follows: 20 L of BD FACSFlow™ sheath solution, 5 L of BD™ FACSClean™ solution, 5 L of BD 
FACS™ shutdown solution and a waste tank with the capacity of 10 L. For FCM analysis, approximately 1 × 106 
cells ml-1 from each sample were fixed with 70% (v/v) ice-cold ethanol. Propidium iodide (PI) stain was used to 
determine the DNA distribution of cells in different phases. Finally, cells were analysed using BD FACSDivaTM 
software. Cell cycle analysis was performed on the acquisition of 10000 events per sample with an approximate 
rate of 100 events per second. (Taken from: http://www.bui.uzh.ch/shared-equipment/2/21.html - Aug 2013) 
5.2.6 Algorithm for the simultaneous analysis of the acquired cell radius, DEP and 
FCM data - a simultaneous system of linear equations 
In order to assess whether the cell radius, DEP and FCM data were correlated with 
each other and were changed through the cell cycle in more detail, an algorithm was 
used for the simultaneous analysis of the acquired results. So, by building a 
simultaneous system of equations [90], contribution of each cell cycle phase to the 
total value of electrophysiological properties at each time point can be determined. 
If we consider the cell cycle to be composed of three main phases (G0/G1, S and 
G2/M-phase) and if each phase has number of cells with their own unique 
electrophysiological properties, we can build a simultaneous system of equations to 
determine the contribution each phase makes to the total value of 
Fluidics cart 
Cytometer 
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electrophysiological properties e.g. cytoplasmic conductivity. This algorithm was a 
MATLAB script (Appendix E - section 8.5) used for solving a system of linear 
equations. For this linear system, the coefficients matrix ([ Ai Bi Ci ]5x3 for i = 1 to 5) 
consisted of DNA content of cells in each phase for each treatment and the constant 
values matrix ([ Ri ]5x1 for i = 1 to 5)  presented the previously acquired data (e.g. cell 
radii data) for each studied time point, as shown in Figure 5.2. 
Since in this system the number of equations (n = 5) were more than the number of 
variables (n = 3), solving the system would result in 10 individual answers. By 
applying the boundary condition to the acquired results (omitting the negative 
answers), the acceptable sets of answers would be finalised. At the end, the variables 
matrix ([ r1 r2 r3 ]3x1) would be identified by averaging the values in the acceptable 
sets of answers. 
 
          Cell radius                  G0/G1           S           G2/M 
Control  R1 =   (A1)r1 +   (B1)r2  +   (C1)r3 
0h  R2 =   (A2)r1 +   (B2)r2  +   (C2)r3 
2h  R3 =   (A3)r1 +   (B3)r2  +   (C3)r3 
4h  R4 =   (A4)r1 +   (B4)r2  +   (C4)r3 
24h  R5 =   (A5)r1 +   (B5)r2  +   (C5)r3 
 
Figure 5.2. A system of linear equations used for the simultaneous analysis of the acquired cell radius 
and FCM results 
This figure shows a system of linear equations used for the simultaneous analysis of the acquired cell radius and 
FCM results. For this system of equations, the coefficients matrix consisted of DNA content of cells in each phase 
for each treatment ([ Ai Bi Ci ]5x3 for i = 1 to 5) and the constant values matrix ([ Ri ]5x1 for i = 1 to 5) was 
presenting the cell radii data for each studied time point. The variables matrix ([ r1 r2 r3 ]3x1) would be find out by 
solving this linear system using a MATALB script (Appendix D - section 8.5). 
5.2.7 Data presentation and statistical analysis 
At least five FCM measurements were carried out for controls and each cell 
synchronisation methods at different time points throughout the cell cycle (0, 2, 4 & 
24h-study). Determination of the percentage of cells in each phases of the cell cycle 
was made by BD FACSDiva
TM
 software analysis (Becton Dickinson Biosciences, 
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Version 5.0.3, 2007, San Jose, CA, USA). Data were presented as mean ± standard 
deviation (SD). 
Statistical analysis was carried out using the SPSS software (IBM SPSS Statistics, 
Version 22, SPSS Inc. Chicago, IL). Cellular electrophysiological properties and cell 
radius measurements were analysed performing the following tests: Non-parametric 
independent-samples Kruskal-Wallis 1-way ANOVA (to compare the distributions 
across groups), Non-parametric Related-samples Wilcoxon signed rank test (to 
compare median of differences between groups) and Non-parametric Related-
samples Friedman’s 2-way ANOVA by ranks (to compare the distributions across 
groups). A p value of less than 0.05 was considered statistically significant. 
5.3 RESULTS 
5.3.1 Cell cycle analysis - DNA content of untreated and treated K562 cells through the 
cell cycle (histograms) 
As described earlier, the cell cycle distribution of untreated and treated K562 cells 
was determined by measuring the intracellular DNA contents of cells using flow 
cytometry technique. Figures 5.3 to 5.5 depict the DNA histograms of control, SS, 
HU and APH treated K562 cells.  
Figure 5.3 shows representative histogram of DNA content of control and serum-
starved K562 cells during the cell cycle. The graph for DNA distribution of control 
cells (Figure 5.3.A) showed two peaks in G0/G1-phase and G2/M-phase and a wide 
distribution of cells in S-phase. After SS treatment and releasing cells back into the 
cell cycle (the 0h-study), the two peaks in G0/G1-phase and G2/M-phase remained 
almost the same as they were in the control. However, the number of cells with the 
S-phase amount of DNA increased (Figure 5.3.B). For the 2h-study (Figure 5.3.C), 
the number of cells with G0/G1-phase amount of DNA decreased, whereas the 
number of cells with S-phase and G2/M-phase amount of DNA increased. As cells 
went through the cycle and at 24 hours after releasing cells back to growth medium, 
the cells distribution was nearly the same as control cells (Figure 5.3.E). 
Figure 5.4 shows the DNA content of the control and HU treated K562 cells during 
the cell cycle. The graph for DNA distribution of control cells (Figure 5.4.A) showed 
two peaks in G0/G1-phase and G2/M-phase and a wide distribution of cells in S-
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phase. After releasing cells from HU treatment (at the 0h-study), the peak value in 
G0/G1-phase slightly increased compared to its value in control cells. However, the 
number of cells with S-phase and G2/M-phase amount of DNA decreased (Figure 
5.4.B). For the 4h-study (Figure 5.4.D), there was a sudden drop in the number of 
cells with G0/G1-phase amount of DNA and a significant increase in this value for 
the cells in S-phase. As cells went through the cycle, at 24 hours after release, the 
cells distribution was almost the same as control cells. The only difference was the 
number of cells with G2/M-phase amount of DNA which was increased compared to 
the control cells (Figure 5.4.E). 
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Figure 5.3. An example of DNA content histogram of control and serum starved (SS) K562 cells v. 
number of counted cells as determined by the flow cytometer 
Based on the gating of single cells, calculated DNA content histogram of control (A) and SS treated K562 cells at 
0, 2, 4, 24 hours after releasing them from the treatment and back to the cycle (B,C,D,E) are shown. This 
experiment was repeated for thirteen times (n = 13). Approximately 1 × 106 cells ml-1 from each sample were 
fixed with 70% (v/v) ice-cold ethanol. Propidium iodide (PI) stain (20 μg ml-1) was used to determine the DNA 
distribution of cells in different phases. After fixation, cells were washed twice with PBS and suspended in 
sufficient volume of PI staining solution to provide a cell concentration of 1 × 106 cells ml-1. Finally, cells were 
analysed using BD FACSDivaTM software and 10,000 events were recorded for each sample. PI data was 
acquired on linear scale.  
 
 
 
 
 
(A) Control (B) SS – 0h 
(E) SS – 24h 
(D) SS – 4h (C) SS – 2h 
DNA content (x1000) - PI fluorescence 
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Figure 5.4. An example of DNA content histogram of control and hydroxyurea (HU) treated K562 cells 
v. number of counted cells as determined by the flow cytometer 
Based on the gating of single cells, calculated DNA content histogram of control (A) and HU treated K562 cells 
at 0, 2, 4, 24 hours after releasing them from the treatment and back to the cycle (B,C,D,E) are shown. This 
experiment was repeated for seventeen times (n = 17). Approximately 1 × 106 cells ml-1 from each sample were 
fixed with 70% (v/v) ice-cold ethanol. Propidium iodide (PI) stain (20 μg ml-1) was used to determine the DNA 
distribution of cells in different phases. After fixation, cells were washed twice with PBS and suspended in 
sufficient volume of PI staining solution to provide a cell concentration of 1 × 106 cells ml-1. Finally, cells were 
analysed using BD FACSDivaTM software and 10,000 events were recorded for each sample. PI data was 
acquired on linear scale.  
Figure 5.5 shows the DNA content of the control and APH treated K562 cells during 
the cell cycle. Overall, these histograms were like those for HU treated cells. The 
graph for DNA distribution of control cells (Figure 5.5.A) showed two peaks in 
G0/G1-phase and G2/M-phase and a wide distribution of cells in S-phase. After 
releasing cells from APH treatment (at the 0h-study), the peak value in G0/G1-phase 
slightly increased compared to its value in control cells. However, the number of 
cells with S-phase and G2/M-phase amount of DNA decreased (Figure 5.5.B). For 
(E) HU – 24h 
(D) HU – 4h (C) HU – 2h 
(B) HU – 0h (A) Control 
DNA content (x1000) - PI fluorescence 
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the 4h-study (Figure 5.5.D), there was a sudden drop in the number of cells with 
G0/G1-phase amount of DNA and a significant increase in this value for the cells in 
S-phase. As cells went through the cycle, at 24 hours after release, the cells 
distribution was almost the same as control cells. The only difference was the 
number of cells with G2/M-phase amount of DNA which was increased compared to 
the control cells (Figure 5.5.E). 
     
          
 
Figure 5.5. An example of DNA content histogram of control and aphidicolin (APH) treated K562 cells 
v. number of counted cells as determined by the flow cytometer 
Based on the gating of single cells, calculated DNA content histogram of control (A) and APH treated K562 cells 
at 0, 2, 4, 24 hours after releasing them from the treatment and back to the cycle (B,C,D,E) are shown. This 
experiment was repeated for five times (n = 5). Approximately 1 × 106 cells ml-1 from each sample were fixed 
with 70% (v/v) ice-cold ethanol. Propidium iodide (PI) stain (20 μg ml-1) was used to determine the DNA 
distribution of cells in different phases. After fixation, cells were washed twice with PBS and suspended in 
sufficient volume of PI staining solution to provide a cell concentration of 1 × 106 cells ml-1. Finally, cells were 
analysed using BD FACSDivaTM software and 10,000 events were recorded for each sample. PI data was 
acquired on linear scale.  
(A) Control (B) APH - 0h 
(C) APH - 2h (D) APH - 4h 
(E) APH - 24h 
DNA content (x1000) - PI fluorescence 
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5.3.2 Cell cycle analysis - DNA distribution of untreated and treated K562 cells through 
the cell cycle (graphs) 
As mentioned before, the cell cycle distribution of K562 cells was determined by 
measuring the intracellular DNA contents of cells using flow cytometry technique. 
Figures 5.6 to 5.8 show the graphs of cells DNA distribution through the cell cycle 
for the SS, HU and APH treated cells as a function of time after each treatment.  
      
Figure 5.6. Summary of DNA distributions of serum starved (SS) K562 cells during the cell cycle 
determined by flow cytometry 
Percentage of DNA as a function of time after releasing cells from treatment for serum starved (SS) treated K562 
cells is shown. This experiment was repeated for thirteen times (n = 13). In order to arrest the cells in G0/G1 
phase, K562 cells were cultured in the growth medium without FBS at a density of 5 × 105 cells ml-1 for 36 hour. 
Approximately 1 × 106 cells ml-1 from each sample were fixed with 70% (v/v) ice-cold ethanol. Propidium iodide 
(PI) stain (20 μg ml-1) was used to determine the DNA distribution of cells in different phases. After fixation, cells 
were washed twice with PBS and suspended in sufficient volume of PI staining solution to provide a cell 
concentration of 1 × 106 cells ml-1. Finally, cells were analysed using BD FACSDivaTM software and 10,000 
events were recorded for each sample. Data are mean values ± SD. The error bars represent the standard 
deviation. 
As shown in Figure 5.6, after SS treatment and releasing cells back into the cell cycle 
(0h-study), the number of cells with G0/G1-phase and G2/M-phase amount of DNA 
content remained almost the same as they were in the control. However, the number 
of cells with the S-phase amount of DNA increased by ~6%. For the 2h-study, the 
number of cells with G0/G1-phase amount of DNA decreased by ~19%, whereas the 
number of cells with S-phase and G2/M-phase amount of DNA increased by ~5.5% 
and ~20.5%, respectively (compared to the 0h-study). At 24 hours after treatment, 
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the cells distribution was nearly the same as control cells. There was an increase in 
the number of cells with the G0/G1-phase amount of DNA and a drop for cells in S-
phase by ~27% and ~21% compared to the 0h-study, respectively. 
     
Figure 5.7. Summary of DNA distributions of hydroxyurea (HU) treated K562 cells during the cell 
cycle determined by flow cytometry 
Percentage of DNA as a function of time after releasing cells from hydroxyurea treatment for K562 cells is 
shown. This experiment was repeated for seventeen times (n = 17). In order to arrest the cells in late G1/S phase, 
they were treated with an aliquot of HU stock solution to provide a final concentration of 10 mM. They were 
cultured at a density of 5 × 105 cells ml-1 for 4 hours. Approximately 1 × 106 cells ml-1 from each sample were 
fixed with 70% (v/v) ice-cold ethanol. Propidium iodide (PI) stain (20 μg ml-1) was used to determine the DNA 
distribution of cells in different phases. After fixation, cells were washed twice with PBS and suspended in 
sufficient volume of PI staining solution to provide a cell concentration of 1 × 106 cells ml-1. Finally, cells were 
analysed using BD FACSDivaTM software and 10,000 events were recorded for each sample. Data are mean 
values ± SD. The error bars represent the standard deviation. 
Figure 5.7 shows the DNA distribution of the control and HU treated K562 cells 
during the cell cycle. After releasing cells from HU treatment (at the 0h-study), the 
peak value in G0/G1-phase slightly increased compared to its value in control cells by 
~21%. However, the number of cells with S-phase and G2/M-phase amount of DNA 
decreased. For the 4h-study, there was a sudden drop (by ~60%) in the number of 
cells with G0/G1-phase amount of DNA and a great increase (by ~63%) in this value 
for the cells in S-phase compared to the 0h-study. As cells went through the cycle, at 
24 hours after release, the cells distribution was almost the same as control cells. The 
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only difference was the number of cells with G2/M-phase amount of DNA which was 
increased compared to the control cells (by ~106%). 
     
Figure 5.8. Summary of DNA distributions of aphidicolin (APH) treated K562 cells during the cell 
cycle determined by flow cytometry 
Percentage of DNA as a function of time after releasing cells from aphidicolin treatment for K562 cells is shown. 
This experiment was repeated for five times (n = 5). In order to arrest the cells in early S-phase, they were 
cultured at a density of 5 × 105 cells ml-1 with an aliquot of APH stock solution to provide a final concentration of 
15 µM for 24 hours (one cycle). Approximately 1 × 106 cells ml-1 from each sample were fixed with 70% (v/v) ice-
cold ethanol. Propidium iodide (PI) stain (20 μg ml-1) was used to determine the DNA distribution of cells in 
different phases. After fixation, cells were washed twice with PBS and suspended in sufficient volume of PI 
staining solution to provide a cell concentration of 1 × 106 cells ml-1. Finally, cells were analysed using BD 
FACSDivaTM software and 10,000 events were recorded for each sample. Data are mean values ± SD. The error 
bars represent the standard deviation. 
As shown in Figure 5.8, after releasing cells from APH treatment (at the 0h-study), 
the peak value in G0/G1-phase and G2/M-phase increased compared to their values in 
control cells by ~24% and ~27%, respectively. However, the number of cells with S-
phase amount of DNA decreased by ~29%. For the 4h-study, there was a sudden 
drop (by ~88%) in the number of cells with G0/G1-phase amount of DNA and a great 
increase (by ~111%) in this value for the cells in S-phase compared to the 0h-study. 
As cells went through the cycle, at 24 hours after release, the cells’ distribution was 
almost the same as control cells. The only difference was the number of cells with 
G2/M-phase amount of DNA which was increased compared to the control cells (by 
~182%). 
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5.3.3 Algorithm for the simultaneous analysis of the acquired cell radius, DEP and 
FCM data - a simultaneous system of linear equations 
As described in section 5.2.6, in order to assess how the cell radius, DEP and FCM 
data were correlated with each other and were changed through the cell cycle in more 
detail, an algorithm was used for the simultaneous analysis of the acquired results. 
So, by building a simultaneous system of equations [90], contribution of each cell 
cycle phase to the total value of electrophysiological properties at each time point 
was determined. 
This algorithm which was a MATLAB script used for solving a simultaneous system 
of linear equations. For this linear system, the coefficients matrix consisted of DNA 
content of cells in each phase for each treatment and the constant values matrix 
presented the previously acquired data (e.g. cell radii data) for each studied time 
point. Figure 5.9 presents the provided answers from solving the systems of 
equations for each treatment. 
For the serum starved K562 cells, the mean cell radius for each cell cycle phase had 
been changed for both parts of the study (applying the serial and parallel design of 
DEP-microwell electrode systems). For using the parallel integrated system, it was 
6.9 µm for cells in G0/G1-phase, 5.5 µm for cells in S-phase and 11.2 µm for cells in 
G2/M-phase. For applying the serial design of DEP, it was 6.1 µm for cells in G0/G1-
phase, 6.8 µm for cells in S-phase and 9.3 µm for cells in G2/M-phase. For the 
cytoplasmic conductivity values, this method couldn’t find any acceptable answer for 
both parts of the study. For ceff values, there can be seen some changes as well in 
both studies. For applying the parallel integrated system, it was 17 mF m
-2
 for cells in 
G0/G1-phase, 4.6 mF m
-2
 for cells in S-phase and 3.2 mF m
-2
 for cells in G2/M-phase. 
For using the serial design of DEP, it was 8.9 mF m
-2
 for cells in G0/G1-phase, 5.9 
mF m
-2
 for cells in S-phase and 24.3 mF m
-2
 for cells in G2/M-phase. For the geff 
values, this method couldn’t find any acceptable answer for both parts of the study.  
For the HU treated K562 cells, the mean cell radius for each cell cycle phase had 
been changed for both parts of the study (applying the serial and parallel design of 
DEP-microwell electrode systems). It was 3.6 µm for cells in G0/G1-phase, 10 µm 
for cells in S-phase and 6.6 µm for cells in G2/M-phase. For the cytoplasmic 
conductivity values, there can be seen some changes as well in both studies. For 
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applying the parallel integrated DEP, it was 0.5 S m
-1 
for cells in G0/G1-phase, 0.3 S 
m
-1 
for cells in S-phase and 0.6 S m
-1 
for cells in G2/M-phase. For using the serial 
design of DEP, it was 0.11 S m
-1 
for cells in G0/G1-phase, 0.99 S m
-1 
for cells in S-
phase and 0.78 S m
-1 
for cells in G2/M-phase. For ceff values, there also can be seen 
some changes in both studies. For applying the parallel integrated system, it was 21.1 
mF m
-2
 for cells in G0/G1-phase, 3.6 mF m
-2
 for cells in S-phase and 7 mF m
-2
 for 
cells in G2/M-phase. For using the serial design of DEP, it was 6.3 mF m
-2
 for cells 
in G0/G1-phase, 0.1 mF m
-2
 for cells in S-phase and 72.8 mF m
-2
 for cells in G2/M-
phase. For geff values, there also can be seen some changes in both studies. For 
applying the parallel integrated DEP, it was 1363 S m
-2
 for cells in G0/G1-phase, 
1746 S m
-2
 for cells in S-phase and 2136 S m
-2
 for cells in G2/M-phase. For using the 
serial design of DEP, it was 2538 S m
-2
 for cells in G0/G1-phase, 394 S m
-2
 for cells 
in S-phase and 467 S m
-2
 for cells in G2/M-phase. 
For the APH treated K562 cells, the mean cell radius for each cell cycle phase had 
been changed. It was 9.8 µm for cells in G0/G1-phase, 4.8 µm for cells in S-phase 
and 14.1 µm for cells in G2/M-phase. For the cytoplasmic conductivity values, there 
can be seen some trivial changes as well. It was 0.3 S m
-1 
for cells in G0/G1-phase, 
0.2 S m
-1 
for cells in S-phase and 0.3 S m
-1 
for cells in G2/M-phase. For ceff values, 
there also can be seen some changes. It was 12.3 mF m
-2
 for cells in G0/G1-phase, 5.8 
mF m
-2
 for cells in S-phase and 13 mF m
-2
 for cells in G2/M-phase. For geff values, 
there also can be seen some changes. It was 0.1 S m
-2
 for cells in G0/G1-phase, 0.3 S 
m
-2
 for cells in S-phase and 2 S m
-2
 for cells in G2/M-phase. 
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Figure 5.9. Provided answers from solving the system of equations for each treatment 
This figure presents the provided answers from solving the system of equations for each treatment. A MATLAB 
script was used for solving the system of linear equations. For this linear system, the coefficients matrix consisted 
of DNA content of cells in each phase for each treatment and the constant values matrix presented the previously 
acquired data (e.g. cell radii data) for each studied time point. 
5.4 DISCUSSION 
This chapter sought to determine the proportion of cells in each cell cycle phase 
using flow cytometry technique in order to validate the obtained cell synchronisation 
results and further investigate the cellular characteristics of untreated and treated 
K562 cells at different phases throughout the cell cycle, in vitro.  
Secondly, it aimed to find out the relation between the intracellular DNA percentage 
in each phase and the acquired DEP data to investigate the possible correlation 
between cell cycle phases and cellular electrophysiological properties in more detail. 
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5.4.1 Cell cycle analysis 
As described earlier in this chapter (section 5.3), the cell cycle distribution of 
untreated and treated K562 cells was determined by measuring the intracellular DNA 
contents of cells using flow cytometry technique. 
According to the flow cytometry data, after SS treatment and releasing cells back 
into the cell cycle (the 0h-study), the number of cells with G0/G1-phase and G2/M-
phase amount of DNA content remained almost the same as they were in the control. 
However, the number of cells with the S-phase amount of DNA increased by ~6%. 
For the 2h-study, the number of cells with G0/G1-phase amount of DNA decreased 
by ~19%, whereas the number of cells with S-phase and G2/M-phase amount of 
DNA increased by ~5.5% and ~20.5%, respectively (compared to the 0h-study). At 
24 hours after treatment, the cells distribution was nearly the same as control cells. 
There was an increase in the number of cells with the G0/G1-phase amount of DNA 
and a drop for cells in S-phase by ~27% and ~21% compared to the 0h-study, 
respectively. 
Thus, these trends indicate that cells were arrested at G0/G1-phase and then went 
through the cell cycle as expected and finally divided and entered the G0/G1-phase 
again. Therefore, it shows that the treated K562 cells were arrested at G0/G1-phase, 
in vitro. However, only around 33% of cells were arrested at this phase. Base on the 
given literature, there are several factors to ensure the success of a cell cycle 
synchronisation. One of which is that large number of synchronous cells should be 
obtained (~75% of a cell population should be arrested [37]). So, the obtained results 
may suggest that the SS synchronisation method did not work properly and up to the 
standard.  
After releasing the cells from HU treatment (at the 0h-study), the peak value in 
G0/G1-phase slightly increased compared to its value in control cells by ~21%. 
However, the number of cells with S-phase and G2/M-phase amount of DNA 
decreased. For the 4h-study, there was a sudden drop (by ~60%) in the number of 
cells with G0/G1-phase amount of DNA and a great increase (by ~63%) in this value 
for the cells in S-phase compared to the 0h-study. As cells went through the cycle, at 
24 hours after release, the cells distribution was almost the same as control cells.  
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Thus, these trends indicate that cells were arrested near the G1/S checkpoint and then 
went through the cell cycle as expected and finally divided and entered the S-phase 
again. Therefore, it shows that the treated K562 cells were arrested at G1/S 
checkpoint, in vitro. Nonetheless, only around 65% of cells were arrested at this 
phase. 
After releasing cells from APH treatment (at the 0h-study), the peak value in G0/G1-
phase and G2/M-phase increased compared to their values in control cells by ~24% 
and ~27%, respectively. However, the number of cells with S-phase amount of DNA 
decreased by ~29%. For the 4h-study, there was a sudden drop (by ~88%) in the 
number of cells with G0/G1-phase amount of DNA and a great increase (by ~111%) 
in this value for the cells in S-phase compared to the 0h-study. As cells went through 
the cycle, at 24 hours after release, the cells distribution was almost the same as 
control cells. 
Thus, these trends indicate that cells were arrested at S-phase and then went through 
the cell cycle as expected and finally divided and entered the S-phase again. 
Therefore, it shows that the treated K562 cells were arrested at S-phase, in vitro. 
However, only around 73% of cells were arrested at this phase. 
5.4.2 Simultaneous analysis of the acquired data from the studies 
As described in section 5.2.6, in order to find out how the cell radius, DEP and FCM 
data were correlated with each other and were changed through the cell cycle in more 
detail, an algorithm was used for the simultaneous analysis of the acquired results. 
So, by building a simultaneous system of equations, contribution of each cell cycle 
phase to the total value of electrophysiological properties at each time point was 
determined. 
This algorithm which was a MATLAB script used for solving a system of linear 
equations. For this linear system, the coefficients matrix consisted of DNA content of 
cells in each phase for each treatment and the constant values matrix presented the 
previously acquired data (e.g. cell radii data) for each studied time point. 
As explained in the results (section 5.3.3), for all three treatment methods the mean 
cell radius for each cell cycle phase had been changed for both parts of the study 
(applying the serial and parallel design of DEP-microwell electrode systems). In case 
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of SS treated cells and using the parallel integrated DEP, it was 6.9 µm for cells in 
G0/G1-phase, 5.5 µm for cells in S-phase and 11.2 µm for cells in G2/M-phase. For 
applying the serial design of DEP, it was 6.1 µm for cells in G0/G1-phase, 6.8 µm for 
cells in S-phase and 9.3 µm for cells in G2/M-phase. In case of HU treated cells and 
using the parallel integrated DEP, it was 3.6 µm for cells in G0/G1-phase, 10 µm for 
cells in S-phase and 6.6 µm for cells in G2/M-phase. For applying the serial design of 
DEP, it was 6.2 µm for cells in G0/G1-phase, 7 µm for cells in S-phase and 9.1 µm 
for cells in G2/M-phase. In case of APH treated cells and using the parallel integrated 
DEP, it was 9.8 µm for cells in G0/G1-phase, 4.8 µm for cells in S-phase and 14.1 µm 
for cells in G2/M-phase.  
Based on the given literature, as cells go through their cycle, they will grow in size 
which results in larger cell radii of the cells. So, it may propose that the expected 
trend for cell radius during the cycle has a rising pattern, i.e. cells in G0/G1-phase 
have the smallest value whereas cells in G2/M-phase show the largest value of radius 
through the cycle. A closer look at the obtained results above will suggest that the 
results of the first part of research (chapter 3) followed this trend while the obtained 
results of chapter 4 did not fall into the proposed pattern. This may be due to the fact 
that the treatment methods did not work properly in the recent study. 
In terms of cytoplasmic conductivity values, for SS treatment, this method 
(simultaneous analysis) couldn’t find any acceptable answer for both parts of the 
study (using serial and parallel design of DEP). For HU treatment there can be seen 
some changes in this value in both studies. For applying the parallel integrated DEP, 
it was 0.5 S m
-1 
for cells in G0/G1-phase, 0.3 S m
-1 
for cells in S-phase and 0.6 S m
-1 
for cells in G2/M-phase. For using the serial design of DEP, it was 0.11 S m
-1 
for 
cells in G0/G1-phase, 0.99 S m
-1 
for cells in S-phase and 0.78 S m
-1 
for cells in G2/M-
phase. For APH treatment study, there can be seen some trivial changes as well. It 
was 0.3 S m
-1 
for cells in G0/G1-phase, 0.2 S m
-1 
for cells in S-phase and 0.3 S m
-1 
for 
cells in G2/M-phase. 
As explained in section 3.4.1, the cytoplasmic conductivity value may inversely be 
proportional to the cell radius which is an indication of the cell volume. Therefore, it 
may suggest that the expected trend for cytoplasmic conductivity value during the 
cycle has a falling pattern, i.e. cells in G0/G1-phase have the largest value whereas 
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cells in G2/M-phase show the smallest value of σ𝐶𝑃 through the cycle. Considering 
the obtained results, it can be seen that the prominent trend in σ𝐶𝑃 values is a 
downward followed by an upward trend. This may show that there is some ion influx 
and increased activity of ion channels between S and G2/M-phase of the cycle. 
In terms of effective membrane capacitance values, for SS treatment, there can be 
seen some changes as well in both studies. For applying the parallel design, it was 17 
mF m
-2
 for cells in G0/G1-phase, 4.6 mF m
-2
 for cells in S-phase and 3.2 mF m
-2
 for 
cells in G2/M-phase. For using the serial design of DEP, it was 8.9 mF m
-2
 for cells 
in G0/G1-phase, 5.9 mF m
-2
 for cells in S-phase and 24.3 mF m
-2
 for cells in G2/M-
phase. For HU treatment, by applying the parallel integrated DEP, it was 21.1 mF m
-
2
 for cells in G0/G1-phase, 3.6 mF m
-2
 for cells in S-phase and 7 mF m
-2
 for cells in 
G2/M-phase. For using the serial design of DEP, it was 6.3 mF m
-2
 for cells in G0/G1-
phase, 0.1 mF m
-2
 for cells in S-phase and 72.8 mF m
-2
 for cells in G2/M-phase. 
Finally for APH treatment study, it was 12.3 mF m
-2
 for cells in G0/G1-phase, 5.8 mF 
m
-2
 for cells in S-phase and 13 mF m
-2
 for cells in G2/M-phase.  
As explained in section 3.4.2, a change in cell membrane effective capacitance is 
mainly due to the changes in the surface morphology of the cells (change in cell 
surface size and complexity). Therefore, it may suggest that the expected trend for 
ceff value during the cycle has a falling followed by a rising pattern. A closer look at 
the obtained results will suggest that the results of the both parts of research (chapter 
3 and 4) followed this trend.  
In case of effective membrane conductance values, for SS treatment, this method 
couldn’t find any acceptable answer for both parts of the study. For HU treatment 
there can be seen some changes in both studies. For applying the parallel design, it 
was 1363 S m
-2
 for cells in G0/G1-phase, 1746 S m
-2
 for cells in S-phase and 2136 S 
m
-2
 for cells in G2/M-phase. For using the serial design of DEP, it was 2538 S m
-2
 for 
cells in G0/G1-phase, 394 S m
-2
 for cells in S-phase and 467 S m
-2
 for cells in G2/M-
phase. Finally for APH treatment study, it was 0.1 S m
-2
 for cells in G0/G1-phase, 0.3 
S m
-2
 for cells in S-phase and 2 S m
-2
 for cells in G2/M-phase. 
Based on the given information from the literature (section 2.6.3), geff is a function of 
the cell membrane’s conductivity and its thickness. Since the nature of lipid bilayer 
is near-insulating, membrane conductance is mainly evidence of the charge (ion) 
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carriers’ net transport (flux) across the membrane through membrane pores, pumps 
and ion channels under the influence of the applied electric field [75, 77-79].  Thus, 
it may indicate that the effective membrane conductance results should correlate 
negatively with the cytoplasmic conductivity values. Therefore, it may suggest that 
the expected trend for geff values during the cycle has a rising pattern, i.e. cells in 
G0/G1-phase have the smallest value whereas cells in G2/M-phase show the largest 
value of geff through the cycle. Considering the obtained results, it can be seen that 
the prominent trend in geff values is a rising trend. This may show that there is some 
increased activity of ion channels and ion flux across the membrane under the 
influence of the applied electric field as cells go through their cycle. 
As a conclusion, the results show: 
1. A rising pattern for cell radii during the cycle 
2. A downward followed by an upward trend in σ𝐶𝑃 values during the cycle 
3. A falling followed by a rising pattern for ceff value during the cycle 
4. A rising pattern for geff values during the cycle  
Therefore, these results suggest that there is a correlation between the obtained 
electrophysiological properties values alongside the proposed trends at different 
phases of the cell cycle. However, properties of different phases did not map on to a 
single sequence of electrophysiological properties across the whole cell cycle. This 
possibly happened due to the weak time resolution (long time taken to perform each 
measurement), applying the serial design of the DEP-microwell electrode system. 
Also, the methods of arrest did not work properly despite the literature. 
5.5 CONCLUDING REMARKS 
This research chapter aimed to validate the obtained cell synchronisation results and 
further investigate the cellular characteristics of untreated and treated K562 
leukaemia cell line at different phases throughout the cell cycle, in vitro. This study 
determined the proportion of cells in each cell cycle phase using flow cytometry 
technique by quantitation of DNA content of cells. It found out that the treated K562 
leukaemia cell line arrested almost up to the level of acceptance at different phases 
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through the cell cycle for HU and APH treatment. But for the SS treatment it was not 
satisfactory enough to rely on properly. 
Moreover, based on the acquired results, the optimised parallel DEP-microwell kit 
successfully revealed electrophysiological properties variation in different phases 
through the cell cycle, in vitro in comparison to the serial design of the DEP-
microwells electrode system. The obtained results of the study indicated that K562 
cell line’s cellular electrophysiological properties (particularly the effective 
membrane capacitance, effective membrane conductance and the cytoplasmic 
conductivity) are distinct in different phases through the cell cycle. Furthermore, 
cytoplasmic conductivity, membrane capacitance and conductance correlated with 
the cell cycle phases through the cycle alongside the proposed trends at different 
phases of the cell cycle. However, properties of different phases did not map on to a 
single sequence of electrophysiological properties across the whole cell cycle. 
Since these dielectric differences in different phases are crucial from a practical point 
of view, this study showed that the parallel DEP-microwell electrode system can be 
adopted as an innovative, real time, portable, cost-effective and high throughput 
approach for cell detection and characterisation at particular stages of the cell cycle 
which could provide a better understanding of cellular mechanism through the cell 
cycle. 
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6 GENERAL DISCUSSION AND CONCLUSIONS 
This thesis explored the main theme in the study of two DEP-microwell electrode 
systems (the serial design and the parallel integrated system) optimisation and its 
application in cell cycle analysis. This micro-engineered technique was developed 
and patented at the University of Surrey and had been applied for the first time in this 
research to characterise the electrophysiological properties of cells in two cell cycle 
phases. 
The first aim of this research was to determine whether the optimised DEP-
microwell electrode system can be applied as a real time, fast, cost-effective, easy to 
use and label-free method to study electrophysiological properties of cells through 
their cell cycle. The second aim was to investigate whether the cellular 
electrophysiological properties (particularly the effective membrane capacitance, 
effective membrane conductance and the cytoplasmic conductivity) vary between 
different phases through the cell cycle, in vitro. Finally, it aimed to identify the 
relation between the intracellular DNA percentage in each phase and the acquired 
DEP data to find out the possible correlation between cell cycle phases and cellular 
electrophysiological properties. 
6.1 KEY FINDINGS 
6.1.1 Cellular electrophysiological properties of K562 cell line are distinct in different 
phases through the cell cycle and correlate with the cell cycle phases, in vitro 
In this research, the serial design and optimised parallel DEP-microwell electrode 
systems were used to reveal any electrophysiological properties variation in different 
phases through the cell cycle, in vitro. Hence, the dielectric spectra of control, serum 
starved, hydroxyurea and aphidicolin treated K562 cell line were obtained. Best-fit 
lines were applied to the spectra and the single-shell model was used to infer the 
cytoplasmic conductivity, geff and ceff for each treatment. 
The obtained results of the study indicated that K562 cell line’s cellular 
electrophysiological properties (particularly the effective membrane capacitance, 
effective membrane conductance and the cytoplasmic conductivity) are distinct in 
different phases through the cell cycle and correlate with the cell cycle phases, in 
vitro alongside the proposed trends at different phases of the cell cycle. However, 
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properties of different phases did not map on to a single sequence of 
electrophysiological properties across the whole cell cycle. 
6.1.2 The DEP-microwell electrode system has the potential to be used as an innovative 
approach for cell detection and characterisation at particular stages of the cell cycle 
In this research, the serial design and the optimised parallel DEP-microwell electrode 
systems were used to reveal any electrophysiological properties variation in different 
phases through the cell cycle, in vitro. The obtained results of the study indicated that 
K562 cell line’s cellular electrophysiological properties (particularly the effective 
membrane capacitance, effective membrane conductance and the cytoplasmic 
conductivity) are distinct in different phases through the cell cycle and correlate with 
the cell cycle phases alongside the proposed trends at different phases of the cell 
cycle. 
Since these dielectric differences in different phases are crucial from a practical point 
of view, this study highlights that the DEP-microwell electrode system can be 
adopted as an innovative, useful, informative, real time, portable, cost-effective and 
high throughput approach for cell detection and characterisation at particular stages 
of the cell cycle which could provide a better understanding of cellular mechanism 
through the cell cycle. 
6.2 RECOMMENDATIONS AND FUTURE DIRECTIONS 
Based on some limitations of this research, some future works could focus on the 
following ideas: 
 Due to time and resources limitations, the presented results were achieved for 
only 3 to 5 sets of experiments. In order to validate the consistency of the results, 
to get statistically reliable conclusions, and to conclusively determine whether 
there is a difference in the electrophysiological properties of the examined cells, 
further investigation by increasing the number of experiments could be done. 
 In order to achieve more complete results, other types of cancerous and non-
cancerous cell lines can be investigated. In addition, different types of 
synchronisation methods and anti-cancer drugs can be applied to investigate the 
cell cycle behaviour in other checkpoints throughout the cycle. 
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 To properly understand and conclusively determine the changes in the 
electrophysiological properties and to investigate the obtained results in more 
detail, work can be extended to look at ion-channel effects during the cell cycle 
and to assess the role of several intracellular signalling pathways contributing to 
cell cycle in K562 cell line (particularly the Ca-calmodulin dependent protein 
phosphatase 3 (PP3), PP1 and PP2A) by applying DEP technique. 
 As noted, the DEP buffer is a low conductivity medium in which cell samples 
were resuspended during DEP experiments. Since all cell electrophysiological 
properties are measured relative to their medium, it has an important effect on 
the results of the experiments. Therefore, further works can be done to modify 
the ionic composition of the DEP buffer with ionic composition close to the 
physiological solution.  
 It can be useful to employ scanning electron microscopy (SEM) to study the 
alterations in morphology of the plasma membrane before and after each 
treatment to achieve a better understanding of cells behaviour towards different 
synchronisation methods. 
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8 APPENDICIES 
8.1 APPENDIX A: GROWTH CURVE OF K562 CELL LINE 
 
Growth curve of K562 cells line suspended in RPMI-1640 growth medium supplemented with 10% 
(v/v) heat inactivated FBS and 2 mM L-glutamine over a period of five days. It was cultured at first at 
a density of 1×10
5
 cells ml
-1
 in suspension under standard cell culture conditions, i.e. in a humidified 
incubator (CO-150, New Brunswick Scientific, Edison, NJ, USA) with constant flow of 5% CO2 and 
95% humidified air at 37 °C. Data are mean values (of three tests) ± SD. 
It can be seen that after 24 hours of each counting, the cell population was almost doubled in number. 
However, for the last two readings, the increase in the cell number was just about 32.5%. This can be 
a sign of cell’s confluencey and starting their plateau stage. So, for this cell line, a population of 
1×10
6
 cells ml
-1 
was considered as 100% confluent. 
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8.2 APPENDIX B: HYDROXYUREA - PRODUCT SPECIFICATION 
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8.3 APPENDIX C: APHIDICOLIN - PRODUCT INFORMATION 
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8.4 APPENDIX D: STATISTICAL ANALYSIS RESULTS  
8.4.1 Changes in the cell radius (serial design of DEP) - Nonparametric test results 
 
 
8.4.2 Changes in the cytoplasmic conductivity (serial design of DEP) - Nonparametric 
test results 
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8.4.3 Changes in the effective membrane capacitance (serial design of DEP) - 
Nonparametric test results 
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8.4.4 Changes in the effective membrane conductance (serial design of DEP) - 
Nonparametric test results 
 
 
8.4.5 Changes in the cell radius (integrated design of DEP) - Nonparametric test results 
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8.4.6 Changes in the cytoplasmic conductivity (integrated design of DEP) - 
Nonparametric test results 
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8.4.7 Changes in the effective membrane capacitance (integrated design of DEP) - 
Nonparametric test results 
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8.4.8 Changes in the effective membrane conductance (integrated design of DEP) - 
Nonparametric test results 
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8.5 APPENDIX E: ALGORITHM FOR THE SIMULTANEOUS 
ANALYSIS OF THE ACQUIRED CELL RADIUS, DEP AND FCM 
DATA - MATLAB SCRIPT 
clear all 
A=[ R1 A1 B1 C1 
R2 A2 B2 C2 
R3 A3 B3 C3 
R4 A4 B4 C4 
R5 A5 B5 C5 
   ]; 
count=1; 
for i=1:3 
    for j=i+1:4 
        for k=j+1:5 
            a=A([i,j,k],:); 
            asolve=a(:,2:4); 
            b=a(:,1); 
            solution=asolve\b; 
            solutions(:,count)=asolve\b 
            count=count+1; 
        end 
       
    end  
   
end 
averagesolutions(1)=mean(solutions(1,:)); %C-G1 
averagesolutions(2)=mean(solutions(2,:)); %C-S 
averagesolutions(3)=mean(solutions(3,:)); %C-M 
averagesolutions'; 
 
In this MATLAB script, matrix A is the matrix of coefficients and constant values from the system of 
equations for the acquired cell radius, DEP and FCM data, such as: 
 
  Cell radius    G0/G1            S            G2/M 
Control  R1 =   (A1)r1 +   (B1)r2  +    (C1)r3 
0h  R2 =   (A2)r1 +   (B2)r2  +    (C2)r3 
2h  R3 =   (A3)r1 +   (B3)r2  +    (C3)r3 
4h  R4 =   (A4)r1 +   (B4)r2  +    (C4)r3 
24h  R5 =   (A5)r1 +   (B5)r2  +    (C5)r3 
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